FEED Validator

Congratulations!

This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

• line 46, column 0: style attribute contains potentially dangerous content: 0.0001pt (245 occurrences) [help]

  <li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">Acc ...
  

• line 70, column 0: content:encoded should not contain fetchpriority attribute [help]

  <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src=" ...
  

• line 70, column 0: content:encoded should not contain decoding attribute (20 occurrences) [help]

  <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src=" ...
  

• line 70, column 0: content:encoded should not contain data-mce-src attribute (19 occurrences) [help]

  <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src=" ...
  

• line 70, column 0: content:encoded should not contain data-mce-style attribute (3 occurrences) [help]

  <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src=" ...
  

• line 70, column 0: content:encoded should not contain data-state attribute (4 occurrences) [help]

  <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src=" ...
  

• line 414, column 0: content:encoded should not contain referrerpolicy attribute (10 occurrences) [help]

  <p><img alt="" src='https://ml.globenewswire.com/media/NTM5MjVlNTItYzFiZC00N ...
  

• line 900, column 0: content:encoded should not contain loading attribute (4 occurrences) [help]

  <p align="center"><b><b><img loading="lazy" decoding="async" data-mce-src="/ ...
  

• line 1263, column 0: content:encoded should not contain bis_size attribute (4 occurrences) [help]

  <p align="center"><img decoding="async" bis_size="{&quot;x&quot;:344,&quot;y ...
  

Source: https://indiachron.com/feed/

1. <?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
2. xmlns:content="http://purl.org/rss/1.0/modules/content/"
3. xmlns:wfw="http://wellformedweb.org/CommentAPI/"
4. xmlns:dc="http://purl.org/dc/elements/1.1/"
5. xmlns:atom="http://www.w3.org/2005/Atom"
6. xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
7. xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
8. >
9.  
10. <channel>
11. <title>The India Chron</title>
12. <atom:link href="https://indiachron.com/feed/" rel="self" type="application/rss+xml" />
13. <link>https://indiachron.com</link>
14. <description></description>
15. <lastBuildDate>Mon, 01 Sep 2025 17:00:00 +0000</lastBuildDate>
16. <language>en-US</language>
17. <sy:updatePeriod>
18. hourly </sy:updatePeriod>
19. <sy:updateFrequency>
20. 1 </sy:updateFrequency>
21. <generator>https://wordpress.org/?v=6.8.2</generator>
22.  
23. <image>
24. <url>https://indiachron.com/wp-content/uploads/2021/06/tic-icon-100x100.png</url>
25. <title>The India Chron</title>
26. <link>https://indiachron.com</link>
27. <width>32</width>
28. <height>32</height>
29. </image>
30. <item>
31. <title>Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy &#124; DelveInsight</title>
32. <link>https://indiachron.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight/424947/</link>
34. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
35. <pubDate>Mon, 01 Sep 2025 17:00:00 +0000</pubDate>
36. <category><![CDATA[Brand Post]]></category>
37. <guid isPermaLink="false">http://indiachron.com/bone-marrow-failure-market-growth-accelerates-with-advances-in-cell-and-gene-therapy-delveinsight</guid>
38.  
39. <description><![CDATA[The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand. New [&#8230;]]]></description>
40. <content:encoded><![CDATA[<p><em>The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand.</em></p>
41. <p align="justify">New York, USA, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; <b>Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy | DelveInsight</b></p>
42. <p align="justify"><b><i>The bone marrow failure market is witnessing steady growth driven by the increasing prevalence of aplastic anemia, myelodysplastic syndromes, and other related disorders. Advancements in stem cell transplantation, gene therapy, and immunosuppressive treatments are expanding therapeutic options and improving patient outcomes. Rising awareness, better diagnostic techniques, and supportive government initiatives are further fueling demand.</i></b></p>
43. <p align="justify">DelveInsight’s <b>Bone Marrow Failure Market Insights</b> report includes a comprehensive understanding of current treatment practices, emerging bone marrow failure drugs, market share of individual therapies, and current and forecasted bone marrow failure market size from 2020 to 2034, segmented into leading markets (the US, EU4, UK, and Japan).</p>
44. <p align="justify"><b>Bone Marrow Failure Market Summary</b></p>
45. <ul type="disc">
46. <li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">According to DelveInsight’s analysis, the total bone marrow failure treatment market size is expected to grow positively by 2034 in the leading markets (the US, EU4, UK, and Japan).</li>
47. </ul>
48. <ul type="disc">
49. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">The United States accounts for the largest market size of Bone Marrow Failure, in comparison to EU4 (Germany, Italy, France, and Spain) and the UK, and Japan.</li>
50. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Bone marrow failure incidence rate is <b>2 per million</b> in Europe, with higher rates in Asia, perhaps resulting from environmental factors.</li>
51. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Key bone marrow failure companies, including <b>Elixirgen Therapeutics, Cellenkos, </b>and others, are actively working on innovative bone marrow failure drugs. </li>
52. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Some of the key bone marrow failure therapies in clinical trials include <b>EXG34217, CK0801</b>, and others. These novel bone marrow failure therapies are anticipated to enter the bone marrow failure market in the forecast period and are expected to change the market.</li>
53. </ul>
54. <p align="justify">Discover which bone marrow failure medications are expected to grab the market share @ <b>Bone Marrow Failure Market Report</b></p>
55. <p align="justify"><b>Key Factors Driving the Growth of the Bone Marrow Failure Market </b></p>
56. <p align="justify"><b>Rising Prevalence and Incidence of Bone Marrow Failure Disorders</b></p>
57. <p align="justify">The increasing number of patients diagnosed with bone marrow failure syndromes is a primary growth driver. Aging populations, greater recognition of inherited bone marrow disorders, and higher survival rates of patients with prior cancer treatments are contributing to the expansion of the market. The 5-year survival rates were 90.7% in patients aged 0–18 years, 90.5% in patients aged 19–39 years, 70.7% in patients aged 40–59 years, and 38.1% in patients aged 60 years or older.</p>
58. <p align="justify"><b>Advancements in Treatment Modalities</b></p>
59. <p align="justify">Therapeutic innovation is reshaping the treatment landscape. The development of targeted therapies, gene therapy, hematopoietic stem cell transplantation (HSCT) techniques, and immunomodulatory drugs has improved survival outcomes. Novel agents addressing underlying molecular mechanisms are attracting investment and accelerating bone marrow failure market growth.</p>
60. <p align="justify"><b>Growing Stem Cell Transplantation Procedures</b></p>
61. <p align="justify">Stem cell transplantation remains the only curative option for many bone marrow failure conditions. Expanding transplantation infrastructure, wider donor registries, and improved conditioning regimens are enabling greater adoption. Emerging approaches, such as haploidentical transplantation and cord blood use, are broadening accessibility to a larger patient pool.</p>
62. <p align="justify"><b>Increased Research and Bone Marrow Failure Clinical Trials</b></p>
63. <p align="justify">The pipeline for bone marrow failure treatments is expanding, with ongoing clinical trials evaluating innovative agents, including complement inhibitors, TPO receptor agonists, and gene-editing technologies. Currently, the therapies in clinical trials for bone marrow failure include EXG34217 (Elixirgen Therapeutics), CK0801 (Cellenkos), and others.</p>
64. <p align="justify"><b>Rising Awareness and Early Diagnosis</b></p>
65. <p align="justify">Public health initiatives, patient advocacy groups, and physician education are leading to earlier recognition of symptoms such as unexplained anemia, infections, or bleeding. Early diagnosis facilitates timely interventions, thereby increasing demand for therapeutic options.</p>
66. <p align="justify"><b>Bone Marrow Failure Market Analysis</b></p>
67. <p align="justify">Currently, two FDA-approved therapies are available for bone marrow failure: <b>REVOLADE/PROMACTA</b> (Novartis) and <b>PIASKY </b>(Chugai Pharmaceutical/Roche).</p>
68. <p align="justify">REVOLADE, marketed globally under this name and as PROMACTA in the US, is an oral thrombopoietin receptor agonist indicated for thrombocytopenia and severe aplastic anemia (SAA), a form of bone marrow failure. It works by stimulating bone marrow activity to increase the production of blood cells, particularly platelets. Eltrombopag is approved for patients with SAA who do not respond to immunosuppressive therapy and can also be used in combination with antithymocyte globulin (ATG) and cyclosporine as part of select first-line regimens. In November 2018, the FDA expanded the indication for PROMACTA to include first-line treatment in combination with standard immunosuppressive therapy (IST) for adults and children aged 2 years and older with SAA. REVOLADE has also received Breakthrough Therapy Designation (BTD) for the management of radiation-induced thrombocytopenia.</p>
69. <p align="justify">PIASKY (crovalimab) is a humanized monoclonal antibody that inhibits complement protein C5. By blocking its cleavage into C5a and C5b, it prevents formation of the membrane attack complex (MAC), thereby reducing intravascular hemolysis and improving symptoms in paroxysmal nocturnal hemoglobinuria (PNH). In August 2024, Roche announced European Commission approval for PIASKY as a treatment for adults and adolescents (≥12 years, ≥40 kg) with PNH, including both treatment-naïve patients and those previously treated with C5 inhibitors.</p>
70. <p align="justify"><img fetchpriority="high" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=39f7e780-4bbb-4958-99bd-69e7355d63c6&amp;size=0" data-mce-style="display: block; margin-left: auto; margin-right: auto;" data-state="draft" height="420" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/39f7e780-4bbb-4958-99bd-69e7355d63c6/bone-marrow-failure-market.jpg" style="display:block; margin-left:auto; margin-right:auto;" title="Bone-Marrow-Failure-Market.jpg" width="800" /></p>
71. <p align="justify">Learn more about the bone marrow failure treatment options @ <b>Bone Marrow Failure Treatment Guidelines</b></p>
72. <p align="justify"><b>Bone Marrow Failure Competitive Landscape</b></p>
73. <p align="justify">The emerging therapies in clinical trials for bone marrow failure include <b>EXG34217 </b>by Elixirgen Therapeutics and <b>CK0801 </b>by Cellenkos.</p>
74. <p align="justify"><b>EXG-34217</b> is an experimental autologous gene therapy being developed by Elixirgen Therapeutics for bone marrow failure linked to telomere biology disorders (TBDs), including dyskeratosis congenita. The treatment involves modifying a patient’s own CD34⁺ hematopoietic stem cells to express ZSCAN4, a protein that facilitates telomere extension through a telomerase-independent mechanism. By lengthening critically short telomeres, the therapy seeks to restore effective blood cell production in patients with marrow failure.</p>
75. <p align="justify">In February 2025, Elixirgen Therapeutics announced that the FDA had granted <b>Regenerative Medicine Advanced Therapy (RMAT) designation</b> to EXG-34217 for the treatment of TBDs. Around the same time, the therapy also received Orphan Drug Designation. EXG-34217 is currently under evaluation in an ongoing Phase I/II clinical trial (NCT04211714) enrolling patients aged 12 years and older, across all genders and ethnicities, with TBD-related bone marrow failure.</p>
76. <p align="justify"><b>CK0801</b>, developed by <b>Cellenkos</b>, is a first-in-class, off-the-shelf regulatory T-cell (Treg) therapy derived from cord blood. It is designed to address bone marrow failure syndromes, including aplastic anemia, by targeting the inflamed marrow microenvironment. The therapy functions by suppressing overactive cytotoxic T cells, thereby reducing inflammation and potentially reversing hematopoietic suppression.</p>
77. <p align="justify">In June 2019, Cellenkos initiated a Phase I clinical trial of CK0801 in patients with bone marrow failure syndromes such as aplastic anemia, hypoplastic myelodysplasia, and primary myelofibrosis. By delivering functional Tregs, CK0801 aims to re-establish immune balance in the bone marrow and restore normal hematopoiesis.</p>
78. <p align="justify">The anticipated launch of these emerging bone marrow failure therapies are poised to transform the bone marrow failure market landscape in the coming years. As these cutting-edge bone marrow failure therapies continue to mature and gain regulatory approval, they are expected to reshape the bone marrow failure market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth.</p>
79. <p align="justify">To know more about new treatment for bone marrow failure, visit @ <b>Bone Marrow Failure Management </b></p>
80. <p align="justify"><b>Recent Developments in the Bone Marrow Failure Market</b></p>
81. <ul type="disc">
82. <li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">In <b>February 2025, Elixirgen Therapeutics</b> announced that the FDA had granted Regenerative Medicine Advanced Therapy (RMAT) designation to EXG-34217, its gene therapy candidate for Telomere Biology Disorders (TBDs).</li>
83. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">In <b>February 2025, Elixirgen Therapeutics</b> announced that the FDA had granted Orphan Drug Designation to EXG-34217, its gene therapy candidate for the treatment of Telomere Biology Disorders (TBDs).</li>
84. </ul>
85. <p align="justify"><b>Bone Marrow Failure Overview</b></p>
86. <p align="justify">Bone marrow failure is a serious condition in which the bone marrow—the soft, spongy tissue inside bones that produces blood cells—fails to generate sufficient numbers of red blood cells, white blood cells, or platelets. This deficiency can cause fatigue, recurrent infections, and excessive bleeding. The disorder may arise from inherited syndromes, such as Fanconi anemia or dyskeratosis congenita, or from acquired conditions like aplastic anemia or myelodysplastic syndromes, as well as exposure to toxins, radiation, autoimmune reactions, or certain infections.</p>
87. <p align="justify">Bone marrow failure is generally categorized as either acquired or inherited. Acquired forms usually develop later in life and are not present at birth. Although the exact causes remain unclear, they are often associated with chemical exposures, medications, or underlying diseases. Inherited forms, on the other hand, result from genetic mutations passed from one or both parents.</p>
88. <p align="justify"><b>Bone Marrow Failure Epidemiology Segmentation</b></p>
89. <p align="justify">The bone marrow failure epidemiology section provides insights into the historical and current bone marrow failure patient pool and forecasted trends for the leading markets (the US, EU4, UK, and Japan). It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders.</p>
90. <p align="justify">The <b>bone marrow failure market report</b> proffers epidemiological analysis for the study period 2020–2034 in the leading markets (the US, EU4, UK, and Japan) segmented into:</p>
91. <ul type="disc">
92. <li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;">Total Incidence Cases of Bone Marrow Failure</li>
93. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Total inherited subtypes-specific Incident Cases of Bone Marrow Failure</li>
94. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Age-specific Incident Cases of Bone Marrow Failure</li>
95. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;">Etiology-specific Incident Cases of Bone Marrow Failure </li>
96. </ul>
97. <p align="justify">Download the report to understand which factors are driving bone marrow failure epidemiology trends @ <b>Bone Marrow Failure Treatment Algorithm</b></p>
98. <table style="border-collapse: collapse; border-collapse:collapse ;">
99. <tr>
100. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; "><b>Bone Marrow Failure Market Report Metrics</b></td>
101. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; "><b>Details</b></td>
102. </tr>
103. <tr>
104. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Study Period</td>
105. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">2020–2034</td>
106. </tr>
107. <tr>
108. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Bone Marrow Failure Market Report Coverage</td>
109. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]</td>
110. </tr>
111. <tr>
112. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Key Bone Marrow Failure Companies</td>
113. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Elixirgen Therapeutics, Cellenkos, Novartis, Chugai Pharmaceutical, Roche, and others</td>
114. </tr>
115. <tr>
116. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">Key Bone Marrow Failure Therapies</td>
117. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: top ; ">EXG34217, CK0801, REVOLADE/PROMACTA, PIASKY, and others</td>
118. </tr>
119. </table>
120. <p align="justify"><b>Scope of the </b><b>Bone Marrow Failure</b><b> Market Report</b></p>
121. <ul type="disc">
122. <li style="margin-top:12pt; margin-bottom:0.0001pt; text-align:justify;"><b>Bone Marrow Failure Therapeutic Assessment: </b>Bone Marrow Failure current marketed and emerging therapies</li>
123. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;"><b>Bone Marrow Failure</b> <b>Market Dynamics:</b> Conjoint Analysis of Emerging Bone Marrow Failure Drugs</li>
124. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;"><b>Competitive Intelligence Analysis:</b> SWOT analysis and Market entry strategies</li>
125. <li style="margin-top:0in; margin-bottom:0.0001pt; text-align:justify;"><b>Bone Marrow Failure Market Unmet Needs, KOL’s views, Analyst’s views, Bone Marrow Failure Market Access and Reimbursement</b></li>
126. </ul>
127. <p align="justify">Discover more about bone marrow failure drugs in development @ <b>Bone Marrow Failure Clinical Trials</b></p>
128. <p align="justify"><b>Table of Contents</b></p>
129. <table style="border-collapse: collapse; border-collapse:collapse ;">
130. <tr>
131. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">1</td>
132. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Key Insights</td>
133. </tr>
134. <tr>
135. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">2</td>
136. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Report Introduction</td>
137. </tr>
138. <tr>
139. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">3</td>
140. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Executive Summary</td>
141. </tr>
142. <tr>
143. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">4</td>
144. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Events</td>
145. </tr>
146. <tr>
147. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">5</td>
148. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Epidemiology and Market Forecast Methodology of Bone Marrow Failure</td>
149. </tr>
150. <tr>
151. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6</td>
152. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Overview at a Glance</td>
153. </tr>
154. <tr>
155. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6.1</td>
156. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Share (%) Distribution of Bone Marrow Failure by Therapies in 2024</td>
157. </tr>
158. <tr>
159. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">6.2</td>
160. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Share (%) Distribution of Bone Marrow Failure by Therapies in 2034</td>
161. </tr>
162. <tr>
163. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7</td>
164. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Disease Background and Overview</td>
165. </tr>
166. <tr>
167. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.1</td>
168. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Introduction</td>
169. </tr>
170. <tr>
171. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.2</td>
172. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Signs and Symptoms </td>
173. </tr>
174. <tr>
175. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.3</td>
176. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Causes</td>
177. </tr>
178. <tr>
179. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">7.4</td>
180. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Diagnosis</td>
181. </tr>
182. <tr>
183. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">8</td>
184. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Treatment</td>
185. </tr>
186. <tr>
187. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9</td>
188. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Epidemiology and Patient Population </td>
189. </tr>
190. <tr>
191. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.1</td>
192. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Findings</td>
193. </tr>
194. <tr>
195. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.2</td>
196. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Assumptions and Rationale</td>
197. </tr>
198. <tr>
199. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.3</td>
200. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Incident Cases of Bone Marrow Failure in the 7MM</td>
201. </tr>
202. <tr>
203. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4</td>
204. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">The United States</td>
205. </tr>
206. <tr>
207. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.1</td>
208. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Total Incidence Cases of Bone Marrow Failure in the United States</td>
209. </tr>
210. <tr>
211. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.2</td>
212. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Total Inherited Subtypes-specific Incident Cases of Bone Marrow Failure in the United States</td>
213. </tr>
214. <tr>
215. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.3</td>
216. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Age-specific Incident Cases of Bone Marrow Failure in the United States</td>
217. </tr>
218. <tr>
219. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.4.4</td>
220. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; vertical-align: bottom ; ">Etiology-specific Incident Cases of Bone Marrow Failure in the United States</td>
221. </tr>
222. <tr>
223. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.5</td>
224. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EU4 and the UK</td>
225. </tr>
226. <tr>
227. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">9.6</td>
228. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Japan</td>
229. </tr>
230. <tr>
231. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">10</td>
232. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Patient Journey of Bone Marrow Failure</td>
233. </tr>
234. <tr>
235. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11</td>
236. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Marketed Bone Marrow Failure Therapies</td>
237. </tr>
238. <tr>
239. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.1</td>
240. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Competitors</td>
241. </tr>
242. <tr>
243. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2</td>
244. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">REVOLADE/PROMACTA (eltrombopag): Novartis</td>
245. </tr>
246. <tr>
247. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.1</td>
248. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Product Description</td>
249. </tr>
250. <tr>
251. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.2</td>
252. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Regulatory Milestone</td>
253. </tr>
254. <tr>
255. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.3</td>
256. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Other Development Activities</td>
257. </tr>
258. <tr>
259. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.4</td>
260. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Safety and Efficacy</td>
261. </tr>
262. <tr>
263. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.5</td>
264. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Development</td>
265. </tr>
266. <tr>
267. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.5.1</td>
268. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Trials Information</td>
269. </tr>
270. <tr>
271. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.2.6</td>
272. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Analyst Views</td>
273. </tr>
274. <tr>
275. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">11.3</td>
276. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">PIASKY (crovalimab): Chugai Pharmaceutical/Roche</td>
277. </tr>
278. <tr>
279. <td colspan="2" style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; "><i>List to be continued in the report…</i></td>
280. </tr>
281. <tr>
282. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12</td>
283. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Emerging Bone Marrow Failure Therapies</td>
284. </tr>
285. <tr>
286. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.1</td>
287. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Competitors</td>
288. </tr>
289. <tr>
290. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2</td>
291. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EXG34217: Elixirgen Therapeutics</td>
292. </tr>
293. <tr>
294. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.1</td>
295. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Product Description</td>
296. </tr>
297. <tr>
298. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.2</td>
299. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Other Development Activities</td>
300. </tr>
301. <tr>
302. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.3</td>
303. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Development</td>
304. </tr>
305. <tr>
306. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.3.1</td>
307. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Clinical Trials Information</td>
308. </tr>
309. <tr>
310. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.4</td>
311. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Safety and Efficacy</td>
312. </tr>
313. <tr>
314. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">12.2.5</td>
315. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Analyst Views</td>
316. </tr>
317. <tr>
318. <td colspan="2" style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; "><i>List to be continued in the report…</i></td>
319. </tr>
320. <tr>
321. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13</td>
322. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market: Seven Major Market Analysis</td>
323. </tr>
324. <tr>
325. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.1</td>
326. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Findings</td>
327. </tr>
328. <tr>
329. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.2</td>
330. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Outlook</td>
331. </tr>
332. <tr>
333. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.3</td>
334. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Conjoint Analysis</td>
335. </tr>
336. <tr>
337. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.4</td>
338. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Key Bone Marrow Failure Market Forecast Assumptions</td>
339. </tr>
340. <tr>
341. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.5</td>
342. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Bone Marrow Failure Market Size in the 7MM</td>
343. </tr>
344. <tr>
345. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.6</td>
346. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Size by Therapies in the 7MM</td>
347. </tr>
348. <tr>
349. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7</td>
350. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">The United States Bone Marrow Failure Market Size</td>
351. </tr>
352. <tr>
353. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7.1</td>
354. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Total Market Size of Bone Marrow Failure in the United States</td>
355. </tr>
356. <tr>
357. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.7.2</td>
358. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Market Size of Bone Marrow Failure by Therapies in the United States</td>
359. </tr>
360. <tr>
361. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.8</td>
362. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">EU4 and the UK Bone Marrow Failure Market Size</td>
363. </tr>
364. <tr>
365. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">13.9</td>
366. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Japan Bone Marrow Failure Market Size</td>
367. </tr>
368. <tr>
369. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">14</td>
370. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Unmet Needs of Bone Marrow Failure</td>
371. </tr>
372. <tr>
373. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">15</td>
374. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">SWOT Analysis of Bone Marrow Failure</td>
375. </tr>
376. <tr>
377. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">16</td>
378. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">KOL Views of Bone Marrow Failure</td>
379. </tr>
380. <tr>
381. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">17</td>
382. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bone Marrow Failure Market Access and Reimbursement</td>
383. </tr>
384. <tr>
385. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">18</td>
386. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Bibliography</td>
387. </tr>
388. <tr>
389. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: justify ; vertical-align: middle; ">19</td>
390. <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: justify ; vertical-align: middle; ">Report Methodology</td>
391. </tr>
392. </table>
393. <p align="justify"><b>Related Reports</b></p>
394. <p align="justify"><b>Acute Lymphocytic Leukemia Market</b></p>
395. <p align="justify"><b>Acute Lymphocytic Leukemia Market Insights, Epidemiology, and Market Forecast – 2034 </b>report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key acute lymphocytic leukemia companies, including <b>AbbVie, Roche (Genentech), Janssen Research &amp; Development, Pharmacyclics (an AbbVie Company), Incyte Corporation, Novartis, Jazz Pharmaceuticals, Autolus Therapeutics, Syndax Pharmaceuticals, Cellectis, ADC Therapeutics, Wugen, Servier, Allogene, Amgen, Astellas Pharma, Gilead Sciences, Syndax, Incyte, Orca Biosystems</b><b>,</b> among others.</p>
396. <p align="justify"><b>Follicular Lymphoma Market</b></p>
397. <p align="justify"><b>Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2034 </b>report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key follicular lymphoma Market companies, including <b>Merck Sharp and Dohme, AstraZeneca, CRISPR Therapeutics, BeiGene, Nektar Therapeutics, NovalGen, Carna Biosciences, Allogene Therapeutics, Xynomic Pharmaceuticals, Bristol-Myers Squibb, Incyte Corporation,</b> among others.</p>
398. <p align="justify"><b>Multiple Myeloma Market</b></p>
399. <p align="justify"><b>Multiple Myeloma Market Insights, Epidemiology, and Market Forecast – 2034 </b>report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key multiple myeloma companies, including <b>Sanofi, Karyopharm Therapeutics, AbbVie, Takeda Pharmaceutical, Celgene, Bristol-Myers Squibb, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Celgene, Aduro Biotech, ExCellThera, Janssen Pharmaceutical, Precision BioSciences, Takeda, Glenmark (Ichnos Sciences SA), Poseida Therapeutics, Molecular Partners AG, Chipscreen Biosciences, AbbVie, Genentech (Roche), Janssen Biotech, Nanjing Legend Biotech, Merck Sharp &amp; Dohme Corp.,</b> among others.</p>
400. <p align="justify"><b>Myelodysplastic Syndrome Market </b></p>
401. <p align="justify"><b>Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast – 2034 </b>report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key MDS companies, including <b>Bristol-Myers Squibb, Astex Pharmaceutical, Taiho Oncology, Fibrogen, AbbVie, Gilead Sciences, Novartis, Syros Pharmaceuticals, Takeda, Pfizer, Geron Corporation, Karyopharm Therapeutics, Antengene Corporation, BerGenBio ASA, Jazz Pharmaceuticals, Aprea Therapeutics, Sanofi, Medac,</b> among others.</p>
402. <p align="justify"><b>Myeloproliferative Neoplasms Market</b></p>
403. <p align="justify"><b>Myeloproliferative Neoplasms Market Insights, Epidemiology, and Market Forecast – 2034 </b>report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key myeloproliferative neoplasms companies, including <b>Incyte Corporation, Galena Biopharma Inc., Chengdu Zenitar Biomedical Technology Co., Ltd, Eli Lilly and Company, AbbVie, Vion Pharmaceuticals,</b> among others.</p>
404. <p align="justify"><b>DelveInsight’s</b><b> Pharma Competitive Intelligence Service</b><b>: </b>Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.</p>
405. <p align="justify"><b>Other Business Pharmaceutical Consulting Services</b></p>
406. <p align="justify"><b>Healthcare Conference Coverage</b></p>
407. <p align="justify"><b>Pipeline Assessment</b></p>
408. <p align="justify"><b>Healthcare Licensing Services</b></p>
409. <p align="justify">Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our <b>Due Diligence Case Study</b></p>
410. <p align="justify"><b>About DelveInsight</b></p>
411. <p align="justify">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve<b>.</b></p>
412. <p align="justify"><b>Connect with us on</b> <b>LinkedIn</b><b>|</b><b>Facebook</b><b>|</b><b>Twitter</b></p>
413. <pre>CONTACT: Contact Us Shruti Thakur  info@delveinsight.com  +14699457679  www.delveinsight.com</pre>
414. <p><img alt="" src='https://ml.globenewswire.com/media/NTM5MjVlNTItYzFiZC00NGE3LWEwNDgtNWQyYjIwODQ4MGMzLTEyMDQ5MzgtMjAyNS0wOS0wMS1lbg==/tiny/DelveInsight-Business-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
415. ]]></content:encoded>
419. </item>
420. <item>
421. <title>Purva Mantri Takes PM Modi&#8217;s &#8216;Aavati Kalay&#8217; on USA Tour, to Showcase Cultural Heritage</title>
422. <link>https://indiachron.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage/424948/</link>
424. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
425. <pubDate>Mon, 01 Sep 2025 16:49:00 +0000</pubDate>
426. <category><![CDATA[Brand Post]]></category>
427. <guid isPermaLink="false">http://indiachron.com/purva-mantri-takes-pm-modis-aavati-kalay-on-usa-tour-to-showcase-cultural-heritage</guid>
428.  
429. <description><![CDATA[MUMBAI, India, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; Popular Bollywood folk-pop artist Purva Mantri is set to take Aavati Kalay, the celebrated Garba song penned by PM Narendra Modi and sung by Purva to her upcoming US Dandiya Purvastic Tour. PM Modi dedicated the garba to Goddess Durga during Navratri 2024 also marking his 25th [&#8230;]]]></description>
430. <content:encoded><![CDATA[<p><img decoding="async" alt="Purva Mantri's USA Tour: A Celebration of Indian Culture with PM Modi's 'Aavati Kalay'" height="600" name="GNW_RichHtml_External_IMG" src="https://ml.globenewswire.com/Resource/Download/e418cc4d-00d3-4c88-a41a-c431e4715b5a/ae3ee3.png" width="490" /></p>
431. <p>MUMBAI, India, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; Popular Bollywood folk-pop artist Purva Mantri is set to take Aavati Kalay, the celebrated Garba song penned by PM Narendra Modi and sung by Purva to her upcoming US Dandiya Purvastic Tour. PM Modi dedicated the garba to Goddess Durga during Navratri 2024 also marking his 25th Year being in public domain as CM of Gujarat first and then PM of India. The tour begins August 28 which also coincides with the Ganpati festival.</p>
432. <p>Purva has been personally acknowledged and chosen by the PM after he came across her work and was impressed by her voice and aura. The garba song will now be a centre piece of her US performances, giving international audiences a glimpse of India’s literary and musical heritage.</p>
433. <p>Purva has earned lot of appreciation and named as “Voice of Festivities” specially in Gujarat for her ultra- high energy performances and powerful singing. Her attempt to connect today’s youth with Divine and countryside music is genuine and lauded. She has been constantly releasing songs encompassed in an EP called 4th Generation to mark her being the 4th generation from her family to be in Divine Music. Her Puneri Dhol performance is unique and has been globally viral.</p>
434. <p>The tour kicks off in Chicago on August 28, followed by Atlantic City on August 30, Seattle on August 31, and Los Angeles, the entertainment capital of the world, on September 6.</p>
435. <p>Alongside the performance of Aavati Kalay, Purva will bring vibrant Garba traditions to the fore, blending Gujarati folk rhythms with contemporary street-inspired sounds. Each stop on the tour will feature dandiya night specials and family-friendly festivities, reimagining India’s countryside music culture for a global stage.</p>
436. <p>Speaking about the upcoming tour, Purva said, “I feel privileged to carry Prime Minister Modi’s garba song Aavati Kalay to international audiences. It is an honour to share India’s folk-pop and street sounds with people from diverse cultures and celebrate the richness of our traditions.”</p>
437. <p>Following her US performances, Purva will return to India for a marquee Garba event in Ahmedabad and Surat during Navratri.</p>
438. <p>The Dandiya Purvastic Tour not only celebrates Aavati Kalay but also highlights Purva’s mission to connect Global Youth with Indian Divinity through her musical performances.</p>
439. <p>Website &#8211; <u>https://www.instagram.com/purvamantrisinger?igsh=dmVya3ltaXVsdWJt</u></p>
440. <p>Contact Person Name &#8211; Sankalp</p>
441. <p>Email id &#8211; <u>admin@purvamantri.com</u></p>
442. <p><strong><em>Disclaimer:</em></strong><em> </em><em>This content is provided by the sponsor. The statements, views, and opinions expressed are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented in this article. The content is intended for informational and cultural purposes only and should not be considered as financial, investment, or business advice. Readers are encouraged to independently verify any details of events, tours, or performances mentioned herein. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or consequences arising from reliance on the information provided in this press release. Globenewswire does not endorse any content on this page.</em></p>
443. <p><strong>Legal Disclaimer:</strong> This media platform provides the content of this article on an &#8220;as-is&#8221; basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.</p>
444. <p>A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e418cc4d-00d3-4c88-a41a-c431e4715b5a</p>
445. <p><img alt="" src='https://ml.globenewswire.com/media/MGFlZThiZWItMjViZi00MjcwLTkzNTUtMDE2MDIwY2QyNmY5LTUwMDE1MTI0OC0yMDI1LTA5LTAxLWVu/tiny/Singer-Purva-Mantri.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
446. ]]></content:encoded>
450. </item>
451. <item>
452. <title>Smart Healthcare Market Size Set to Cross USD 1,497.89 Billion by 2034: How AI, Telemedicine, and Wearables Are Redefining Patient Care</title>
453. <link>https://indiachron.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care/424949/</link>
455. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
456. <pubDate>Mon, 01 Sep 2025 15:06:00 +0000</pubDate>
457. <category><![CDATA[Brand Post]]></category>
458. <guid isPermaLink="false">http://indiachron.com/smart-healthcare-market-size-set-to-cross-usd-1497-89-billion-by-2034-how-ai-telemedicine-and-wearables-are-redefining-patient-care</guid>
459.  
460. <description><![CDATA[According to Precedence Research, the global smart healthcare market size will grow from USD 360.02 billion in 2025 to nearly USD 1,497.89 billion by 2034, with an expected CAGR of 17.18% from 2025 to 2034. The growing prevalence of chronic disease, the focus on enhancing patient care, and technological advancements drive the market growth. Ottawa, [&#8230;]]]></description>
461. <content:encoded><![CDATA[<p><em>According to Precedence Research, the global smart healthcare market size will grow from USD 360.02 billion in 2025 to nearly USD 1,497.89 billion by 2034, with an expected CAGR of 17.18% from 2025 to 2034. The growing prevalence of chronic disease, the focus on enhancing patient care, and technological advancements drive the market growth.</em></p>
462. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The <strong>global smart healthcare market size</strong> accounted for USD 418.59 billion in 2026 and is estimated to cross over USD 1,497.89 billion by 2034, forecasted to advance at a double-digit CAGR of 17.18% between 2025 and 2034. Market growth is fueled by the rising prevalence of chronic diseases, increasing adoption of telemedicine and mHealth solutions, and rapid advancements in AI, IoT, and wearable devices.</p>
463. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=17d39881-5020-4913-b0b0-9dfe533162f7&amp;size=3" height="375.06px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/17d39881-5020-4913-b0b0-9dfe533162f7/image1.png" width="666.77px" /></p>
464. <p><strong>The Full Study is Readily Available | Download the Sample Pages of this Report@ </strong><strong>https://www.precedenceresearch.com/sample/1173</strong></p>
465. <p><strong>Smart Healthcare Market Overview</strong></p>
466. <p><strong>How is Smart Healthcare Market Growing?</strong></p>
467. <p>Smart healthcare is a platform for the healthcare system that uses technologies like big data, <strong>machine learning</strong>, <strong>Internet of Things</strong>, <strong>artificial intelligence</strong>, and many more to enhance patient care. Smart healthcare focuses on creating personalised, interconnected, and intelligent healthcare infrastructure. It optimizes resource allocation, enhances patient care, and streamlines various operations.</p>
468. <p>It uses technologies to connect doctors, healthcare providers, patients, and hospitals. Smart healthcare collects data through sources like <strong>electronic health records</strong>, wearables, and sensors to understand healthcare system performance, patient health, and diseases. Smart healthcare includes remote patient monitoring, smart medication management, wearable devices, AI-powered diagnostics, and smart home healthcare.</p>
469. <p><strong>Smart Healthcare Market Highlights:</strong></p>
470. <ul type="disc">
471. <li style="margin-bottom:8pt;">In terms of revenue, the smart healthcare market is expected to reach USD 360.02 billion in 2025.</li>
472. <li style="margin-bottom:8pt;">It is forecasted to hit an estimated USD 1,497.89 billion by 2034, driven by digital health innovations and rising chronic disease burden.</li>
473. <li style="margin-bottom:8pt;">North America held a market share of 17.18% in 2024.</li>
474. <li style="margin-bottom:8pt;">Asia Pacific region is estimated to expand the fastest CAGR of 24.68% between 2025 and 2034.</li>
475. <li style="margin-bottom:8pt;">By product, the telemedicine segment registered a maximum market share of 42.42% in 2024.</li>
476. </ul>
477. <p><b>Case Study: Remote Patient Monitoring in Action – A Transformational Shift in Diabetes Care</b></p>
478. <p><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=0d3d110f-35bd-4bb8-9f85-034802bffcfb&amp;size=0" data-mce-style="display: block; margin-left: auto; margin-right: auto;" data-state="draft" height="678" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/0d3d110f-35bd-4bb8-9f85-034802bffcfb/chatgpt-image-sep-1-2025-08-28-56-pm.png" style="display:block; margin-left:auto; margin-right:auto;" title="ChatGPT Image Sep 1, 2025, 08_28_56 PM.png" width="452" /></p>
479. <p>One of the most impactful examples of smart healthcare adoption comes from the integration of <strong>remote patient monitoring (RPM) platforms for diabetes management</strong>. In India, where nearly <strong>101 million people live with diabetes</strong>, healthcare providers have increasingly turned to RPM solutions to reduce hospital visits and improve daily care.</p>
480. <p>Patients using connected <strong>glucometers, wearable patches, and mobile health apps</strong> are able to track their blood sugar levels in real time. These data points are automatically transmitted to cloud-based platforms, where AI algorithms analyze fluctuations and alert both patients and physicians of any critical deviations.</p>
481. <p>A 2024 pilot program run jointly by a leading hospital group in Bengaluru and a digital health startup demonstrated significant outcomes:</p>
482. <ul>
483. <li> <strong>30% reduction in hospital admissions</strong> linked to diabetic complications. </li>
484. <li> Improved medication adherence, as patients received <strong>personalized reminders via smartphone apps</strong>. </li>
485. <li> Enhanced doctor-patient communication, with physicians able to review health dashboards remotely and adjust treatment plans accordingly. </li>
486. </ul>
487. <p>This case underscores the <strong>core growth drivers</strong> of the smart healthcare market — an aging population, rising prevalence of chronic conditions, and demand for <strong>cost-efficient, real-time care delivery</strong>. By leveraging connected devices, big data, and AI-driven insights, healthcare systems are moving closer to <strong>personalized, proactive, and preventive healthcare</strong>.</p>
488. <p><strong> <em>Stay ahead of healthcare innovation. Explore Precedence Research subscriptions for continuous access to healthcare and technology market intelligence. Browse Plans Here.</em> </strong></p>
489. <p><strong>What are the Growth Factors for the Smart Healthcare Market? </strong></p>
490. <ul type="disc">
491. <li style="margin-bottom:8pt;">The growing prevalence of chronic diseases like cancer, cardiovascular conditions, and diabetes requires continuous monitoring.</li>
492. <li style="margin-bottom:8pt;">The increasing adoption of telehealth apps, wearable devices, and smartphone apps.</li>
493. <li style="margin-bottom:8pt;">The strong government support for the digitalization of the healthcare industry.</li>
494. <li style="margin-bottom:8pt;">The rising demand for personalized medicine and remote patient monitoring.</li>
495. <li style="margin-bottom:8pt;">The ongoing advancements in medical devices.</li>
496. </ul>
497. <p><strong>Top Smart Healthcare Applications in India:</strong></p>
498. <table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;">
499. <tr>
500. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; "><strong>Apps</strong></td>
501. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; "><strong>Features</strong></td>
502. </tr>
503. <tr>
504. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Tata 1 mg</td>
505. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
506. <ol style="list-style-type:decimal;">
507. <li>Discounts and Savings on Medical Bills</li>
508. <li>Online Doctor Consultations from Specialists</li>
509. <li>2000 Types of Lab Tests</li>
510. <li>Health Check-Ups</li>
511. <li>Medicines and Personal Hygiene Products Available</li>
512. </ol>
513. </td>
514. </tr>
515. <tr>
516. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Practo</td>
517. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
518. <ol style="list-style-type:decimal;">
519. <li>Provides Reminders</li>
520. <li>Various Healthcare Services</li>
521. <li>Online Appointment Booking</li>
522. <li>Pharmacy Delivery</li>
523. <li>Coupons for Medical Tests and Blood Tests</li>
524. </ol>
525. </td>
526. </tr>
527. <tr>
528. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">MFine</td>
529. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
530. <ol style="list-style-type:decimal;">
531. <li>Online Treatment, Diagnosis, and Consultations</li>
532. <li>Chat, Video, and Audio Consultation</li>
533. <li>Offers a Various Range of Medical Specialities</li>
534. </ol>
535. </td>
536. </tr>
537. <tr>
538. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Netmeds</td>
539. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
540. <ol style="list-style-type:decimal;">
541. <li>Provides Wellness Products, Medical Devices, OTC Medications, and Personal Care Items</li>
542. <li>Offers Cashback Deals, Discounts, and Promotional Offers</li>
543. </ol>
544. </td>
545. </tr>
546. <tr>
547. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">PharmEasy</td>
548. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">
549. <ol style="list-style-type:decimal;">
550. <li>Teleconsultation</li>
551. <li>Medicine Deliveries</li>
552. <li>Sample Collections and Home Tests</li>
553. </ol>
554. </td>
555. </tr>
556. </table>
557. <p><strong><br />Smart Healthcare Market Opportunity</strong></p>
558. <p><strong>What is an Opportunity for the Smart Healthcare Market?</strong></p>
559. <p><strong>Growing Demand for Remote Patient Monitoring</strong></p>
560. <p>The growing prevalence of chronic diseases like hypertension, diabetes, &amp; heart disease, and an aging population, increases the demand for remote patient care (RPM). It offers early detection of any potential issues and prevents further complications. It offers customized treatment plans and optimizes patient care. The growing patient demand for making informed decisions and accurate information to monitor health requires RPM. The increasing demand for virtual monitoring and consultations in remote areas increases the adoption of the RPM.</p>
561. <p>The increasing focus on reducing healthcare costs by healthcare systems and patients increases demand for RPM. The growing advancements, like implantable devices and wearable devices, lead to higher demand for RPM. The growing focus on expanding healthcare in rural communities fuels the adoption of RPM. The growing demand for remote patient monitoring creates the opportunity for the smart healthcare market.   </p>
562. <p><strong>Limitations and Challenges in the Smart Healthcare Market</strong></p>
563. <p><strong>What is the Limitation of the Smart Healthcare Market?</strong></p>
564. <p><strong>High Initial Investment Limits the Adoption of Smart Healthcare</strong></p>
565. <p>Despite several benefits of smart healthcare in patient care, the high initial investment restricts the market growth. Factors like infrastructure upgrade, customization, stringent security measures, and high technology cost are responsible for the high initial investment. The development of diagnostic tools, medical devices, and sensors is expensive. The IT infrastructure, like powerful computing resources, high-speed networks, and secure data storage, requires a high initial investment.</p>
566. <p>The development of software for telemedicine, AI-powered analytics, EHRs, and remote patient monitoring requires a high initial investment. The cost of upgrading existing or building new healthcare facilities is high. The growing customization of smart healthcare increases the cost. The high initial investment hampers the growth of the smart healthcare market.</p>
567. <p><strong>Smart Healthcare Market Key Regional Analysis:</strong></p>
568. <p><strong>How Big is the U.S. Smart Healthcare Market?</strong></p>
569. <p align="justify">The <strong>U.S. smart healthcare market size</strong> accounted for USD 69.58 billion in 2024 and is expected to rise from USD 80.86 billion in 2025 to approximately USD 276.00 billion by 2034, at a CAGR of 14.77% from 2025 to 2034.</p>
570. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=57941984-bded-4e54-a59e-3e60a2fc625d&amp;size=3" height="367.56px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/57941984-bded-4e54-a59e-3e60a2fc625d/image2.png" width="653.43px" /></p>
571. <p><strong>Note: </strong><u>This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.</u></p>
572. <p><strong>Try Before You Buy – Get the Sample Report@ </strong><strong>https://www.precedenceresearch.com/sample/1173</strong></p>
573. <p><strong>How did North America Dominate the Smart Healthcare Market in 2024?</strong></p>
574. <p><strong>North America dominated the smart healthcare market in 2024. </strong>The well-established technological infrastructure, like a strong presence of technological companies, high-speed internet, and rising smartphone usage, increases focus on the development of smart healthcare. The presence of advanced healthcare systems like personalised medicine, electronic health records, and telehealth services helps the market growth.</p>
575. <p>The strong government support for smart healthcare solutions and digital health increases the development of smart healthcare infrastructure. The growing prevalence of chronic disease and rising healthcare spending increases demand for smart healthcare solutions. The rapid adoption of connected healthcare technologies like remote patient monitoring, wearable devices, and mHealth drives the overall growth of the market.</p>
576. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d3c15227-2cbb-404e-9874-ce00ef1fa178&amp;size=3" height="384.4px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d3c15227-2cbb-404e-9874-ce00ef1fa178/image3.png" width="683.38px" /></p>
577. <p><strong>Asia Pacific Smart Healthcare Market Trends:</strong></p>
578. <p><strong>Asia Pacific is experiencing the fastest growth in the market during the forecast period.</strong> The growing prevalence of chronic conditions like cardiovascular disease, diabetes, heart attack, hypertension, and many more increases the adoption of smart healthcare technologies for continuous monitoring. The aging population and rising age-related health issues fuel demand for smart healthcare services, helping the market growth.</p>
579. <p>The rising healthcare spending increases demand for smart healthcare devices like wearable devices. The ongoing technological advancements, like artificial intelligence, sensor technology, and data analytics, increase development in smart healthcare solutions. The strong government support for digital transformation and the increasing expansion of 5G networks drive the market growth.</p>
580. <p><strong>Smart Healthcare Market Segmentation Analysis</strong></p>
581. <p><strong>Product Type Analysis:</strong></p>
582. <p>The telemedicine segment dominated the smart healthcare market in 2024. The growing focus on providing healthcare services in underserved and remote areas increases demand for telemedicine. The increasing patient demand for virtual consultation for convenience and flexibility helps the market growth. The rise in chronic conditions increases the adoption of telemedicine for remote patient management and monitoring. The increasing age-related health problems fuel <strong>demand for telemedicine</strong>. The growing advancements in communication technology, like wearable technology, video calls, and secure messaging, help in the market growth. The strong government support for telemedicine increases the adoption of telemedicine. The focus on the integration of telemedicine with IoT and AI to enhance diagnostics, remote patient care, and personalised care drives the market growth.</p>
583. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d3c546ff-17fe-4a06-b532-8298abeb40cb&amp;size=3" height="374.48px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d3c546ff-17fe-4a06-b532-8298abeb40cb/image4.png" width="665.75px" /></p>
584. <p>The <strong>mHealth</strong> segment is the fastest-growing in the market during the forecast period. The growing <strong>smartphone</strong> penetration and high-speed internet availability increase the adoption of mHealth. The increasing demand for remote healthcare services like management, monitoring, and consultations for health problems helps the market growth. The growing focus on patient empowerment, like wellness programs, medical records, and medication reminders, increases demand for mHealth.</p>
585. <p>The growing rate of chronic conditions like heart conditions, diabetes, and many more increases the demand for mHealth technologies. The increasing focus on patient-centric care fuels the adoption of mHealth technologies. The rising adoption of wearable devices like fitness trackers and smartwatches supports the market growth.</p>
586. <p><strong>Top Companies in the Smart Healthcare Market:</strong></p>
587. <ul type="disc">
588. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Allscripts</strong> – Provides innovative electronic health records (EHR), practice management, and <strong>data analytics</strong> <strong>solutions to improve clinical workflows</strong> and patient care.</li>
589. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Logi-Tag Systems</strong> – Specializes in RFID-based solutions for real-time tracking and inventory management in healthcare facilities.</li>
590. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Cerner Corporation</strong> – Offers comprehensive health information technologies, including EHRs and population health management tools to enhance care delivery.</li>
591. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>SAMSUNG</strong> – Develops <strong>wearable medical devices</strong> and digital diagnostic solutions, contributing to the growing remote and mobile healthcare segment.</li>
592. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Cisco Systems</strong> – Delivers secure networking and telemedicine infrastructure that supports connected healthcare systems and real-time communication.</li>
593. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>GENERAL ELECTRIC COMPANY (GE Healthcare)</strong> – Provides smart imaging technologies, AI-powered diagnostics, and <strong>digital health</strong> platforms for better decision-making.</li>
594. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Siemens Healthcare Private Limited</strong> – Offers AI-driven diagnostics, smart imaging systems, and digital platforms for hospital efficiency and <strong>precision medicine</strong>.</li>
595. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>IBM Corporation</strong> – Known for IBM Watson Health, it utilizes AI and cloud computing to improve diagnostics, treatment planning, and operational efficiency.</li>
596. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>BD (Becton, Dickinson and Company)</strong> – Focuses on connected medication management, diagnostics, and smart medical devices to enhance patient safety and outcomes.</li>
597. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>AirStrip</strong> – Enables real-time clinical decision-making through mobile interoperability platforms that deliver patient data to clinicians anytime, anywhere.</li>
598. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Terumo Corporation</strong> – Innovates in smart infusion and interventional systems that enhance safety, monitoring, and precision in treatment delivery.</li>
599. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>eClinicalWorks</strong> – Offers cloud-based EHR and practice management <strong>software</strong> with integrated <strong>telehealth</strong> and patient engagement tools.</li>
600. <li style="margin-top:5pt; margin-bottom:5pt;"><strong>Resideo Technologies, Inc.</strong> – Provides smart home health monitoring solutions that support aging-in-place and chronic disease management.</li>
601. </ul>
602. <p><strong>Recent Developments:</strong></p>
603. <ul type="disc">
604. <li style="margin-bottom:8pt;">In October 2024, Tencent collaborated with Pfizer to launch a smart healthcare innovation ecosystem. The innovation combines big data, cloud computing, and AI with the WeCom and WeChat ecosystem. The integration enhances connectivity between governments, institutions, users, businesses, and healthcare. WeChat offers services like code recognition, searching, and dissemination. (Source: https://www.prnewswire.com)</li>
605. </ul>
606. <ul type="disc">
607. <li style="margin-bottom:8pt;">In April 2025, Baby &amp; Mom Retail launched a new brand, CORVELL, for smart healthcare equipment. The company’s focus is to make smart healthcare solutions more affordable, accessible, and reliable. The products are approved by the Government of India, and the flagship product of the brand is the smart nebulizer. The products are available on e-commerce platforms.  (Source: https://www.indianretailer.com)</li>
608. </ul>
609. <ul type="disc">
610. <li style="margin-bottom:8pt;">In March 2025, Airtel Business and Fortis Healthcare launched the Smart Clinics Solution. The solution helps to reach patients across rural and urban areas. The clinics support telemedicine by offering connected medical devices, live health tracking, real-time consultations, secure record management, and advanced point-of-care diagnostics. The clinics focus on a smoother patient experience and better care. (Source: https://telecomtalk.info)</li>
611. </ul>
612. <p><strong>Smart Healthcare Market Segments Covered in the Report</strong></p>
613. <p><strong>By Product Type</strong></p>
614. <ul type="disc">
615. <li style="margin-top:5pt; margin-bottom:5pt;">RFID Kanban Systems</li>
616. <li style="margin-top:5pt; margin-bottom:5pt;">RFID Smart Cabinets</li>
617. <li style="margin-top:5pt; margin-bottom:5pt;">Electronic Health Records (EHR)</li>
618. <li style="margin-top:5pt; margin-bottom:5pt;">Telemedicine</li>
619. <li style="margin-top:5pt; margin-bottom:5pt;">mHealth</li>
620. <li style="margin-top:5pt; margin-bottom:5pt;">Smart Pills</li>
621. <li style="margin-top:5pt; margin-bottom:5pt;">Smart Syringes</li>
622. </ul>
623. <p><strong>By Region</strong></p>
624. <ul type="disc">
625. <li style="margin-bottom:8pt;">North America
626. <ul type="circle">
627. <li style="margin-bottom:8pt;">U.S.</li>
628. <li style="margin-bottom:8pt;">Canada</li>
629. </ul>
630. </li>
631. <li style="margin-bottom:8pt;">Europe
632. <ul type="circle">
633. <li style="margin-bottom:8pt;">Germany</li>
634. <li style="margin-bottom:8pt;">UK</li>
635. <li style="margin-bottom:8pt;">France</li>
636. <li style="margin-bottom:8pt;">Italy</li>
637. <li style="margin-bottom:8pt;">Spain</li>
638. <li style="margin-bottom:8pt;">Sweden</li>
639. <li style="margin-bottom:8pt;">Denmark</li>
640. <li style="margin-bottom:8pt;">Norway</li>
641. </ul>
642. </li>
643. <li style="margin-bottom:8pt;">Asia Pacific
644. <ul type="circle">
645. <li style="margin-bottom:8pt;">China</li>
646. <li style="margin-bottom:8pt;">Japan</li>
647. <li style="margin-bottom:8pt;">India</li>
648. <li style="margin-bottom:8pt;">South Korea</li>
649. <li style="margin-bottom:8pt;">Thailand</li>
650. </ul>
651. </li>
652. <li style="margin-bottom:8pt;">Latin America
653. <ul type="circle">
654. <li style="margin-bottom:8pt;">Brazil</li>
655. <li style="margin-bottom:8pt;">Mexico</li>
656. <li style="margin-bottom:8pt;">Argentina</li>
657. </ul>
658. </li>
659. <li style="margin-top:5pt; margin-bottom:5pt;">Middle East &amp; Africa
660. <ul type="circle">
661. <li style="margin-top:5pt; margin-bottom:5pt;">South Africa</li>
662. <li style="margin-top:5pt; margin-bottom:5pt;">UAE</li>
663. <li style="margin-top:5pt; margin-bottom:5pt;">Saudi Arabia</li>
664. <li style="margin-top:5pt; margin-bottom:5pt;">Kuwait</li>
665. </ul>
666. </li>
667. </ul>
668. <p><em>Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as </em><strong><em>North America, Europe, or Asia Pacific.</em></strong></p>
669. <p><strong>Immediate Delivery Available | Buy This Premium Research Report@ </strong><strong>https://www.precedenceresearch.com/checkout/1173</strong></p>
670. <p><strong>You can place an order or ask any questions, please feel free to contact at </strong><strong>sales@precedenceresearch.com</strong><strong> | </strong><strong>+1 804 441 9344</strong></p>
671. <p><strong>Stay Ahead with Precedence Research Subscriptions</strong></p>
672. <p>Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.</p>
673. <p><strong>Browse Our Subscription Plans@ </strong><strong>https://www.precedenceresearch.com/get-a-subscription</strong></p>
674. <p><strong>About Us</strong></p>
675. <p>Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &amp; defense, among different ventures present globally.</p>
676. <p><strong>Web: </strong><strong>https://www.precedenceresearch.com</strong></p>
677. <p><strong>Our Trusted Data Partners:</strong></p>
678. <p><strong><u>Towards Healthcare</u></strong><strong> |</strong> <strong><u>Towards Packaging</u></strong><strong> | </strong><strong><u>Towards Automotive</u></strong><strong> | </strong><strong><u>Towards Chem and Materials</u></strong><strong> | </strong><strong><u>Towards FnB</u></strong><strong> |</strong> <strong><u>Towards Consumer Goods</u></strong><strong> | </strong><strong><u>Statifacts</u></strong><strong> | </strong><strong><u>Towards EV Solutions</u></strong><strong> | </strong><strong><u>Towards Dental</u></strong><strong> | </strong><strong><u>Nova One Advisor</u></strong> | <strong>Market Stats Insight</strong></p>
679. <p><strong>Get Recent News: </strong></p>
680. <p><strong>https://www.precedenceresearch.com/news</strong></p>
681. <p><strong>For the Latest Update Follow Us:</strong></p>
682. <p><strong>LinkedIn</strong><strong> | </strong><strong>Medium</strong><strong> | </strong><strong>Facebook</strong><strong> | </strong><strong>Twitter</strong></p>
683. <p><strong>✚ </strong><strong>Related Topics You May Find Useful:</strong>        </p>
684. <ul type="disc">
685. <li style="margin-bottom:8pt;">The global <strong>smart healthcare products market size</strong> accounted for USD 177.17 billion in 2024 and is predicted to reach around USD 515.12 billion by 2034, growing at a CAGR of 11.26% from 2025 to 2034.</li>
686. <li style="margin-bottom:8pt;">The global <strong>smart medical devices market size</strong> was estimated at USD 52.66 billion in 2024 and is predicted to increase from USD 59.26 billion in 2025 to approximately USD 168 billion by 2034, expanding at a CAGR of 12.30% from 2025 to 2034.</li>
687. <li style="margin-bottom:8pt;">The global <strong>flexible electronics in healthcare market size</strong> accounted for USD 7.00 billion in 2024 and is predicted to increase from USD 8.40 billion in 2025 to approximately USD 43.57 billion by 2034, expanding at a CAGR of 20.70% from 2025 to 2034.</li>
688. <li style="margin-bottom:8pt;">The global <strong>artificial intelligence (AI) in healthcare market size</strong> was estimated at USD 26.69 billion in 2024 and is predicted to increase from USD 36.96 billion in 2025 to approximately USD 613.81 billion by 2034, expanding at a CAGR of 36.83% from 2025 to 2034.</li>
689. <li style="margin-bottom:8pt; text-align:justify;">The global <strong>smart hospitals market size</strong> accounted for USD 58.18 billion in 2024 and is expected to be worth around USD 296.87 billion by 2034, at a CAGR of 17.7% from 2024 to 2034. </li>
690. <li style="margin-bottom:8pt;">The global <strong>healthcare software as a service market size</strong> is estimated at USD 34.84 billion in 2024 and is anticipated to reach around USD 94.56 billion by 2034, expanding at a CAGR of 10.50% from 2024 to 2034.</li>
691. <li style="margin-bottom:8pt;">The global <strong>internet of things (IOT) in healthcare market size</strong> is estimated at USD 53.64 billion in 2024 and is anticipated to reach around USD 368.06 billion by 2034, expanding at a CAGR of 21.24% from 2024 to 2034.</li>
692. <li style="margin-bottom:8pt;">The global <strong>augmented and virtual reality in healthcare market size</strong> was estimated at USD 3.40 billion in 2024 and it is expected to hit around USD 18.38 billion by 2034, poised to grow at a CAGR of 18.38% during the forecast period 2025 to 2034.</li>
693. <li style="margin-bottom:8pt;">The global <strong>healthcare metaverse market size</strong> was calculated at USD 4.77 billion in 2024 and is predicted to increase from USD 6.79 billion in 2025 to approximately USD 144.37 billion by 2034, expanding at a CAGR of 40.64%.</li>
694. <li style="margin-bottom:8pt;">The <strong>U.S. digital health market size</strong> was estimated at USD 79.10 billion in 2024 and is predicted to surpass around USD 248.11 billion by 2034, poised to grow at a CAGR of 11.64% from 2025 to 2034. </li>
695. <li style="margin-bottom:8pt;">The global <strong>healthcare information systems market size</strong> accounted at USD 519.23 billion in 2024 and is predicted to reach around USD 1773.33 billion by 2034, growing at a CAGR of 13.07% from 2025 to 2034.</li>
696. <li style="margin-top:5pt;">The global <strong>internet of medical things (IoMT) market size</strong> accounted for USD 225.81 billion in 2024 and is expected to exceed around USD 2,294.87 billion by 2034, growing at a CAGR of 26.09% from 2025 to 2034.</li>
697. </ul>
698. <p><img alt="" src='https://ml.globenewswire.com/media/NjI3N2UyNDUtYzJhOS00ZmVmLTg5ZWEtMjczMDMxYTEyZGJmLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
699. ]]></content:encoded>
703. </item>
704. <item>
705. <title>Breast Pump Market Size Surges USD 7.58 Billion at 8.63% CAGR by 2034</title>
706. <link>https://indiachron.com/breast-pump-market-size-surges-usd-7-58-billion-at-8-63-cagr-by-2034/424950/</link>
708. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
709. <pubDate>Mon, 01 Sep 2025 15:00:00 +0000</pubDate>
710. <category><![CDATA[Brand Post]]></category>
711. <guid isPermaLink="false">http://indiachron.com/breast-pump-market-size-surges-usd-7-58-billion-at-8-63-cagr-by-2034</guid>
712.  
713. <description><![CDATA[The global breast pump market is valued at approximately USD 3.52 billion in 2025 and is projected to grow to about USD 7.58 billion by 2034, expanding at an estimated compound annual growth rate (CAGR) of 8.63% over the forecast period. Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; Towards Healthcare, a sister firm of Precedence [&#8230;]]]></description>
714. <content:encoded><![CDATA[<p><em>The global breast pump market is valued at approximately USD 3.52 billion in 2025 and is projected to grow to about USD 7.58 billion by 2034, expanding at an estimated compound annual growth rate (CAGR) of 8.63% over the forecast period.</em></p>
715. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; Towards Healthcare, a sister firm of Precedence Research, reports that the global <strong>breast pump market</strong> was valued at USD 3.23 billion in 2024 and is expected to reach approximately USD 7.58 billion by 2034, growing at a CAGR of 8.63%. The growth of the market is driven by the growing number of working women and increasing awareness of the benefits offered fuels the demand for the market.</p>
716. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=1e49a4c1-c6c5-4ecc-8f28-0de7e0e27886&amp;size=3" height="338.47px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/1e49a4c1-c6c5-4ecc-8f28-0de7e0e27886/image1.png" width="601.74px" /></p>
717. <p><strong>The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ </strong><strong>https://www.towardshealthcare.com/download-sample/5427</strong></p>
718. <p><strong>Key Takeaways</strong></p>
719. <ul type="disc">
720. <li style="margin-bottom:8pt;">North America dominated the global breast pump market share by 54% in 2024.</li>
721. <li style="margin-bottom:8pt;">Europe is anticipated to grow significantly in the market during the forecast period, holding 23% shares.</li>
722. <li style="margin-bottom:8pt;">By product, the closed system segment held a dominant presence in the market in 2024 and is expected to grow at the fastest CAGR during the forecast period.</li>
723. <li style="margin-bottom:8pt;">By product, the open system segment is predicted to witness significant growth in the market over the forecast period.</li>
724. <li style="margin-bottom:8pt;">By technology, the electric pumps segment held the largest share of the market in 2024 and is expected to grow at the fastest CAGR during the forecast period.</li>
725. <li style="margin-bottom:8pt;">By technology, the manual pumps segment will gain a significant share of the breast pump market over the studied period.</li>
726. <li style="margin-bottom:8pt;">By application, the hospital-grade segment led the global market in 2024 and is expected to grow at the fastest CAGR during the forecast period.</li>
727. <li style="margin-bottom:8pt;">By application, the personal use segment is anticipated to grow with a significant CAGR in the market during the studied years.</li>
728. </ul>
729. <p><strong>Market Overview &amp; Potential</strong></p>
730. <p>A breast pump is a device used by lactating women to extract milk from their breasts. It can be manual or powered, operating by hand, battery, or electricity. This device helps maintain milk supply when the mother is away or the infant cannot breastfeed temporarily. Common reasons for using a breast pump include working mothers needing to store milk, difficulty latching, separation in intensive care, infants who cannot draw enough milk, or to prevent transfer of medication through breast milk.</p>
731. <p>Some women also use pumps to dispose of excess milk or store it for babies unable to receive their mother’s milk. The market grows due to the rise in working women worldwide and supportive policies. Increased awareness of breast pump benefits and government efforts to encourage breastfeeding also drive demand. Advances in medical technology and increased R&amp;D funding by organizations further boost the market.</p>
732. <p><strong>What is the Growth Potential Responsible for The Growth of The Breast Pump Market?</strong></p>
733. <p>The growth of the market is driven by the growing demand for pumps due to the benefits they offer fuels the growth of the market. The other key growth drivers are the rising employment rates of women, which demand the breast pumps for continued breastfeeding, fueling the growth, growing awareness of breastfeeding benefits, technological advancemnets, supportive government policies and programs, improved healthcare infrastructure, increased disposable income, and specific solutions are the factors that boost the growth and expansion of the market.</p>
734. <p><strong>You can place an order or ask any questions, please feel free to contact us at </strong><strong>sales@towardshealthcare.com</strong></p>
735. <p><strong>What Are the Growing Trends Associated with the Breast Pump Market?</strong></p>
736. <p><strong>Rising Working Mothers: </strong></p>
737. <ul type="disc">
738. <li style="margin-bottom:8pt;">The increasing global employment rates for women are a primary driver, creating a need for efficient and portable breast pumps to express milk in the workplace.</li>
739. </ul>
740. <p><strong>Technological Innovation:</strong></p>
741. <ul type="disc">
742. <li style="margin-bottom:8pt;">The innovation in wearable and smart, and closed system technology pumps, fuels the growth of the market.</li>
743. </ul>
744. <p><strong>Increased Awareness &amp; Initiatives:</strong></p>
745. <ul type="disc">
746. <li style="margin-bottom:8pt;">Growing awareness of the benefits of breastfeeding and supportive government and employer initiatives are boosting the demand for breast pumps.</li>
747. </ul>
748. <p><strong>E-commerce Expansion:</strong></p>
749. <ul type="disc">
750. <li style="margin-bottom:8pt;">Direct-to-consumer (DTC) e-commerce platforms are expanding access to modern pumping solutions.</li>
751. </ul>
752. <p><strong>What is the Challenge in the Breast Pump Market?</strong></p>
753. <p>The key challenges that hinder the growth of the market are the high price of premium devices, lack of insurance coverage, and maintenance costs, limiting the growth of the market. The social and cultural factors, like lack of awareness and misinformation, social stigma and embarrassment, and workplace barriers, create an unsupportive environment that limits the growth of the market. The logistical issues, like supply chain disruptions and limited availability in rural areas, also limit the growth. The major challenge is the hygiene and safety concerns, which restrict the growth of the market.</p>
754. <p><strong>Regional Analysis</strong></p>
755. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=0e5503bc-c242-4503-b90d-dee73f26bd2c&amp;size=3" height="338.47px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/0e5503bc-c242-4503-b90d-dee73f26bd2c/image2.png" width="601.74px" /></p>
756. <p><strong>How Did North America Dominate the Breast Pump Market in 2024?</strong></p>
757. <p>North America dominated the global breast pump market share by 54% in 2024. The growth of the market in North America is driven by the high awareness among consumers, with supportive government policies driving the growth of the market. The rising number of working women drives demand for breast pumps as they balance work and breastfeeding, which increases the growth of the market. Other key drivers are the advanced healthcare infrastructure and reimbursement policies in the region, which boost the growth and demand for the market.</p>
758. <p><strong>What Made Europe Significantly Grow in The Breast Pump Market In 2024? </strong></p>
759. <p>Europe is anticipated to grow significantly in the market during the forecast period, holding 23% shares. The growth of the market in the region is driven by technological advancements, like the development of efficient and portable user-friendly pumps, which align with the needs of consumers, increasing the demand. There is increased public and consumer awareness regarding the health benefits of breastfeeding for both mothers and infants, which boosts the growth and expansion of the market in the region. </p>
760. <p><strong>Become a valued research partner with us &#8211; </strong><strong>https://www.towardshealthcare.com/schedule-meeting</strong></p>
761. <p><strong>Segmental Insights</strong></p>
762. <p><strong>By Product, </strong></p>
763. <p><strong>Which Product Segment Dominated Breast Pump Market In 2024?</strong></p>
764. <p>The closed system segment held a dominant presence in the market in 2024 and is expected to grow at the fastest CAGR during the forecast period. Closed system breast pumps dominate the market due to their hygienic design that prevents breast milk from entering the tubing or motor. This reduces contamination risks, ensuring safer feeding for infants. They are widely preferred by working mothers and healthcare facilities for their reliability and ease of cleaning. Manufacturers focus on advanced suction technology and portability, boosting adoption among women seeking safe, convenient, and efficient breast milk expression solutions.</p>
765. <p>The open system segment is predicted to witness significant growth in the market over the forecast period. Open system breast pumps are generally more affordable and accessible, making them popular among mothers looking for economical options. Unlike closed systems, they allow airflow between milk and tubing, which requires careful cleaning to maintain hygiene. They are lightweight and easy to use, especially for occasional pumping. Despite hygiene concerns, open systems remain in demand due to lower costs and availability in both manual and electric pump categories.</p>
766. <p><strong>By Technology, </strong></p>
767. <p><strong>How Did Electric Pumps Segment Dominated Breast Pump Market In 2024?</strong></p>
768. <p>The electric pumps segment held the largest share of the market in 2024 and is expected to grow at the fastest CAGR during the forecast period. Electric breast pumps hold a significant share of the market, offering efficiency and convenience for mothers who pump frequently. These devices are available as single or double pumps, with adjustable suction levels and advanced features such as portability, rechargeable batteries, and smart connectivity. Hospital-grade electric pumps are essential for mothers with preterm infants or breastfeeding difficulties. Their speed, efficiency, and comfort features make them highly preferred worldwide.</p>
769. <p>The manual pumps segment will gain a significant share of the breast pump market over the studied period. Manual breast pumps cater to mothers who require occasional or on-the-go pumping solutions. They are lightweight, portable, and cost-effective, with no reliance on power sources, making them ideal for travel and quick use. Although less efficient than electric pumps, manual pumps are quiet and user-friendly. Their affordability and ease of maintenance support strong demand among women in developing regions and those seeking simple, low-maintenance breastfeeding solutions.</p>
770. <p><strong>By Application, </strong></p>
771. <p><strong>Which Application Segment Dominated Breast Pump Market In 2024?</strong></p>
772. <p>The hospital-grade segment led the global market in 2024 and is expected to grow at the fastest CAGR during the forecast period. Hospital-grade breast pumps are designed for multiple users in healthcare facilities, featuring closed system technology for hygiene and safety. These pumps are high-powered and durable, making them essential for mothers with preterm or hospitalized infants. They provide efficient milk expression, supporting lactation when direct breastfeeding is not possible. Hospitals, maternity centers, and lactation clinics drive demand, ensuring this segment remains crucial for infant nutrition and maternal health support.</p>
773. <p>The personal use segment is anticipated to grow with a significant CAGR in the market during the studied years. Personal use breast pumps are the largest application segment, driven by working mothers and women balancing breastfeeding with busy lifestyles. Both electric and manual pumps are available for this category, catering to different needs and budgets. Personal use pumps emphasize portability, ease of cleaning, and affordability, with smart features gaining popularity. Growing awareness of breastfeeding benefits and rising female workforce participation strongly influence this segment’s expansion.</p>
774. <p><strong>Get the latest insights on life science industry segmentation with our Annual Membership: </strong><strong>https://www.towardshealthcare.com/get-an-annual-membership</strong></p>
775. <p><strong>Recent Developments</strong></p>
776. <ul type="disc">
777. <li style="margin-bottom:8pt;">In January 2025, Momcozy announced the launch of its groundbreaking Air-1 Ultra Slim Breast Pump in the U.S. in the first quarter of 2025. The pump was designed for innovation, comfort, and discretion to meet the needs of modern moms.</li>
778. <li style="margin-bottom:8pt;">In October 2024, Elvie unveiled their newest and smart breast pump, Elvie Stride 2, a hands-free and noise-free pump offering hospital-grade suction. The pump could optimize milk output with the comfort of lightweight, ultra-soft silicone cups.</li>
779. </ul>
780. <p><strong>Breast Pump Market Key Players</strong></p>
781. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=a2c29a18-88c4-459c-9262-7bcbfbe56047&amp;size=3" height="356.27px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/a2c29a18-88c4-459c-9262-7bcbfbe56047/image3.png" width="601.74px" /></p>
782. <ul type="disc">
783. <li style="margin-bottom:8pt;">Accelleron Medical Products</li>
784. <li style="margin-bottom:8pt;">Ameda, Inc.</li>
785. <li style="margin-bottom:8pt;">Ardo Medical AG</li>
786. <li style="margin-bottom:8pt;">Chemco Group</li>
787. <li style="margin-bottom:8pt;">Elvie</li>
788. <li style="margin-bottom:8pt;">Lansinoh Laboratories Inc.</li>
789. <li style="margin-bottom:8pt;">Luvlap Store</li>
790. <li style="margin-bottom:8pt;">Medela</li>
791. <li style="margin-bottom:8pt;">Momcozy</li>
792. <li style="margin-bottom:8pt;">Motif Medical</li>
793. <li style="margin-bottom:8pt;">PIGEON</li>
794. <li style="margin-bottom:8pt;">Royal Philips</li>
795. <li style="margin-bottom:8pt;">Willow</li>
796. </ul>
797. <p><strong>Browse More Insights of Towards Healthcare:</strong></p>
798. <p>The global <strong>oncology biosimilars market</strong> is valued at USD 6.7 billion in 2024 and is expected to grow to USD 7.94 billion in 2025, ultimately reaching approximately USD 36.23 billion by 2034. The market is set to expand at a robust CAGR of 18.47% between 2025 and 2034.</p>
799. <p>The <strong>breast cancer liquid biopsy market</strong> is estimated at USD 200 million in 2024 and is projected to rise to USD 229.6 million in 2025, reaching around USD 795.42 million by 2034, growing at a CAGR of 14.8% over the forecast period.</p>
800. <p>The <strong>breast cancer screening tests market</strong> is valued at USD 4.44 billion in 2024, increasing to USD 4.75 billion in 2025, and is anticipated to reach USD 8.77 billion by 2034, expanding at a CAGR of 7.04% from 2025 to 2034.</p>
801. <p>The <strong>breast implants market</strong> stands at USD 2.72 billion in 2024 and is expected to grow to USD 2.93 billion in 2025, reaching approximately USD 5.62 billion by 2034, at a CAGR of 7.54% during the forecast period.</p>
802. <p>The <strong>South Korea breast pump market</strong> is projected at USD 20.41 million in 2024, rising to USD 21.93 million in 2025, and expected to reach USD 41.66 million by 2034, growing at a CAGR of 7.44% from 2025 to 2034.</p>
803. <p>The global <strong>digital breast tomosynthesis market</strong> is valued at USD 3.03 billion in 2024 and is projected to grow to USD 3.45 billion in 2025, reaching around USD 10.89 billion by 2034, with a CAGR of 13.63% between 2025 and 2034.</p>
804. <p>The <strong>AI in breast imaging market</strong> is forecast to reach USD 844.52 million by 2034, up from USD 538.39 million in 2025, expanding at a moderate CAGR of 3.30% over the forecast period.</p>
805. <p><strong>Segments Covered in The Report</strong></p>
806. <p><strong>By Product</strong></p>
807. <ul type="disc">
808. <li style="margin-bottom:8pt;">Open System</li>
809. <li style="margin-bottom:8pt;">Closed System</li>
810. </ul>
811. <p><strong>By Technology</strong></p>
812. <ul type="disc">
813. <li style="margin-bottom:8pt;">Manual Pumps</li>
814. <li style="margin-bottom:8pt;">Battery-Powered Pumps</li>
815. <li style="margin-bottom:8pt;">Electric Pumps</li>
816. </ul>
817. <p><strong>By Application</strong></p>
818. <ul type="disc">
819. <li style="margin-bottom:8pt;">Personal Use</li>
820. <li style="margin-bottom:8pt;">Hospital-Grade</li>
821. </ul>
822. <p><strong>By Region</strong></p>
823. <ul type="disc">
824. <li style="margin-bottom:8pt;">North America
825. <ul type="circle">
826. <li style="margin-bottom:8pt;">U.S.</li>
827. <li style="margin-bottom:8pt;">Canada</li>
828. </ul>
829. </li>
830. <li style="margin-bottom:8pt;">Asia Pacific
831. <ul type="circle">
832. <li style="margin-bottom:8pt;">China</li>
833. <li style="margin-bottom:8pt;">Japan</li>
834. <li style="margin-bottom:8pt;">India</li>
835. <li style="margin-bottom:8pt;">South Korea</li>
836. <li style="margin-bottom:8pt;">Thailand</li>
837. </ul>
838. </li>
839. <li style="margin-bottom:8pt;">Europe
840. <ul type="circle">
841. <li style="margin-bottom:8pt;">Germany</li>
842. <li style="margin-bottom:8pt;">UK</li>
843. <li style="margin-bottom:8pt;">France</li>
844. <li style="margin-bottom:8pt;">Italy</li>
845. <li style="margin-bottom:8pt;">Spain</li>
846. <li style="margin-bottom:8pt;">Sweden</li>
847. <li style="margin-bottom:8pt;">Denmark</li>
848. <li style="margin-bottom:8pt;">Norway</li>
849. </ul>
850. </li>
851. <li style="margin-bottom:8pt;">Latin America
852. <ul type="circle">
853. <li style="margin-bottom:8pt;">Brazil</li>
854. <li style="margin-bottom:8pt;">Mexico</li>
855. <li style="margin-bottom:8pt;">Argentina</li>
856. </ul>
857. </li>
858. <li style="margin-bottom:8pt;">Middle East and Africa (MEA)
859. <ul type="circle">
860. <li style="margin-bottom:8pt;">South Africa</li>
861. <li style="margin-bottom:8pt;">UAE</li>
862. <li style="margin-bottom:8pt;">Saudi Arabia</li>
863. <li style="margin-bottom:8pt;">Kuwait</li>
864. </ul>
865. </li>
866. </ul>
867. <p><strong>Immediate Delivery Available | Buy This Premium Research @ </strong><strong>https://www.towardshealthcare.com/price/5427</strong></p>
868. <p>Access our exclusive, data-rich dashboard dedicated to the healthcare market &#8211; built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.</p>
869. <p><strong>Access the Dashboard: </strong><strong>https://www.towardshealthcare.com/access-dashboard</strong></p>
870. <p><strong>About Us</strong></p>
871. <p><strong>Towards Healthcare</strong> is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a <strong>strong emphasis on life science research</strong>. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.</p>
872. <p><strong>You can place an order or ask any questions, please feel free to contact us at </strong><strong>sales@towardshealthcare.com</strong></p>
873. <p><strong>Europe Region: </strong>+44 778 256 0738</p>
874. <p><strong>North America Region: </strong>+1 8044 4193 44</p>
875. <p><strong>APAC Region</strong>: +91 9356 9282 04</p>
876. <p><strong>Web: </strong><strong>https://www.towardshealthcare.com</strong></p>
877. <p><strong>Our Trusted Data Partners</strong></p>
878. <p><strong>Precedence Research</strong><strong> | </strong><strong>Statifacts</strong><strong> | </strong><strong>Towards Packaging</strong><strong> | </strong><strong>Towards Automotive</strong><strong> |</strong> <strong>Towards Food and Beverages</strong><strong> | </strong><strong>Towards Chemical and Materials</strong><strong> | </strong><strong>Towards Consumer Goods</strong><strong> |</strong> <strong>Towards Dental</strong><strong> | </strong><strong>Towards EV Solutions</strong><strong> | </strong><strong>Nova One Advisor</strong><strong> | </strong><strong>Healthcare Webwire</strong><strong> | </strong><strong>Packaging Webwire</strong><strong> | </strong><strong>Automotive Webwire</strong></p>
879. <p><strong>Find us on social platforms: </strong><strong>LinkedIn</strong><strong> | </strong><strong>Twitter</strong><strong> | </strong><strong>Instagram</strong><strong> | </strong><strong>Medium</strong><strong> | </strong><strong>Pinterest</strong></p>
880. <p><img alt="" src='https://ml.globenewswire.com/media/ZTNlYTdkNTQtYjEwYS00NDRiLTkyNjAtYzM0YmJkZjZkNDBiLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
881. ]]></content:encoded>
885. </item>
886. <item>
887. <title>Security Service Edge Market Size to Surpass USD 33.27 Billion by 2032, Owing to Rising Demand for Cloud-Native and Zero-Trust Security Solutions &#124; Report by SNS Insider</title>
888. <link>https://indiachron.com/security-service-edge-market-size-to-surpass-usd-33-27-billion-by-2032-owing-to-rising-demand-for-cloud-native-and-zero-trust-security-solutions-report-by-sns-insider/424951/</link>
890. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
891. <pubDate>Mon, 01 Sep 2025 14:30:00 +0000</pubDate>
892. <category><![CDATA[Brand Post]]></category>
893. <guid isPermaLink="false">http://indiachron.com/security-service-edge-market-size-to-surpass-usd-33-27-billion-by-2032-owing-to-rising-demand-for-cloud-native-and-zero-trust-security-solutions-report-by-sns-insider</guid>
894.  
895. <description><![CDATA[The Security Service Edge market is witnessing remarkable growth, fueled by the rapid shift to cloud environments, the expanding remote workforce, and growing emphasis on zero-trust security frameworks. Austin, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The Security Service Edge Market size was USD 6.17 billion in 2024 and is expected to reach USD 33.27 billion by [&#8230;]]]></description>
896. <content:encoded><![CDATA[<p><em>The Security Service Edge market is witnessing remarkable growth, fueled by the rapid shift to cloud environments, the expanding remote workforce, and growing emphasis on zero-trust security frameworks.</em></p>
897. <p align="left">Austin, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The <b><u><b><u>Security Service Edge Market</u></b></u></b> size was USD 6.17 billion in 2024 and is expected to reach USD 33.27 billion by 2032, growing at a CAGR of 23.4% over the forecast period of 2025–2032.</p>
898. <p align="left"><b><b>Security Service Edge Market Enters Transformative Phase as Enterprises Embrace Unified Cloud-Native Security Frameworks</b></b></p>
899. <p align="left">The Security Service Edge (SSE) market is entering a transformative phase, driven by the accelerated adoption of cloud-native security frameworks. SSE integrates multiple core security components, Secure Web Gateway (SWG), Cloud Access Security Broker (CASB), and Zero Trust Network Access (ZTNA), into a unified cloud-delivered platform. Enterprises are increasingly implementing SSE to address challenges brought on by hybrid work models, cross-border data flows, and complex regulatory requirements.</p>
900. <p align="center"><b><b><img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d038d758-f670-4327-b499-68b6a153df4c&amp;size=0" data-state="draft" height="400" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d038d758-f670-4327-b499-68b6a153df4c/security-service-edge-market.jpg" title="Security-Service-Edge-Market.jpg" width="600" /><br /></b></b></p>
901. <p align="center"><b><b>Download PDF Sample of</b></b><b><b> Security Service Edge Market @ </b></b><b><u><b><u>https://www.snsinsider.com/sample-request/8297</u></b></u></b><b><b> </b></b></p>
902. <p align="left">The U.S. continues to lead in adoption, valued at USD 1.44 billion in 2024 and projected to hit USD 7.25 billion by 2032, growing at a CAGR of 22.4%. Rising cloud adoption, regulatory scrutiny, and the expansion of remote workforces are fueling this growth. SSE is now viewed as a foundational layer for enterprise cybersecurity strategies worldwide.</p>
903. <p align="left"><b>Key Players:</b></p>
904. <ul>
905. <li style="text-align:left;">Zscaler</li>
906. <li style="text-align:left;">Cisco</li>
907. <li style="text-align:left;">Broadcom</li>
908. <li style="text-align:left;">Palo Alto Networks</li>
909. <li style="text-align:left;">Netskope</li>
910. <li style="text-align:left;">Fortinet</li>
911. <li style="text-align:left;">Cloudflare</li>
912. <li style="text-align:left;">Check Point (Perimeter 81)</li>
913. <li style="text-align:left;">Skyhigh Security</li>
914. <li style="text-align:left;">Citrix</li>
915. <li style="text-align:left;">HPE Aruba Networks</li>
916. <li style="text-align:left;">Menlo Security</li>
917. <li style="text-align:left;">Versa Networks</li>
918. <li style="text-align:left;">TwinGate</li>
919. <li style="text-align:left;">Banyan Security</li>
920. <li style="text-align:left;">Akamai Technologies</li>
921. <li style="text-align:left;">Forcepoint</li>
922. <li style="text-align:left;">Lookout</li>
923. <li style="text-align:left;">iboss</li>
924. <li style="text-align:left;">Open Systems</li>
925. </ul>
926. <p align="center"><b>Security Service Edge Market </b><b>Report Scope:</b></p>
927. <table style="border-collapse: collapse; margin-left:auto; margin-right:auto; border-collapse:collapse ;">
928. <tr>
929. <td style="width:308.07px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: top ; "><b><b>Report Attributes</b></b></td>
930. <td style="width:308.07px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: top ; "><b><b>Details</b></b></td>
931. </tr>
932. <tr>
933. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size in 2024</td>
934. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">USD 6.17 Billion</td>
935. </tr>
936. <tr>
937. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size by 2032</td>
938. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">USD 33.27 Billion</td>
939. </tr>
940. <tr>
941. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">CAGR</td>
942. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">CAGR of 23.4% From 2025 to 2032</td>
943. </tr>
944. <tr>
945. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Base Year</td>
946. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">2024</td>
947. </tr>
948. <tr>
949. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Forecast Period</td>
950. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">2025-2032</td>
951. </tr>
952. <tr>
953. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Historical Data</td>
954. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">2021-2023</td>
955. </tr>
956. <tr>
957. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Report Scope &amp; Coverage</td>
958. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC &amp; SWOT Analysis, Forecast Outlook</td>
959. </tr>
960. <tr>
961. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Key Segments</td>
962. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">• By Component Type (Solutions [Secure Web Gateway (SWG), Cloud Access Security Broker (CASB), Zero Trust Network Access (ZTNA), Firewall-as-a-Service (FWaaS), Data Loss Prevention (DLP), Remote Browser Isolation (RBI)], Services [Professional Services, Managed Services])<br />• By Deployment Mode (On-Premises, Cloud-based, Hybrid)<br />• By Enterprise Size (Large Size Enterprise, Small and Medium-Sized Enterprise (SMEs))<br />• By End-Use Industry (IT and Telecommunication, BFSI, Government &amp; Public Sector, Healthcare, Retail and e-Commerce, Manufacturing, Education, Others)</td>
963. </tr>
964. <tr>
965. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Customization Scope</td>
966. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Available upon request</td>
967. </tr>
968. <tr>
969. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Pricing</td>
970. <td style="width:308.07px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: top ; ">Available upon request</td>
971. </tr>
972. </table>
973. <p align="left"><b><b>If You Need Any Customization on</b></b><b><b> Security Service Edge Market </b></b><b><b>Report, </b></b><b><b>I</b></b><b><b>nquire Now</b></b><b><b> @ </b></b><b><u><b><u>https://www.snsinsider.com/enquiry/8297</u></b></u></b><b><b> </b></b></p>
974. <p align="left"><b><b>Segmentation Analysis:</b></b></p>
975. <p align="left"><b><b>By Component</b></b></p>
976. <p align="left">In 2024, the Solutions segment dominated the market share, is 65%, as enterprises increasingly favored unified, cloud-native platforms that integrate SWG, CASB, and ZTNA in a single suite. These solution-driven deployments enhance threat detection, improve policy enforcement, and streamline operations. However, the Services segment is forecast to grow at the fastest CAGR of 24.56% through 2032, fueled by rising demand for expert-led integration, consulting, and managed offerings.</p>
977. <p align="left"><b><b>By End-Use</b></b></p>
978. <p align="left">The BFSI sector led with a market share 39% in 2024, driven by strict compliance requirements and exposure to financial fraud and cyberattacks. Meanwhile, the IT &amp; Telecommunications segment is expected to post the fastest growth rate of 26.52% CAGR as multi-cloud adoption and decentralized access increase, demanding advanced SSE frameworks for infrastructure security.</p>
979. <p align="left"><b><b>By Deployment</b></b></p>
980. <p align="left">Cloud-based models dominated the market with a 55% share in 2024, driven by SaaS adoption and the rise of remote work. Real-time scalability and lower operational costs made cloud deployment a preferred choice. At the same time, hybrid models are expected to grow with the fastest CAGR of 25.20% rapidly, particularly in regulated sectors requiring a blend of on-premise and cloud solutions.</p>
981. <p align="left"><b><b>By Enterprise Size</b></b></p>
982. <p align="left">In 2024, large enterprises captured 68% of the Security Service Edge market, driven by complex IT infrastructures, global operations, and stringent compliance needs. They rely on SSE to protect sensitive data, secure multi-cloud access, and enforce adaptive trust policies. Conversely, the SME segment is expected to grow fastest through 2032, supported by lightweight, cost-effective, and easy-to-deploy SSE solutions. Flexible pricing models and intuitive dashboards are enabling smaller businesses to adopt enterprise-grade and cloud-delivered security with minimal IT overhead.</p>
983. <p align="left"><b><b>North America Leads Security Service Edge Market, While Asia Pacific Emerges as Fastest-Growing Region</b></b></p>
984. <p align="left">In 2024, North America led the market with 39% revenue share, thanks to advanced IT infrastructure, widespread cloud adoption, and strict cybersecurity regulations. The U.S. remains the region’s growth engine, supported by strong BFSI, healthcare, and government sector adoption, alongside significant zero-trust investments.</p>
985. <p align="left">Asia Pacific is the fastest-growing region, expected to record a 25.3% CAGR between 2025 and 2032. Cloud adoption, regulatory reforms, and rising cyberattacks in manufacturing, telecom, and retail are fueling growth. China dominates within the region, driven by state-led cybersecurity initiatives and enterprise cloud migration.</p>
986. <p align="left">Europe shows steady growth, supported by stringent GDPR-driven regulations and the adoption of zero-trust strategies across industries. Germany leads, with investments in AI-driven cybersecurity, manufacturing security, and multi-cloud protection.</p>
987. <p align="left">In LATAM and MEA, adoption is accelerating due to rapid digital transformation, high exposure to cyber threats, and reduced reliance on legacy systems. Brazil leads in LATAM, driven by its expanding digital ecosystem and finance sector adoption. In MEA, South Africa leads with increasing investment in enterprise cloud security and protection for critical sectors such as finance and energy.</p>
988. <p align="left"><b><b>Recent Developments:</b></b></p>
989. <ul>
990. <li style="text-align:left;"><b><b>May 2025</b></b> – At the RSA Conference 2025, Google Cloud and Broadcom announced a collaboration to deliver AI-powered SSE solutions at scale, ensuring global policy enforcement and high-performance cloud security.</li>
991. <li style="text-align:left;"><b><b>April 2025</b></b> – Palo Alto Networks launched Prisma Access Browser 2.0, the world’s first SASE-native secure browser. With real-time GenAI-based data loss prevention and advanced defenses against phishing, it strengthens enterprise security at the browser level.</li>
992. </ul>
993. <p align="left"><b><b>Buy Full Research Report on</b></b><b><b> </b></b><b><b>Security Service Edge Market</b></b><b> </b><b><b>202</b></b><b><b>5</b></b><b><b>-2032 </b></b><b><b>@ </b></b><b><u><b><u>https://www.snsinsider.com/checkout/8297</u></b></u></b><b><b> </b></b></p>
994. <p align="left"><b><b>Exclusive Sections of the Report (The USPs)</b></b></p>
995. <ul>
996. <li style="text-align:left;"><b><b>Regional market leadership –</b></b> helps you understand how north america currently leads the market, while asia pacific is emerging as the fastest growing region supported by cloud adoption, regulatory reforms, and rising cyber threats.</li>
997. <li style="text-align:left;"><b><b>Enterprise adoption metrics –</b></b> helps you assess how large enterprises dominate due to complex it needs, while smes present high growth opportunities through lightweight, cost-effective, and easy-to-deploy sse solutions.</li>
998. <li style="text-align:left;"><b><b>Technological integration index –</b></b> helps you track the unification of secure web gateway, cloud access security broker, and zero trust network access into cloud-delivered platforms, providing seamless security across hybrid environments.</li>
999. <li style="text-align:left;"><b><b>Zero-trust implementation score –</b></b> helps you gauge the rising adoption of zero-trust frameworks as enterprises prioritize stronger access control and reduced vulnerabilities in cloud-first ecosystems.</li>
1000. <li style="text-align:left;"><b><b>Sector-specific adoption insights –</b></b> helps you evaluate why bfsi leads in adoption due to regulatory demands, while it and telecom are projected to grow fastest driven by multi-cloud adoption and decentralized data access.</li>
1001. <li style="text-align:left;"><b><b>Deployment model trends –</b></b> helps you uncover why cloud-based deployment dominates supported by saas and remote work trends, while hybrid models are accelerating in regulated industries needing flexibility between cloud and on-premises security.</li>
1002. <li style="text-align:left;"><b><b>Competitive innovation tracker –</b></b> helps you analyze vendor strategies such as ai-driven threat detection, adaptive policy enforcement, and new product launches shaping the sse landscape.</li>
1003. </ul>
1004. <p align="left"><b><b>About Us:</b></b></p>
1005. <p align="left">SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company&#8217;s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.</p>
1006. <pre>CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)</pre>
1007. <p><img alt="" src='https://ml.globenewswire.com/media/YjQxMjcxODQtZDBmMS00NzBiLWIyY2MtMjJlMDYzN2YyMjRhLTEyNjg4MTktMjAyNS0wOS0wMS1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1008. ]]></content:encoded>
1012. </item>
1013. <item>
1014. <title>AI in Food and Beverages Market Size to Hit USD 320.94 Billion by 2034, Fueled by Advanced Technology and Consumer Demand</title>
1015. <link>https://indiachron.com/ai-in-food-and-beverages-market-size-to-hit-usd-320-94-billion-by-2034-fueled-by-advanced-technology-and-consumer-demand/424957/</link>
1017. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
1018. <pubDate>Mon, 01 Sep 2025 14:00:00 +0000</pubDate>
1019. <category><![CDATA[Brand Post]]></category>
1020. <guid isPermaLink="false">http://indiachron.com/ai-in-food-and-beverages-market-size-to-hit-usd-320-94-billion-by-2034-fueled-by-advanced-technology-and-consumer-demand</guid>
1021.  
1022. <description><![CDATA[According to Towards FnB, the global AI in food and beverages market size is calculated at USD 16.36 billion in 2025 and surge to an astounding USD 320.94 billion by 2034, driven by an impressive CAGR of 39.2% throughout the forecast period. Key factors like automation and predictive analytics are revolutionizing how businesses meet evolving [&#8230;]]]></description>
1023. <content:encoded><![CDATA[<p><em>According to Towards FnB, the global AI in food and beverages market size is calculated at USD 16.36 billion in 2025 and surge to an astounding USD 320.94 billion by 2034, driven by an impressive CAGR of 39.2% throughout the forecast period. Key factors like automation and predictive analytics are revolutionizing how businesses meet evolving consumer demands, all while minimizing costs and reducing waste.</em></p>
1024. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The global <strong>AI in food and beverages market size</strong> stood at USD 11.75 billion in 2024 and is predicted to increase form USD 16.36 billion in 2025 to around USD 320.94 billion by 2034, expanding at a CAGR of 39.2% from 2025 to 2034, according to study published by Towards FnB, a sister firm of Precedence Research.</p>
1025. <p>The market is burgeoning in recent times as advanced technology helps in optimizing supply chain, aiding in personalized nutrition, and helping the food and beverage industry in the form of smart packaging and manufacturing.</p>
1026. <p align="center"><img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=3ff09bb7-6038-4dca-ba50-aff7dd0f210a&amp;size=3" height="392" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/3ff09bb7-6038-4dca-ba50-aff7dd0f210a/image1.png" width="697" /></p>
1027. <p><strong>Note: </strong><em><u>This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.</u></em></p>
1028. <p><strong>Access the Full Study Instantly | Download Sample Pages of the Report Now@ </strong><strong>https://www.towardsfnb.com/download-sample/5622</strong> </p>
1029. <p><strong>AI in Food and Beverages Market</strong> <strong>Overview</strong></p>
1030. <p>The AI in the food and beverages market is expanding due to multiple factors aiding in the growth of the market. Advanced technology for supply chain optimization, enhancing food quality, lowering food wastage, product development, and enhancing safety are some of the major factors helping the growth of AI in the food and beverages market. Reduced labor costs and <strong>smart packaging</strong> are also some of the major factors helpful for the growth of the market. AI also helps the food and beverage industry in the form of AI and ML by detecting minute issues immediately, which is not possible to detect manually with the naked eye, further enhancing the quality of the final product as well. AI is also beneficial for enhanced customization, helpful to cater to the specific needs of consumers, and helpful to target the growth of the market.</p>
1031. <p><strong>Key Highlights of AI in Food and Beverages Market</strong></p>
1032. <ul type="disc">
1033. <li style="margin-bottom:8pt;">By region, North America led the AI in the food and beverages market in 2024 with the largest share of 33%, whereas the Asia Pacific is expected to grow with the highest CAGR in the forecast period.</li>
1034. <li style="margin-bottom:8pt;">By technology, the machine learning segment contributed the largest market share of 30% in 2024, whereas the robotics and automation segment is expected to grow in the forecast period.</li>
1035. <li style="margin-bottom:8pt;">By deployment, the cloud segment dominated the AI in food and beverages market in 2024, whereas the on-premises segment is expected to grow in the foreseen period.</li>
1036. <li style="margin-bottom:8pt;">By end-use, the food processing segment dominated the AI in food and beverages market in 2024, whereas the supply-chain management is expected to grow in the forecast period.</li>
1037. <li style="margin-bottom:8pt;">By application, the quality control and safety compliance segment led the AI in the food and beverages market in 2024, whereas the production and packaging segment is expected to grow in the expected timeframe.</li>
1038. </ul>
1039. <p><strong>What are the Current Trends of AI in Food and Beverages Market?</strong></p>
1040. <ul type="disc">
1041. <li style="margin-bottom:8pt;">Advanced robotics, helpful in product designing and innovation, is one of the major factors for the growth of AI in the food and beverages market.</li>
1042. <li style="margin-bottom:8pt;">Increased demand for automation and innovation is another major factor for the growth of the market.</li>
1043. <li style="margin-bottom:8pt;">AI-powered analytics for supply chain management and keeping the consumers engaged and loyal towards the industry are also aiding the market’s growth.</li>
1044. <li style="margin-bottom:8pt;">AI algorithms are also essential for the food and beverage industry as they help in predictive analysis, which is helpful to detect the right time for maintenance of machines used for food manufacturing. It helps to lower the downtime chances and reduce time wastage, along with product wastage.</li>
1045. </ul>
1046. <p><strong>View Full Market Intelligence@ </strong><strong>https://www.towardsfnb.com/insights/ai-in-food-and-beverages-market</strong></p>
1047. <p><strong>Recent Developments in AI in Food and Beverages Market</strong></p>
1048. <ul type="disc">
1049. <li style="margin-bottom:8pt;"><strong>In August 2025</strong>, Kido Group, Vietnam’s leading food producer, teamed up with Chinese firm Yuguangtongchen to establish a joint venture named ‘AIRO’. The venture will specialize in AI-driven TV commercials, short films, and movies. (<strong>Source</strong>&#8211; https://theinvestor.vn/)</li>
1050. <li style="margin-bottom:8pt;"><strong>In June 2025</strong>, Yum China Holding, Inc. launched its AI-enabled assistant called Q-Smart to help restaurant managers manage daily operational tasks. The tool can be easily paired with various electronic devices such as smart watches and wireless earphones. (<strong>Source</strong>&#8211; https://www.restaurantindia.in)</li>
1051. </ul>
1052. <p><strong>Market Dynamics</strong></p>
1053. <p><strong>What Are the Drivers Helpful for the Growth of AI in Food and Beverages Market?</strong></p>
1054. <p>AI helps to automate repetitive tasks in production and packaging procedures, which is helpful for the growth of AI in the food and beverages market. AI algorithms help the industry in predictive analysis for lower downtime, enhanced operation of the machinery, and aid in timely maintenance of machines, which is helpful to lower wastage. The advanced technology also helps in product innovation and smart packaging, which is helpful for brands and the industry to keep the customers loyal and engaged, along with enhancing the pool of customers as well. AI also helps to manage supply chains and immediately detect events such as a shortage of raw materials, managing inventory, and streamline logistics as well.</p>
1055. <p><strong>Challenge</strong></p>
1056. <p><strong>Higher Costs and a Lack of Skilled Workers are hampering the Growth of the Market</strong>.</p>
1057. <p>Implementing AI solutions involving the purchase of hardware and software solutions can be expensive and, hence, is not an affordable option for small-scale F&amp;B industries. Hence, such industries follow the traditional methods of manufacturing and packaging filled with errors, leading to obstruction in the growth of AI in the food and beverages market. Costs incurred to recruit skilled personnel experienced in data science, along with experience in the F&amp;B segment, are another barrier to the growth of the market.</p>
1058. <p><strong>Opportunity</strong></p>
1059. <p><strong>Emerging Markets helping the Growth of AI in Food and Beverages Market in the Foreseen Period.  </strong></p>
1060. <p>Emerging markets are helping AI to flourish in the industry and making it more advanced. AI is helping the F&amp;B industry to enhance food safety, improve the quality of the product, automate repetitive tasks, and is also helpful for timely machine maintenance. Hence, the advanced technology has a huge opportunity to enhance the growth of AI in the food and beverage market. The advanced technology is also essential to enhance supply chains and keep a tap on various processes involved in the food manufacturing procedure.</p>
1061. <p><strong>AI in Food and Beverages Market Regional Analysis</strong></p>
1062. <p><strong>North America led the AI in Food and Beverages Market in 2024</strong></p>
1063. <p>Use of advanced technology for its infrastructure and in the form of reliable IT systems, data centers, and fast internet helped the growth of AI in the food and beverages market in North America in 2024. <strong>Growing demand for functional food</strong>, <strong>plant-based food</strong>, and personalized nutrition also helped the growth of the market in the region. Improved food quality and automation in maximum procedures also helped the growth of AI in the food and beverages market in the region.</p>
1064. <p align="center"><img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=c0910dfa-aedb-4921-b512-8a92a91f84d6&amp;size=3" height="385" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/c0910dfa-aedb-4921-b512-8a92a91f84d6/image2.png" width="685" /></p>
1065. <p><strong>Asia Pacific is Expected to Grow in the Forecast Period</strong></p>
1066. <p>Rising disposable income, growing middle class, and rapid urbanization are some of the factors helping the growth of AI in the food and beverages market in the Asia Pacific in the expected timeframe. Advanced technology is helping the industry to improve the food quality, automate maximum procedures, and manage the supply chains, and food safety is also helping the growth of the market in the region. The technology is also helping the industry in the form of <strong>personalized nutrition</strong> for specific customers as per their health conditions.</p>
1067. <p><strong>AI in Food and Beverages Market Report Scope</strong></p>
1068. <table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;">
1069. <tr>
1070. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; "><strong>Report Attribute</strong></td>
1071. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; "><strong>Key Statistics</strong></td>
1072. </tr>
1073. <tr>
1074. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Base Year</td>
1075. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">2024</td>
1076. </tr>
1077. <tr>
1078. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Forecast Period</td>
1079. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">2025 to 2034</td>
1080. </tr>
1081. <tr>
1082. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Growth Rate from 2025 to 2034</td>
1083. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">CAGR of 39.2%</td>
1084. </tr>
1085. <tr>
1086. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size in 2024</td>
1087. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">USD 11.75 Billion</td>
1088. </tr>
1089. <tr>
1090. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size in 2025</td>
1091. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">USD 16.36 Billion</td>
1092. </tr>
1093. <tr>
1094. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size by 2034</td>
1095. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">USD 320.94 Billion</td>
1096. </tr>
1097. <tr>
1098. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Dominated Region</td>
1099. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">North America</td>
1100. </tr>
1101. <tr>
1102. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Fastest Growing Region</td>
1103. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Asia Pacific</td>
1104. </tr>
1105. <tr>
1106. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Regions Covered</td>
1107. <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">North America, Europe, Asia-Pacific, Latin America and Middle East &amp; Africa</td>
1108. </tr>
1109. </table>
1110. <p><strong><br />Have Questions? Let’s Talk—Schedule a Meeting with Our Insights Team: </strong><strong>https://www.towardsfnb.com/schedule-meeting</strong></p>
1111. <p><strong>AI in Food and Beverages Market Segmental Analysis</strong></p>
1112. <p><strong>Technology Analysis</strong></p>
1113. <p>The <strong>machine learning segment</strong> led the AI in the food and beverages market in 2024. The food and beverage companies are optimizing machine learning to get useful insights, such as forecast details, changing consumer behavior, seasonal variations, and understanding market disruptions for the growth of the market. Machine learning is also helping the market to study in-depth consumer preferences, menu designing for maximum consumer retention, and pinpoint popular menu items for enhanced market growth.</p>
1114. <p>The robotics and automation segment is expected to grow in the expected timeframe, helping the growth of AI in the food and beverages market in the foreseeable period. The segment helps the industry to manage the rising demand for food and beverages, along with maintaining the food quality and safety, helping the growth of the market in the foreseeable future. The automation technology helps to automate multiple procedures, which are helpful for the growth of the market by lowering human intervention and reducing the chances of errors in manual procedures. Japan has made a major contribution to the growth of the market in the region in the form of AI-driven culinary robots to transform the food service segment.</p>
1115. <p><strong>Deployment Analysis</strong></p>
1116. <p>The cloud segment led the AI in the food and beverages market in 2024 because cloud-based services have helped the industry to improve customer service by streamlining ordering processes and enhancing delivery experience. The segment also enhances the importance of cloud systems to aid the decision-making procedure of the food and beverage industry, along with enhancing its operational efficiency as well. The segment also helps in managing various operations of the industry, managing supply chains, and offering creative solutions, with the help of remote services available on the internet. Inventory control, customer support, and Chatbots driven by AI are also some of the major factors helpful for the growth of the market.</p>
1117. <p>The on-premises segment is expected to grow in the foreseen period as the segment fulfills various needs such as data sovereignty, security, and compliance. The segment also highlights its benefits, such as cost controls and customization in various options, helping the growth of the market. The segment is also essential in scenarios where internet connectivity is weak and the industry needs to take immediate action and make decisions. The on-premises segment, under such circumstances, aids immediate decision-making and guarantees dependable performance.</p>
1118. <p><strong>End-Use Analysis</strong></p>
1119. <p>The <strong>food processing</strong> segment dominated the AI in food and beverages market in 2024, as the segment highlights the importance of automation in streamlining the manufacturing and <strong>food packaging</strong> procedures. It helps in enhancing the food quality and safety, further fueling the growth of AI in the food and beverages market. Machine learning procedures help to streamline and simplify the huge amount of data gathered along with historical data, and make beneficial decisions accordingly. The food and beverage industries are using AI on a higher scale these days to enhance operational procedures, improve food quality, and meet the rising market needs by regularizing supply chains.</p>
1120. <p>The supply chain management segment is expected to grow in the foreseen period by utilizing AI and aiding various procedures, such as optimizing the flow of materials, organizing them efficiently, and ensuring proper flow of such procedures for improved results. A variety of advanced technologies are helpful for supply chain management, enhancing delivery experience, and helping overall growth of the market in the forecast period.</p>
1121. <p><strong>Application Analysis</strong></p>
1122. <p>The quality control and safety compliance segment dominated the AI in food and beverages market in 2024 by enhancing food safety, improving food quality, keeping a tap on food inspection and quality control, upgrading shelf-life predictions, risk predictions, and improve public health and safety. Increasing demand for transparency and complete view of the procedures followed for food manufacturing to ensure safety is also helping the growth of market.</p>
1123. <p>The production and packaging segment is expected to grow in the foreseen period as AI-powered robots can manage various procedures such as sorting, packaging, and assembling items to lower human intervention and automate the whole procedure. Use of AI for smart packaging involving the use of sensors for tracking the packaging is also helping the growth of the market in the foreseeable future.</p>
1124. <p><strong>Feel Free to Get in Touch with Us for Orders or Any Questions at: </strong><strong>sales@towardsfnb.com</strong></p>
1125. <p><strong>Additional Topics Worth Exploring:</strong></p>
1126. <ul type="disc">
1127. <li style="margin-bottom:8pt;"><strong>Food and Beverage Industry Pumps Market</strong>: The global <strong>food and beverage industry pumps market size</strong> is expected to grow from USD 11.65 billion in 2025 to USD 22.57 billion by 2034, at a CAGR of 7.63% over the forecast period from 2025 to 2034.</li>
1128. <li style="margin-bottom:8pt;"><strong>Food Grade Lubricants Market: </strong>The global <strong>food grade lubricants market size</strong> increasing from USD 491.01 million in 2025 to USD 1,120.43 million by 2034, driven by a CAGR of 9.6% during the forecast period from 2025 to 2034.</li>
1129. <li style="margin-bottom:8pt;"><strong>Food Automation Market: </strong>The global <strong>food automation market size</strong> is set for steady growth increasing from USD 14.92 billion in 2025 to USD 28.61 billion by 2034, with a CAGR of 7.5% during the forecast period from 2025 to 2034.</li>
1130. <li style="margin-bottom:8pt;"><strong>3D Food Printing Market: </strong>The global <strong>3d food printing market size</strong> is projected to expand from USD 535.08 million in 2025 to USD 7,605.04 million by 2034, growing at a CAGR of 34.3% during the forecast period from 2025 to 2034.</li>
1131. <li style="margin-bottom:8pt;"><strong>Food Processing Market: </strong>The global <strong>food processing market size</strong> is projected to grow from USD 177.56 billion in 2025 to USD 318.29 billion by 2034, reflecting a CAGR of 6.7% over the forecast period from 2025 to 2034.</li>
1132. <li style="margin-bottom:8pt;"><strong>Food Processing Blades Market: </strong>The global <strong>food processing blades market size</strong> was calculated at USD 1.05 billion in 2024 and is anticipated to reach USD 2.46 billion by 2034, growing at a CAGR of 8.9% during the forecast period from 2025 to 2034.</li>
1133. <li style="margin-bottom:8pt;"><strong>Cheese Powder Market: </strong>The global <strong>cheese powder market size</strong> is projected to expand from USD 5.21 billion in 2025 to USD 9.33 billion by 2034, growing at a CAGR of 6.7% during the forecast period from 2025 to 2034.</li>
1134. <li style="margin-bottom:8pt;"><strong>Compound Feed Market: </strong>The global <strong>compound feed market size</strong> is expected to grow from USD 614.57 billion in 2025 to USD 986.58 billion by 2034, at a CAGR of 5.4% over the forecast period from 2025 to 2034.</li>
1135. </ul>
1136. <p><strong>AI in Food and Beverages Market Top Companies</strong></p>
1137. <ul type="disc">
1138. <li style="margin-bottom:8pt;">Rockwell Automation Inc.</li>
1139. <li style="margin-bottom:8pt;">TOMRA Sorting Solutions AS</li>
1140. <li style="margin-bottom:8pt;">Milltec Clarfai, Inc.</li>
1141. <li style="margin-bottom:8pt;">ABB Ltd.</li>
1142. <li style="margin-bottom:8pt;">INTELLIGENT Brewing Co.</li>
1143. <li style="margin-bottom:8pt;">Honeywell International Inc.</li>
1144. <li style="margin-bottom:8pt;">Sight Machine Inc.</li>
1145. <li style="margin-bottom:8pt;">Raytec Vision SpA</li>
1146. <li style="margin-bottom:8pt;">Key Technology Inc.</li>
1147. <li style="margin-bottom:8pt;">Google LLC</li>
1148. <li style="margin-bottom:8pt;">Impact Vision</li>
1149. <li style="margin-bottom:8pt;">SAP SE</li>
1150. <li style="margin-bottom:8pt;">NVIDIA Corporation</li>
1151. <li style="margin-bottom:8pt;">Buhler Group</li>
1152. <li style="margin-bottom:8pt;">IBM Corporation</li>
1153. <li style="margin-bottom:8pt;">Microsoft Corporation</li>
1154. </ul>
1155. <p><strong>Segments Covered in the Report</strong></p>
1156. <p><strong>By Technology </strong></p>
1157. <ul type="disc">
1158. <li style="margin-bottom:8pt;">Machine Learning</li>
1159. <li style="margin-bottom:8pt;">Computer Vision</li>
1160. <li style="margin-bottom:8pt;">Natural Language Processing</li>
1161. <li style="margin-bottom:8pt;">Robotics &amp; Automation</li>
1162. </ul>
1163. <p><strong>By Deployment </strong></p>
1164. <ul type="disc">
1165. <li style="margin-bottom:8pt;">Cloud</li>
1166. <li style="margin-bottom:8pt;">On-premises</li>
1167. </ul>
1168. <p><strong>By End-use </strong></p>
1169. <ul type="disc">
1170. <li style="margin-bottom:8pt;">Food Processing</li>
1171. <li style="margin-bottom:8pt;">Supply Chain Management</li>
1172. <li style="margin-bottom:8pt;">Hotel &amp; Restaurant</li>
1173. </ul>
1174. <p><strong>By Application</strong></p>
1175. <ul type="disc">
1176. <li style="margin-bottom:8pt;">Food Sorting</li>
1177. <li style="margin-bottom:8pt;">Consumer Engagement</li>
1178. <li style="margin-bottom:8pt;">Quality Control and Safety Compliance</li>
1179. <li style="margin-bottom:8pt;">Production and Packaging</li>
1180. <li style="margin-bottom:8pt;">Maintenance</li>
1181. <li style="margin-bottom:8pt;">Others</li>
1182. </ul>
1183. <p><strong>By Region</strong></p>
1184. <p>North America</p>
1185. <ul type="disc">
1186. <li style="margin-bottom:8pt;">U.S.</li>
1187. <li style="margin-bottom:8pt;">Canada</li>
1188. </ul>
1189. <p>Asia Pacific</p>
1190. <ul type="disc">
1191. <li style="margin-bottom:8pt;">China</li>
1192. <li style="margin-bottom:8pt;">Japan</li>
1193. <li style="margin-bottom:8pt;">India</li>
1194. <li style="margin-bottom:8pt;">South Korea</li>
1195. <li style="margin-bottom:8pt;">Thailand</li>
1196. </ul>
1197. <p>Europe</p>
1198. <ul type="disc">
1199. <li style="margin-bottom:8pt;">Germany</li>
1200. <li style="margin-bottom:8pt;">UK</li>
1201. <li style="margin-bottom:8pt;">France</li>
1202. <li style="margin-bottom:8pt;">Italy</li>
1203. <li style="margin-bottom:8pt;">Spain</li>
1204. <li style="margin-bottom:8pt;">Sweden</li>
1205. <li style="margin-bottom:8pt;">Denmark</li>
1206. <li style="margin-bottom:8pt;">Norway</li>
1207. </ul>
1208. <p>Latin America</p>
1209. <ul type="disc">
1210. <li style="margin-bottom:8pt;">Brazil</li>
1211. <li style="margin-bottom:8pt;">Mexico</li>
1212. <li style="margin-bottom:8pt;">Argentina</li>
1213. </ul>
1214. <p>Middle East and Africa (MEA)</p>
1215. <ul type="disc">
1216. <li style="margin-bottom:8pt;">South Africa</li>
1217. <li style="margin-bottom:8pt;">UAE</li>
1218. <li style="margin-bottom:8pt;">Saudi Arabia</li>
1219. <li style="margin-bottom:8pt;">Kuwait</li>
1220. </ul>
1221. <p><strong>Thank you for exploring our insights. For more targeted information, customized chapter-wise sections and region-specific editions such as North America, Europe, or Asia Pacific—are also available upon request.</strong></p>
1222. <p><strong>For Detailed Pricing and Tailored Market Report Options, Click Here: </strong><strong>https://www.towardsfnb.com/price/5622</strong></p>
1223. <p><strong>Feel Free to Get in Touch with Us for Orders or Any Questions at: </strong><strong>sales@towardsfnb.com</strong></p>
1224. <p>Unlock expert insights, custom research, and premium support with the Towards FnB Annual Membership. For USD 495/month (billed annually), get full access to exclusive F&amp;B market data and personalized guidance. It’s your strategic edge in the food and beverage industry: <strong>https://www.towardsfnb.com/get-an-annual-membership</strong></p>
1225. <p><strong>About Us</strong></p>
1226. <p>Towards FnB is a global consulting firm <strong>specializing in the food and beverage industry</strong><strong>,</strong> providing innovative solutions and expert guidance to elevate businesses. With an in-depth understanding of the dynamic F&amp;B sector, we deliver customized market analysis and strategic insights. Our team of seasoned professionals is committed to empowering clients with the knowledge needed to make informed decisions, ensuring they stay ahead of market trends. Partner with us as we redefine success in the rapidly evolving food and beverage landscape, and together, we’ll navigate this transformative journey.</p>
1227. <p><strong>Web: </strong><strong>https://www.towardsfnb.com/</strong></p>
1228. <p><strong>Our Trusted Data Partners</strong></p>
1229. <p><strong>Precedence Research</strong><strong> | </strong><strong>Statifacts</strong><strong> | </strong><strong>Towards Packaging</strong><strong> | </strong><strong>Towards Chemical and Materials</strong><strong>| </strong><strong>Nova One Advisor</strong> <strong>|</strong> <strong>Food Beverage Strategies</strong><strong> |</strong></p>
1230. <p><strong>For Latest Update Follow Us: </strong></p>
1231. <p><strong>LinkedIn</strong> | <strong>Medium</strong>| <strong>Twitter</strong></p>
1232. <p><strong>Discover More Market Trends and Insights from Towards FnB:</strong></p>
1233. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Sugar-Free Food Market: </strong><strong>https://www.towardsfnb.com/insights/sugar-free-food-market</strong></p>
1234. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Snack Food Market: </strong><strong>https://www.towardsfnb.com/insights/snack-food-market</strong></p>
1235. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Food Additives Market: </strong><strong>https://www.towardsfnb.com/insights/food-additives-market</strong></p>
1236. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Confectionery Market: </strong><strong>https://www.towardsfnb.com/insights/confectionery-market</strong></p>
1237. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Meal Kits Market: </strong><strong>https://www.towardsfnb.com/insights/meal-kits-market</strong></p>
1238. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Baking Ingredients Market: </strong><strong>https://www.towardsfnb.com/insights/baking-ingredients-market</strong></p>
1239. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Probiotic Food Market: </strong><strong>https://www.towardsfnb.com/insights/probiotic-food-market</strong></p>
1240. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Protein Bar Market: </strong><strong>https://www.towardsfnb.com/insights/protein-bar-market</strong></p>
1241. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong> Smoothie Market: </strong><strong>https://www.towardsfnb.com/insights/smoothie-market</strong></p>
1242. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong>Functional Ingredients Market: </strong><strong>https://www.towardsfnb.com/insights/functional-ingredients-market</strong></p>
1243. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong>Functional Ice Cream Market: </strong><strong>https://www.towardsfnb.com/insights/functional-ice-cream-market</strong></p>
1244. <p><strong><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/27a1.png" alt="➡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></strong><strong>Yeast Extract Market: </strong><strong>https://www.towardsfnb.com/insights/yeast-extract-market</strong></p>
1245. <p><img alt="" src='https://ml.globenewswire.com/media/Yzc5YmZiNGQtYzY0ZS00N2YwLWIxYWYtNzNhY2RiZWJjODMwLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1246. ]]></content:encoded>
1250. </item>
1251. <item>
1252. <title>Automotive Casting Market Worth USD 11.72 Billion by 2034 &#124; Towards Automotive</title>
1253. <link>https://indiachron.com/automotive-casting-market-worth-usd-11-72-billion-by-2034-towards-automotive/424956/</link>
1255. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
1256. <pubDate>Mon, 01 Sep 2025 14:00:00 +0000</pubDate>
1257. <category><![CDATA[Brand Post]]></category>
1258. <guid isPermaLink="false">http://indiachron.com/automotive-casting-market-worth-usd-11-72-billion-by-2034-towards-automotive</guid>
1259.  
1260. <description><![CDATA[According to Towards Automotive, the automotive casting market size was USD 5.55 billion in 2024 and is projected to reach USD 11.72 billion by 2024, growing at a CAGR of 7.76% from 2024 to 2034. Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The automotive casting market size is expected to increase from USD 5.98 billion in [&#8230;]]]></description>
1261. <content:encoded><![CDATA[<p><em>According to Towards Automotive, the automotive casting market size was USD 5.55 billion in 2024 and is projected to reach USD 11.72 billion by 2024, growing at a CAGR of 7.76% from 2024 to 2034.</em></p>
1262. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The <strong>automotive casting market size</strong> is expected to increase from USD 5.98 billion in 2025 to USD 11.72 billion by 2034, growing at a CAGR of 7.76% throughout the forecast period from 2025 to 2034. A study published by Towards Automotive a sister firm of Precedence Research.</p>
1263. <p align="center"><img decoding="async" bis_size="{&quot;x&quot;:344,&quot;y&quot;:160,&quot;w&quot;:612,&quot;h&quot;:344,&quot;abs_x&quot;:386,&quot;abs_y&quot;:878}" data-mce-src="/api/ImageRender/DownloadFile?resourceId=deca7deb-fa7c-42f2-b95a-455faeee62f7&amp;size=3" height="344.76px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/deca7deb-fa7c-42f2-b95a-455faeee62f7/image1.png" width="612.9px" /></p>
1264. <p><strong>Request a Custom Case Study Built Around Your Goals: </strong><strong>sales@towardsautomotive.com</strong></p>
1265. <p>The automotive casting market has gained traction in recent periods due to a hike in the <strong>automotive industry</strong>, along with the <strong>high adoption of EVs globally</strong>. The market is also growing as it aids in fuel efficiency, improves vehicle performance, and allows automotive brands to adhere to stringent emission regulations led by the government, which is further helpful for the growth of the market.</p>
1266. <p><strong>Key Highlights of the Automotive Casting Market</strong></p>
1267. <ul type="disc">
1268. <li style="margin-bottom:8pt;">By region, Asia Pacific led the automotive casting market, whereas North America is set to grow in the foreseen period due to rising automotive brands along with growing EV adoption in the region.</li>
1269. <li style="margin-bottom:8pt;">By material type, the aluminum segment led the automotive casting market, whereas the magnesium segment is expected to grow in the foreseeable period.</li>
1270. <li style="margin-bottom:8pt;">By process type, the die-casting segment led the automotive casting market, whereas the gravity casting segment is expected to grow in the expected timeframe.</li>
1271. <li style="margin-bottom:8pt;">By application, the engine parts segment led the automotive casting market, whereas the body assemblies segment is expected to grow in the forecast period.</li>
1272. <li style="margin-bottom:8pt;">By vehicle type, the passenger vehicles segment led the automotive casting market, whereas the <strong>commercial vehicles segment is expected to grow</strong> in the forecast period.</li>
1273. </ul>
1274. <p><strong>Market Overview </strong></p>
1275. <p>The rising automotive sector globally is helping the growth of the automotive casting market. The rise of EVs globally is also aiding the market’s growth, helping sustainable transport solutions as well. EVs require the use of specialized components, further fueling the growth of the market. The market deals with the manufacturing of various automotive parts, ensuring enhanced performance of the vehicle, enabling fuel efficiency, and following the emission regulations laid by the government as well.</p>
1276. <p>High demand for lightweight and efficient automotive parts is fueling the growth of the automotive casting market. Integration of AI in the automotive casting market is also helping its growth by keeping a tap on predictive analysis for lower downtime, real-time process, and analyzing the right time for maintenance to avoid high costs incurred for huge unexpected failures of the vehicle.</p>
1277. <p><strong>Download a Sample of Our Market Intelligence: </strong><strong>https://www.towardsautomotive.com/download-sample/1646</strong></p>
1278. <p><strong>New Trends of the Automotive Casting Market</strong></p>
1279. <ul type="disc">
1280. <li style="margin-bottom:8pt;">Numerous automotive market players are collaborating for the manufacturing of developed casting parts to maintain the supply chain, further enhancing the growth of the automotive casting market.</li>
1281. <li style="margin-bottom:8pt;">Automotive brands are also partnering with casting companies to design different types of automotive parts for improved performance of a vehicle.</li>
1282. <li style="margin-bottom:8pt;">The automotive casting companies are setting up new plants to maintain the casting supply chain and meet the growing automotive casting need, further fueling the market’s growth.</li>
1283. <li style="margin-bottom:8pt;">Advanced technology in the form of die casting and 3D printing further fuels the growth of the automotive casting market.</li>
1284. <li style="margin-bottom:8pt;">Stricter emission regulations are compelling casting companies to manufacture lightweight and fuel-efficient components, helping the growth of the automotive casting market.</li>
1285. </ul>
1286. <p><strong>Market Dynamics</strong></p>
1287. <p><strong>Driver</strong></p>
1288. <p><strong>What are the growth drivers of the Automotive Casting Market? </strong></p>
1289. <p>The rising automotive industry, along with the rising adoption of EVs globally, are the vital factors for the growth of the automotive casting market. Automotive brands today focus on components helpful to enhance the performance of a vehicle, along with adhering to strict emission regulations led by the government, which is enhancing the growth of the market.</p>
1290. <p>Technological advancements helpful for manufacturing components for monitoring real-time processes, optimizing predictive analysis for a vehicle’s timely maintenance, and lowering the downtime chances to reduce wastage are also some of the major components helpful for the market’s growth. Material flexibility, allowing casting companies to make lightweight as well as durable automotive parts, is also fueling the market’s growth.</p>
1291. <p><strong>Challenge</strong></p>
1292. <p><strong>What are the restraining factors obstructing the growth of the Automotive Casting Market?</strong></p>
1293. <p>High costs incurred due to fluctuating processes of various materials for the manufacturing of various automotive parts are one of the major factors obstructing the growth of the automotive casting market. High costs of energy consumption are another major market restraining factor. Capital investment required for upgrading casting facilities is also blocking the market’s growth, as a huge chunk of the required amount for upgrading the facility may not be possible for small casting companies. Intricate component designs and the use of advanced molding techniques, which are difficult for less-skilled workers, are also among the major challenges for the growth of the market.</p>
1294. <p><strong>Opportunity</strong></p>
1295. <p><strong>Rising Adoption of EVs is helping the Market Expand Globally </strong></p>
1296. <p>Rising adoption of EVs, further fueling the demand for intricate and lightweight components, is helping the market grow in the foreseeable period. High demand for aluminum and magnesium automotive components, as they are lightweight, is also helping the market grow. Technological advancements for EVs for predictive analysis, real-time monitoring, and analyzing timely maintenance for lowering the downtime chances are another major opportunity helpful for the growth of the automotive casting market.</p>
1297. <p><strong>Become a Valued Research Partner with Us &#8211; Schedule a meeting: </strong><strong>https://www.towardsautomotive.com/schedule-meeting</strong></p>
1298. <p><strong>Regional Analysis</strong></p>
1299. <p>High ownership of EVs and traditional vehicles in the Asia Pacific led the region to dominate the automotive casting market. High demand for aluminum die-cast parts such as motor housings and structural parts for vehicles is another major reason for the growth of the market in the region. Mass vehicle production in countries like India, China, and South Korea has made a major contribution to the growth of the market in the Asia Pacific. High demand for lightweight and durable components for efficient performance of vehicles, along with maintaining emission regulations, also helped in the growth of the automotive casting market.</p>
1300. <p>North America is expected to grow in the foreseen period due to high demand for aluminum and lightweight parts, which are helpful for fuel efficiency and enhanced performance of the vehicle. The US has a major contribution to the growth of the automotive casting market in North America due to high technological innovation in the area and rising manufacturing bases. Technological advancements in the die-cast process and various other fields also aid in the growth of the market in the foreseen period.</p>
1301. <p><strong>Segmental Analysis </strong></p>
1302. <p><strong>By Material Type</strong></p>
1303. <p>The aluminum segment led the automotive casting market due to high demand for lightweight and durable automotive components. It helps to enhance a vehicle’s performance, maintain fuel efficiency, and comply with emission regulations. The lightweight aluminum components are highly utilized for the manufacturing of various components such as structural heads, engine blocks, and various other essential parts.</p>
1304. <p>The magnesium segment is expected to grow in the foreseeable period as lightweight and durable components are in high demand. Such components are essential for <strong>ICEs</strong> and EVs globally as they aid in a vehicle’s efficient performance, utilize less fuel, promote cost savings, and allow companies to follow the stringent regulations helpful to lower the carbon footprint and maintain sustainability. The magnesium segment also allows for the manufacturing of specialized corrosion-resistant magnesium alloys, which are helpful for the market’s growth in the forecast period.</p>
1305. <p><strong>By Process Type</strong></p>
1306. <p>The die casting segment led the automotive casting market due to high demand for precision, lightweight, and cost-effective components for traditional as well as EVs globally. Magnesium components are essential for lightweight components for EVs, which are helpful to promote the vehicle’s improved performance. Simulation-based casting for durable and lightweight parts also helps the growth of the segment, further fueling the growth of the market. Advanced die casting solutions also help the growth of the market in the region.</p>
1307. <p>The gravity casting segment is expected to grow in the foreseen period as the segment utilizes gravity to fill permanent molds, producing high-integrity complex parts such as engine blocks and transmission parts. The segment also observes growth in the recent period due to the high importance of lightweight and durable parts for improved performance of the vehicle. Such lightweight parts also help in observing fuel efficiency and following emission regulations for the growth of the market. The segment is also expected to grow in the foreseen period due to lower tooling costs compared to other high-pressure methods.</p>
1308. <p><strong>More Insights of Towards Automotive:</strong></p>
1309. <ul type="disc">
1310. <li style="margin-bottom:8pt;"><strong>Electric Vehicle Power Inverter Market Growth, Demand, and Production Forecast 2034</strong> &#8211; The electric vehicle power inverter market is forecasted to expand from USD 8.16 billion in 2025 to USD 17.18 billion by 2034.</li>
1311. <li style="margin-bottom:8pt;"><strong>Battery Electric Vehicles (BEVs) Market Driven by 15.05% CAGR</strong> &#8211; The battery electric vehicles (BEVs) market is forecast to grow from USD 487.32 billion in 2025 to USD 1721.03 billion by 2034.</li>
1312. <li style="margin-bottom:8pt;"><strong>Europe Electric Vehicle Market Strategic Analysis and Growth Opportunities</strong> &#8211; The Europe electric vehicle market is projected to reach USD 6141.22 billion by 2034, expanding from USD 615.19 billion in 2025.</li>
1313. <li style="margin-bottom:8pt;"><strong>U.S. Electric Vehicle Market Analysis, Growth, Trends and Projections By 2034</strong> &#8211; The U.S. electric vehicle market is expected to increase from USD 136.31 billion in 2025 to USD 434.24 billion by 2034.</li>
1314. <li style="margin-bottom:8pt;"><strong>Electric Vehicle Taxi Market Size, Share and Growth Projections by 2034</strong> &#8211; The electric vehicle taxi market is projected to reach USD 80.77 billion by 2034, growing from USD 27.69 billion in 2025.</li>
1315. <li style="margin-bottom:8pt;"><strong>Micro Electric Vehicle Market Growth Drivers, Challenges and Opportunities</strong> &#8211; The micro electric vehicle market is forecasted to expand from USD 10.16 billion in 2025 to USD 28.49 billion by 2034</li>
1316. <li style="margin-bottom:8pt;"><strong>United Kingdom Electric Vehicle Adhesive Market Trends, Disruptors and Competitive Strategy</strong> &#8211; The United Kingdom electric vehicle adhesive market is expected to increase from USD 68.69 million in 2025 to USD 866.41 million by 2034.</li>
1317. <li style="margin-bottom:8pt;"><strong>Electric Vehicle Battery Thermal Management System Market Strategic Analysis by 2034</strong> &#8211; The electric vehicle battery thermal management system market is forecast to grow from USD 7.24 billion in 2025 to USD 93.89 billion by 2034.</li>
1318. <li style="margin-bottom:8pt;"><strong>Electric Vehicle Battery Coolant Market Size, Share and Growth Projections</strong> &#8211; The electric vehicle battery coolant market is projected to reach USD 3.15 billion by 2034, expanding from USD 2.24 billion in 2025.</li>
1319. <li style="margin-bottom:8pt;"><strong>Semiconductor Devices for Electric Vehicle Market Size, Share and Growth Projections</strong> &#8211; The semiconductor devices for electric vehicle market is set to grow from USD 13.47 billion in 2025 to USD 44.08 billion by 2034.</li>
1320. </ul>
1321. <p><strong>By Application Type</strong></p>
1322. <p>The engine parts segment led the automotive casting market, as the segment comprises key components such as cylinder blocks and cylinder heads. The segment led the market as it plays a vital role in a vehicle’s performance, maintaining fuel efficiency, and achieving accuracy with the help of proper casting.</p>
1323. <p>The body assemblies segment is observed to grow in the forecast period as the segment focuses on lightweight aluminum and magnesium parts for fuel efficiency and enhanced vehicle performance. Such vehicles also help in maintaining environmental regulations for sustainability. Precision die-cast parts and structural components help to lower the weight of the overall vehicles, contributing to the growth of the automotive casting market in the foreseeable period.</p>
1324. <p><strong>By Vehicle Type</strong></p>
1325. <p>The passenger vehicle segment led the automotive casting market due to high demand for lightweight vehicles and EVs globally, fueling the growth of the market. Such vehicles generally consist of aluminum and magnesium parts; they are lightweight, contributing to a vehicle’s improved performance and maintaining fuel efficiency. They also help in maintaining emission regulations to maintain sustainability. Components for engine blocks, transmission systems, chassis, and suspension are the key components for the segment, helpful for the growth of the market.</p>
1326. <p>The commercial vehicle segment is expected to grow in the foreseen period as the segment focuses on cast components for HCVs and LCVs, requiring high-strength iron and steel for chassis, engine, and transmission parts. Industrial growth, high demand for logistics, and evolving regulatory landscapes are some of the major factors helping the growth of the segment, further fueling the growth of the market in the foreseeable period.</p>
1327. <p><strong>Get the latest insights on automotive industry segmentation with our Annual Membership: </strong><strong>https://www.towardsautomotive.com/get-an-annual-membership</strong></p>
1328. <p><strong>Recent Developments in the Automotive Casting Market</strong></p>
1329. <ul type="disc">
1330. <li style="margin-bottom:8pt;">In June 2025, the BOD of Uno Minda Limited approved the establishment of an aluminium die casting manufacturing plant in Aurangabad, Maharashtra. The main aim of the establishment is to meet the increasing demand for casting components and smooth the supply chains as well.</li>
1331. <li style="margin-bottom:8pt;">In January 2025, Hot Wheels and Ferrari announced their partnership to develop a full range of Hot Wheels products. The partnership observed for the first time in 10 years will consist of die-cast products available for pre-order on Mattel Creations.</li>
1332. </ul>
1333. <p>Access our exclusive, data-rich dashboard dedicated to the automotive market – designed specifically for decision-makers, strategists, and industry leaders. Towards Automotive dashboard offers in-depth statistical insights, segment-wise market analysis, regional share breakdowns, comprehensive company profiles, annual updates, and much more. From market sizing to competitive benchmarking, this all-in-one platform is your strategic gateway to smarter, data-driven decisions.</p>
1334. <p><strong>Access the Dashboard: </strong><strong>https://www.towardsautomotive.com/contact-us</strong></p>
1335. <p><strong>Top Companies of the Automotive Casting Market</strong></p>
1336. <p align="center"><img decoding="async" bis_size="{&quot;x&quot;:347,&quot;y&quot;:3764,&quot;w&quot;:606,&quot;h&quot;:359,&quot;abs_x&quot;:389,&quot;abs_y&quot;:4482}" data-mce-src="/api/ImageRender/DownloadFile?resourceId=f4fea8d8-26aa-4994-a9e7-a2bd757188b0&amp;size=3" height="359.35px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/f4fea8d8-26aa-4994-a9e7-a2bd757188b0/image2.png" width="606.91px" /></p>
1337. <ul type="disc">
1338. <li style="margin-bottom:8pt;">Gibbs Die Casting</li>
1339. <li style="margin-bottom:8pt;">Regensburger Druckgusswerk Wolf GmbH</li>
1340. <li style="margin-bottom:8pt;">CFS Foundry</li>
1341. <li style="margin-bottom:8pt;">Endurance Technologies</li>
1342. <li style="margin-bottom:8pt;">Impro</li>
1343. <li style="margin-bottom:8pt;">Zetwerk</li>
1344. <li style="margin-bottom:8pt;">Zollern GmbH</li>
1345. </ul>
1346. <p><strong>Automotive Casting Market Segmentations</strong></p>
1347. <p><strong>By Material Type</strong></p>
1348. <ul type="disc">
1349. <li style="margin-bottom:8pt;">Aluminum</li>
1350. <li style="margin-bottom:8pt;">Iron (Gray Iron, Ductile Iron)</li>
1351. <li style="margin-bottom:8pt;">Magnesium</li>
1352. <li style="margin-bottom:8pt;">Zinc</li>
1353. <li style="margin-bottom:8pt;">Others (Steel, Copper, etc.)</li>
1354. </ul>
1355. <p><strong>By Process Type</strong></p>
1356. <ul type="disc">
1357. <li style="margin-bottom:8pt;">Die Casting</li>
1358. <li style="margin-bottom:8pt;">Sand Casting</li>
1359. <li style="margin-bottom:8pt;">Investment Casting</li>
1360. <li style="margin-bottom:8pt;">Gravity Casting</li>
1361. <li style="margin-bottom:8pt;">Others (Pressure Die Casting, Squeeze Casting, etc.)</li>
1362. </ul>
1363. <p><strong>By Application</strong></p>
1364. <ul type="disc">
1365. <li style="margin-bottom:8pt;">Engine Parts</li>
1366. <li style="margin-bottom:8pt;">Transmission Parts</li>
1367. <li style="margin-bottom:8pt;">Body Assemblies</li>
1368. <li style="margin-bottom:8pt;">Chassis</li>
1369. <li style="margin-bottom:8pt;">Others (Exhaust, Fuel System, etc.)</li>
1370. </ul>
1371. <p><strong>By Vehicle Type</strong></p>
1372. <ul type="disc">
1373. <li style="margin-bottom:8pt;">Passenger Vehicles</li>
1374. <li style="margin-bottom:8pt;">Commercial Vehicles</li>
1375. <li style="margin-bottom:8pt;">Electric Vehicles (EVs)</li>
1376. <li style="margin-bottom:8pt;">Off-highway Vehicles (Construction, Agriculture)</li>
1377. </ul>
1378. <p>By Sales Channel</p>
1379. <ul type="disc">
1380. <li style="margin-bottom:8pt;">OEMs (Original Equipment Manufacturers)</li>
1381. <li style="margin-bottom:8pt;">Aftermarket</li>
1382. </ul>
1383. <p><strong>By Region</strong></p>
1384. <ul type="disc">
1385. <li style="margin-bottom:8pt;">Asia-Pacific</li>
1386. <li style="margin-bottom:8pt;">Europe</li>
1387. <li style="margin-bottom:8pt;">North America</li>
1388. <li style="margin-bottom:8pt;">Latin America</li>
1389. <li style="margin-bottom:8pt;">Middle East &amp; Africa</li>
1390. </ul>
1391. <p><strong>Invest in Our Premium Strategic Solution: </strong><strong>https://www.towardsautomotive.com/price/1646</strong></p>
1392. <p><strong>Request a Custom Case Study Built Around Your Goals: </strong><strong>sales@towardsautomotive.com</strong></p>
1393. <p><strong>About Us</strong></p>
1394. <p>Towards Automotive is a leading research and consulting firm specializing in the global automotive industry. We deliver actionable insights across key segments such as electric vehicles (EVs), autonomous driving, connected cars, automotive software, aftermarket services, and more. Our expert team supports both global enterprises and start-ups with tailored research on market trends, technology, and consumer behavior. With a focus on accuracy and innovation, we empower clients to make informed decisions and stay competitive in a rapidly evolving landscape.</p>
1395. <p><strong>Stay Connected with Towards Automotive:</strong></p>
1396. <ul type="disc">
1397. <li style="margin-bottom:8pt;"><strong>Find us on Social Platforms: </strong><strong>LinkedIn</strong><strong> | </strong><strong>Twitter</strong><strong> | </strong><strong>Instagram</strong></li>
1398. <li style="margin-bottom:8pt;"><strong>Subscribe to Our Newsletter: </strong><strong>Towards AutoTech</strong></li>
1399. <li style="margin-bottom:8pt;"><strong>Read Our Printed Chronicle: </strong><strong>Automotive Web Wire</strong></li>
1400. <li style="margin-bottom:8pt;"><strong>Visit Towards Automotive for In-depth Market Insights: </strong><strong>Towards Automotive</strong></li>
1401. <li style="margin-bottom:8pt;"><strong>APAC: +91 9356 9282 04 | Europe: +44 778 256 0738 | North America: +1 8044 4193 44</strong></li>
1402. </ul>
1403. <p><strong>Get ahead of the trends – follow us for exclusive insights and industry updates: </strong><strong>Tumbler</strong><strong> | </strong><strong>Bloglovin</strong><strong> | </strong><strong>Medium</strong><strong> | </strong><strong>Hashnode</strong><strong> | </strong><strong>Pinterest</strong></p>
1404. <p><img alt="" src='https://ml.globenewswire.com/media/Mjk3YjVjYWEtM2EzNy00MTA1LTkxOWUtOTQzYmE4MjY0NGY3LTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1405. ]]></content:encoded>
1409. </item>
1410. <item>
1411. <title>Veterinary Artificial Insemination Market to Surpass USD 12.15 Billion by 2032 on Rising Demand for Genetic Improvement and Livestock Productivity – SNS Insider</title>
1412. <link>https://indiachron.com/veterinary-artificial-insemination-market-to-surpass-usd-12-15-billion-by-2032-on-rising-demand-for-genetic-improvement-and-livestock-productivity-sns-insider/424955/</link>
1414. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
1415. <pubDate>Mon, 01 Sep 2025 14:00:00 +0000</pubDate>
1416. <category><![CDATA[Brand Post]]></category>
1417. <guid isPermaLink="false">http://indiachron.com/veterinary-artificial-insemination-market-to-surpass-usd-12-15-billion-by-2032-on-rising-demand-for-genetic-improvement-and-livestock-productivity-sns-insider</guid>
1418.  
1419. <description><![CDATA[U.S. Veterinary Artificial Insemination Market to Grow from USD 1.52 Billion in 2024 to USD 2.65 Billion by 2032, Driven by Advancements in Reproductive Technologies and Expanding Dairy Industry Practices. Austin, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; Veterinary Artificial Insemination Market Size &#38; Growth Analysis: According to SNS Insider, the Veterinary Artificial Insemination Market size [&#8230;]]]></description>
1420. <content:encoded><![CDATA[<p><em>U.S. Veterinary Artificial Insemination Market to Grow from USD 1.52 Billion in 2024 to USD 2.65 Billion by 2032, Driven by Advancements in Reproductive Technologies and Expanding Dairy Industry Practices.</em></p>
1421. <p align="justify">Austin, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; <b>Veterinary Artificial Insemination Market Size &amp; Growth Analysis:</b></p>
1422. <p align="justify">According to SNS Insider, the <b>Veterinary Artificial Insemination Market</b> size was valued at USD 6.83 billion in 2024 and is projected to reach USD 12.15 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.48% between 2025 and 2032. The global veterinary artificial insemination market is entering a period of robust expansion, powered by growing demand for advanced breeding solutions, genetic improvement initiatives, and increasing reliance on sustainable livestock practices.</p>
1423. <p align="justify">In the United States, one of the leading markets worldwide, the veterinary artificial insemination industry was valued at USD 1.52 billion in 2024 and is expected to reach USD 2.65 billion by 2032, expanding at a CAGR of 7.26% during the forecast period. The U.S. market is benefitting from a strong commercial dairy sector, increased adoption of advanced reproductive technologies, and widespread use of AI for cattle breeding.</p>
1424. <p align="center"><b><img loading="lazy" decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=98baa309-a850-441f-90a2-8c095c8def46&amp;size=0" data-state="draft" height="400" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/98baa309-a850-441f-90a2-8c095c8def46/veterinary-artificial-insemination-market.jpg" title="Veterinary-Artificial-Insemination-Market.jpg" width="600" /><br /></b></p>
1425. <p align="center"><b>Get Free Sample Report of the Veterinary Artificial Insemination Market: https://www.snsinsider.com/sample-request/8261</b></p>
1426. <p align="justify"><b>Major Players Analysis</b></p>
1427. <p align="justify"><b><i>Leading companies in the veterinary artificial insemination market include:</i></b></p>
1428. <ul>
1429. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Cogent Breeding Ltd.</li>
1430. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">CRV Holding B.V.</li>
1431. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Genus plc (ABS Global, Inc.)</li>
1432. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">IMV Technologies</li>
1433. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">LIC (Livestock Improvement Corporation)</li>
1434. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Neogen Corporation</li>
1435. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Select Sires Inc.</li>
1436. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Semen Cardona </li>
1437. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Semex Alliance</li>
1438. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">ST Genetics</li>
1439. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Topigs Norsvin</li>
1440. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">URUS Group LP</li>
1441. <li style="margin-top:0cm; margin-bottom:8pt; text-align:justify;">Zoetis Inc.</li>
1442. </ul>
1443. <p align="justify"><b>Segment Analysis</b></p>
1444. <p align="justify"><b>By Solutions</b></p>
1445. <p align="justify">In 2024, services dominated the Veterinary Artificial Insemination Market with a 47.03% share. This growth is fueled by the increasing abundance of trained technicians, on-farm insemination procedures, genetic consulting, and reproductive health monitoring. Many farmers and livestock owners nowadays are availing of professional services to achieve efficiency, accuracy, and sustainability for their herds.</p>
1446. <p align="justify"><b>By Type</b></p>
1447. <p align="justify">The bovine segment accounted for the largest share of 62.64% in 2024 within the Veterinary Artificial Insemination Market. This dominance is due to large-scale adoption in dairy and beef production systems. In bovines, artificial insemination increases fertility, improves the quality of milk, and plays an important role in genetic grading of high-quality breeds.</p>
1448. <p align="justify"><b>By Distribution Channel</b></p>
1449. <p align="justify">Private channels held a commanding 76.98% market share in the Veterinary Artificial Insemination industry in 2024. This is increasingly adopted by commercial livestock farms, private veterinary practitioners, and breeding cooperatives. Faster adoption of advanced technologies, tailored services, and low-cost solutions makes private players a preferred option over public distribution systems.</p>
1450. <p align="center"><b>Need Any Customization Research on Veterinary Artificial Insemination Market, Enquire Now: https://www.snsinsider.com/enquiry/8261</b></p>
1451. <p align="justify"><b>North America Leads While Asia Pacific Emerges as Fastest-Growing Region in Veterinary Artificial Insemination Market 2024</b></p>
1452. <p align="justify">In 2024, North America dominated the Veterinary Artificial Insemination Market, accounting for 32.50% of overall revenue. Leadership in livestock industries derives from established livestock infrastructure, high awareness levels of the benefits of genetic improvement, and early adopters of AI in commercial dairy, beef and swine sectors. Service provision is bolstered by large networks of technicians and providers of specialised equipment, while collaborative research advances both the technology for sex-sorting and cryopreservation. Strict biosecurity measures and educational initiatives for farmers further point to AI as a better-sealed containment of breeding, solidifying North America as the market leader.</p>
1453. <p align="justify">The Asia Pacific region is projected to register the fastest CAGR of 7.94% over the forecast period, fueled by growing livestock populations, rising demand for animal protein, and government support programs. Programs such as the Rashtriya Gokul Mission and National AI Program in India subsidise AI services and promote their supply among smallholder dairy farmers. Country-specific example: Semen production and distribution networks are growing in countries like India and China, as livestock modernisation accelerates. Asia Pacific has been identified as fast-growing, along with stimulating factors like increased farmer awareness towards genetic advantages, rising income of farmers, and targeted extension services, accelerating the demand for AI and ultimately growing the Veterinary Artificial Insemination Market in the region.</p>
1454. <p align="justify"><b>Precision, Biosecurity, and Economic Gains Drive Veterinary Artificial Insemination Market Growth</b></p>
1455. <ul>
1456. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Sex-sorted semen and AI allow us to breed toward better traits — increasing herd advancement</li>
1457. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Compared to natural mating, Veterinary Artificial Insemination avoids the transmission of several diseases.</li>
1458. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Advanced reproductive solutions are also available for remote and smallholder farmers through mobile AI kits and technician-based services.</li>
1459. <li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Improved fertility and milk/meat yields deliver strong ROI for breeders, underpinning market adoption.</li>
1460. <li style="margin-top:0cm; margin-bottom:8pt; text-align:justify;">Government subsidy programs (e.g., India’s NAIP) plus industry services amplify AI penetration and scale in the Veterinary Artificial Insemination Market.</li>
1461. </ul>
1462. <p><strong>Recent Developments</strong></p>
1463. <ul>
1464. <li style="margin-top:0cm; margin-bottom:0cm;">Select Sires Inc. expanded its AI service portfolio in 2024 with advanced genomic testing solutions for dairy cattle.</li>
1465. <li style="margin-top:0cm; margin-bottom:0cm;">Zoetis introduced fertility management software integrated with AI tools in early 2025.</li>
1466. <li style="margin-top:0cm; margin-bottom:0cm;">ST Genetics launched new sexed semen technology in 2024, designed to optimize female calf production.</li>
1467. <li style="margin-top:0cm; margin-bottom:0cm;">Semex Alliance partnered with Canadian universities in 2025 to enhance cattle genomics research.</li>
1468. <li style="margin-top:0cm; margin-bottom:8pt;">IMV Technologies released next-generation cryopreservation tanks with improved storage efficiency in late 2024.</li>
1469. </ul>
1470. <p><strong>Statistical Insights &amp; Trends</strong></p>
1471. <ul>
1472. <li style="margin-top:0cm; margin-bottom:0cm;">Over 70% of dairy cattle in developed markets are bred using artificial insemination, a figure expected to rise further by 2032.</li>
1473. <li style="margin-top:0cm; margin-bottom:0cm;">AI adoption in swine breeding is expanding, with projected penetration reaching 45% by 2032.</li>
1474. <li style="margin-top:0cm; margin-bottom:0cm;">The average cost of AI per insemination ranges from USD 25–50, making it affordable compared to natural breeding management.</li>
1475. <li style="margin-top:0cm; margin-bottom:0cm;">Sexed semen technology is gaining traction, with demand increasing by 18% annually, particularly in dairy farming.</li>
1476. <li style="margin-top:0cm; margin-bottom:8pt;">Research suggests AI reduces the spread of venereal diseases in livestock by over 80% compared to natural mating practices.</li>
1477. </ul>
1478. <p align="center"><b>Buy the Full Veterinary Artificial Insemination Market Report (Single-User License) Now: https://www.snsinsider.com/checkout/8261</b></p>
1479. <p align="center"><b>Veterinary Artificial Insemination Market Report Scope</b></p>
1480. <table style="border-collapse: collapse; margin-left:auto; margin-right:auto; width:406pt; border-collapse:collapse ;">
1481. <tr>
1482. <td style="width:270.67px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; "><b>Report Attributes</b></td>
1483. <td style="width:270.67px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; "><b>Details</b></td>
1484. </tr>
1485. <tr>
1486. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size in 2024</td>
1487. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">USD 6.83 billion     </td>
1488. </tr>
1489. <tr>
1490. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size by 2032</td>
1491. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">USD 12.15 billion      </td>
1492. </tr>
1493. <tr>
1494. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">CAGR</td>
1495. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">CAGR of 7.48% From 2025 to 2032</td>
1496. </tr>
1497. <tr>
1498. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Base Year</td>
1499. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2024</td>
1500. </tr>
1501. <tr>
1502. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Forecast Period</td>
1503. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2025-2032</td>
1504. </tr>
1505. <tr>
1506. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Historical Data</td>
1507. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2021-2023</td>
1508. </tr>
1509. <tr>
1510. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Report Coverage</td>
1511. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC &amp; SWOT Analysis, Forecast Outlook</td>
1512. </tr>
1513. <tr>
1514. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Key Segments</td>
1515. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">By Solutions (Equipment &amp; Consumables, Semen, Services)</p>
1516. <p>By Type (Bovine, Swine, Ovine &amp; Caprine, Equine, Other Animals)</p>
1517. <p>By Distribution Channel (Private, Public)</td>
1518. </tr>
1519. <tr>
1520. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Regional Analysis</td>
1521. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East &amp; Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East &amp; Africa), Latin America (Brazil, Argentina, Rest of Latin America)</td>
1522. </tr>
1523. <tr>
1524. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Customization Scope</td>
1525. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Available upon request</td>
1526. </tr>
1527. <tr>
1528. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Pricing</td>
1529. <td style="width:270.67px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Available upon request</td>
1530. </tr>
1531. </table>
1532. <p align="center"><b>Access Complete Report Details of Veterinary Artificial Insemination Market Analysis &amp; Outlook@ https://www.snsinsider.com/reports/veterinary-artificial-insemination-market-8261</b></p>
1533. <p align="center"><b>[For more information or need any customization research mail us at info@snsinsider.com]</b></p>
1534. <p><b>About Us:</b></p>
1535. <p>SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company&#8217;s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.</p>
1536. <pre>CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com </pre>
1537. <p><img alt="" src='https://ml.globenewswire.com/media/Y2VkNjAxNGItODZjNS00YmY0LTgyZjMtNzRkMGM0ZWY2NzdlLTEyNjg4MTktMjAyNS0wOS0wMS1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1538. ]]></content:encoded>
1542. </item>
1543. <item>
1544. <title>Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034</title>
1545. <link>https://indiachron.com/acne-medicine-market-size-projected-to-reach-usd-23-33-billion-by-2034/424954/</link>
1547. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
1548. <pubDate>Mon, 01 Sep 2025 14:00:00 +0000</pubDate>
1549. <category><![CDATA[Brand Post]]></category>
1550. <guid isPermaLink="false">http://indiachron.com/acne-medicine-market-size-projected-to-reach-usd-23-33-billion-by-2034</guid>
1551.  
1552. <description><![CDATA[The global acne medication market is valued at USD 14.86 billion in 2025 and is projected to grow to approximately USD 23.33 billion by 2034, registering a compound annual growth rate (CAGR) of 5.14% over the forecast period. Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The global acne medication market size to rise from USD 14.13 [&#8230;]]]></description>
1553. <content:encoded><![CDATA[<p><em>The global acne medication market is valued at USD 14.86 billion in 2025 and is projected to grow to approximately USD 23.33 billion by 2034, registering a compound annual growth rate (CAGR) of 5.14% over the forecast period.</em></p>
1554. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The global <strong>acne medication market size</strong> to rise from USD 14.13 billion in 2024 and is expected to reach around USD 23.33 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.14%, according to a study by Towards Healthcare, a sister company of Precedence Research.</p>
1555. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=cc83ab09-681a-48c7-9705-1c662a55b2d9&amp;size=3" data-mce-style="display: block; margin-left: auto; margin-right: auto;" height="338.47px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/cc83ab09-681a-48c7-9705-1c662a55b2d9/image1.png" style="display:block; margin-left:auto; margin-right:auto;" width="601.74px" /><strong>The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @</strong> <strong>https://www.towardshealthcare.com/download-sample/5309</strong></p>
1556. <p><strong>Key Takeaways</strong></p>
1557. <ul type="disc">
1558. <li style="margin-bottom:8pt;">North America dominated the acne medicine market in 2023</li>
1559. <li style="margin-bottom:8pt;">Asia Pacific is the fastest-growing region in the acne medicine market.</li>
1560. <li style="margin-bottom:8pt;">By therapeutic class, the retinoid segment dominated the global acne medicine market in 2023.</li>
1561. <li style="margin-bottom:8pt;">Based on formulation, the topical medication segment dominated the acne medicine market in 2023.</li>
1562. <li style="margin-bottom:8pt;">Based on types, the prescription medicine segment dominated the acne medicine market.</li>
1563. <li style="margin-bottom:8pt;">Based on acne types, the non-inflammatory acne segment dominated the acne medicine market in 2023.</li>
1564. <li style="margin-bottom:8pt;">Based on distribution channels, the pharmacy and drug store segment dominated the acne medicine market in 2023.</li>
1565. </ul>
1566. <p><strong>Market Overview &amp; Potential</strong></p>
1567. <p>As lifestyles change, people of all ages can develop skin problems like acne that require proper medications and treatments to prevent them from worsening. Dermatologists play a crucial role in providing suitable preventive measures to patients through topical medications, oral medications, and therapies. These medications help reduce excess oils and swelling caused by bacterial infections or other common issues. Topical medications often include retinoids, antibiotics, azelaic acid, salicylic acid, or dapsone gel. Oral medications may include combined oral contraceptives or anti-androgen agents.</p>
1568. <p>Additionally, various therapies are available, such as light therapy, chemical peels, steroid injections, and more. In 2013, over 5.1 million people received medical treatment for acne, including children and adults. The demand for acne medications is growing rapidly, driving significant growth in the acne medicine market.</p>
1569. <p><strong>What is the Growth Potential Responsible for The Growth of The Acne Medicine Market?</strong></p>
1570. <p>The growth of the market is driven by the growing prevalence of acne due to various factors like stress, environmental factors, and hormonal imbalance, which increases the demand for medicine for treatment. The growing awareness of treatment and demand for technologically advanced therapies through integration of AI and <strong>telemedicine for remote consultations</strong>, which boosts the growth of the market. Other key drivers are the hormonal therapies demand, advancements treatment options, focus on clean and natural ingredients, and increased healthcare spending fuel the growth and expansion of the market.</p>
1571. <p><strong>You can place an order or ask any questions, please feel free to contact us at </strong><strong>sales@towardshealthcare.com</strong></p>
1572. <p><strong>What Are the Growing Trends Associated with the Acne Medicine Market?</strong></p>
1573. <p><strong>Increased demand for advanced therapies:</strong></p>
1574. <ul type="disc">
1575. <li style="margin-bottom:8pt;">There is a growing demand for <strong>innovative solutions like biologics</strong>, light-based therapies, and new drug formulations that offer better results, improved patient tolerance, and reduced reliance on antibiotics for severe acne.</li>
1576. </ul>
1577. <p><strong>Focus on retinoids and combination therapies:</strong></p>
1578. <ul type="disc">
1579. <li style="margin-bottom:8pt;">Retinoids are projected to see faster growth as demand increases for treating moderate to severe acne. The use of combination therapies is also on the rise, with treatments combining different types of agents for better efficacy.</li>
1580. </ul>
1581. <p><strong>Growing prevalence and awareness:</strong></p>
1582. <ul type="disc">
1583. <li style="margin-bottom:8pt;">The increasing prevalence of acne, a common skin condition affecting many people globally, combined with rising skin awareness and cosmetic concerns, is a major driver of market growth.</li>
1584. </ul>
1585. <p><strong>Advancements in telemedicine:</strong></p>
1586. <ul type="disc">
1587. <li style="margin-bottom:8pt;">The development of teledermatology and direct-to-consumer platforms is improving access to prescription acne care, especially in regions like India, where the market is rapidly expanding.</li>
1588. </ul>
1589. <p><strong>What Is the Growing Challenge in the Acne Medicine Market?</strong></p>
1590. <p>The key challenge which hinders the growth of the market is the adverse side effects associated with the medicines, like skin irritation or dizziness, lack of patient awareness of treatment option availability, availability of alternatives, high research and development costs, which affect the profitability and also result in high cost of final products, cost effectiveness, and treatment efficacy and duration. These factors limit the growth and expansion of the market.</p>
1591. <p><strong>Get the latest insights on life science industry segmentation with our Annual Membership: </strong><strong>https://www.towardshealthcare.com/get-an-annual-membership</strong></p>
1592. <p><strong>Regional Analysis</strong></p>
1593. <p><strong>How Did North America Dominate the Acne Medicine Market?</strong></p>
1594. <p>North America dominated the acne medicine market in 2023. The growth of the market is driven by the high prevalence of acne, which drives the demand for treatments due to the <strong>growing focus on skincare treatment</strong>. Innovation in treatments, and <strong>strong pharmaceutical presence in North America</strong>, also engage in research and development fuels the growth of the market. The key players like Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Galderma SA, and Johnson &amp; Johnson also play a crucial role in the growth and expansion of the market through innovation and research.</p>
1595. <p><strong>What Made the Asia Pacific Significantly Grow in The Acne Medicine Market? </strong></p>
1596. <p>Asia Pacific is the fastest-growing region in the acne medicine market. The growth of the market in the region is driven by the rising demand for patches due to their properties and benefits offered, which fuel the growth of the market. Other key drivers are the dominant distribution channels like E-commerce, and strategic partnerships to expand product portfolios boost the growth of the market. Key players like Ranbaxy Laboratories, Roche Diagnostics, Johnson &amp; Johnson, and Galderma play a significant role in the growth of the market.</p>
1597. <p><strong>Segmental Insights</strong></p>
1598. <p><strong>By therapeutic class, </strong></p>
1599. <p>The retinoid segment dominated the global acne medicine market in 2023. Retinol plays a crucial role in the acne medicine market as a widely used therapeutic class known for promoting cell turnover and preventing clogged pores. It helps reduce acne lesions, improve skin texture, and minimize scars. Retinol-based products are commonly prescribed for mild to moderate acne and are also incorporated into over-the-counter skincare formulations, making them a versatile solution for long-term acne management across diverse consumer groups.</p>
1600. <p><strong>Based on the formulation, </strong></p>
1601. <p>The topical medication segment dominated the acne medicine market in 2023. Topical medications are the most common formulation in acne treatment, offering direct application to affected areas with minimal systemic effects. These include creams, gels, and ointments containing retinoids, benzoyl peroxide, or antibiotics. Their ease of use, accessibility, and effectiveness in treating mild to moderate acne make them highly popular. Topical formulations are widely prescribed by dermatologists and are also available as over-the-counter products for self-care and prevention.</p>
1602. <p><strong>Become a valued research partner with us &#8211; </strong><strong>https://www.towardshealthcare.com/schedule-meeting</strong></p>
1603. <p><strong>Based on types, </strong></p>
1604. <p>The prescription medicine segment dominated the acne medicine market. Prescription medicines hold a significant share of the acne medicine market, targeting moderate to severe cases. These include stronger retinoids, oral antibiotics, and hormonal therapies prescribed under medical supervision. Prescription products offer higher efficacy and are tailored to individual patient needs, often used when over-the-counter solutions are insufficient. Growing dermatological consultations and awareness of advanced treatments continue to expand the demand for prescription acne medicines globally.</p>
1605. <p><strong>Based on acne types, </strong></p>
1606. <p>The non-inflammatory acne segment dominated the acne medicine market in 2023. The treatment of non-inflammatory acne, such as blackheads and whiteheads, is a key focus in the acne medicine market. Medications targeting excess sebum production and clogged pores, like retinoids and exfoliating agents, are highly effective. Demand is driven by a growing teenage population, lifestyle changes, and skincare awareness. Non-inflammatory acne treatments are often the first step before progressing to advanced solutions for inflammatory or severe acne types.</p>
1607. <p><strong>Based on distribution channels, </strong></p>
1608. <p>The pharmacy and drug store segment dominated the acne medicine market in 2023. Pharmacies and drug stores serve as primary distribution channels for acne medicines, offering both prescription and over-the-counter products. Their accessibility, immediate availability, and wide product variety make them the most preferred point of purchase. Consumers rely on these outlets for professional advice and convenient access to dermatology-recommended products. Growing retail pharmacy chains and the expansion of drug stores in urban and rural areas further strengthen this distribution segment.</p>
1609. <p><strong>Recent Developments</strong></p>
1610. <p>In April 2024, Bausch Health Companies Inc. announced the launch of its topical prescription treatment for acne vulgaris named PrARAZLO (tazarotene lotion, 0.045%). It is available to patients through BC PharmaCare, which is the public drug program of British Columbia.</p>
1611. <p><strong>Browse More Insights of Towards Healthcare:</strong></p>
1612. <p>The global <strong>AI in telehealth and telemedicine market</strong> is experiencing remarkable growth. From a valuation of US$ 3.89 billion in 2024, it surged to US$ 5.3 billion in 2025 and is projected to reach approximately US$ 86.31 billion by 2034, expanding at an impressive CAGR of 36.35% over the forecast period.</p>
1613. <p>Meanwhile, the <strong>nuclear medicine software market</strong> is steadily expanding. Starting at US$ 895.04 million in 2024, it grew to US$ 975.15 million in 2025 and is expected to cross US$ 2.1 billion by 2034, growing at a CAGR of 8.95%.</p>
1614. <p>In the <strong>U.S. life sciences sector</strong>, the market is poised for significant revenue growth, with projections suggesting it could reach hundreds of millions between 2025 and 2034.</p>
1615. <p>The <strong>nuclear medicine equipment market</strong> also shows consistent growth. From US$ 6.33 billion in 2024, it is anticipated to reach US$ 6.62 billion in 2025 and US$ 9.91 billion by 2034, supported by a CAGR of 4.58%.</p>
1616. <p>The global <strong>portable ultrasound market</strong> continues its upward trajectory. Valued at US$ 2.35 billion in 2024, it is expected to grow to US$ 2.56 billion in 2025 and hit US$ 5.53 billion by 2034, reflecting a CAGR of 8.94%.</p>
1617. <p>The <strong>precision diagnostics and medicine market</strong> is expanding rapidly, reaching USD 146.88 billion in 2024 and growing to USD 162.88 billion in 2025. By 2034, the market is projected to hit USD 412.95 billion, with a CAGR of 10.89% over the forecast period.</p>
1618. <p>The <strong>synthetic tissue engineering market</strong> is on a strong growth path as well. From US$ 1.51 billion in 2024, it rose to US$ 1.72 billion in 2025 and is projected to reach US$ 5.61 billion by 2034, at a CAGR of 14.14%.</p>
1619. <p>Similarly, the <strong>glycobiology market</strong> is expanding, starting from US$ 0.65 billion in 2024, growing to US$ 0.75 billion in 2025, and expected to reach US$ 2.63 billion by 2034, reflecting a CAGR of 14.91%.</p>
1620. <p>The <strong>life science lab equipment market</strong> continues its steady growth, valued at USD 57.71 billion in 2024, rising to USD 61.08 billion in 2025, and projected to reach USD 101.37 billion by 2034, expanding at a CAGR of 5.84%.</p>
1621. <p>Finally, the <strong>NGS-based RNA sequencing market</strong> is witnessing significant momentum. From USD 3.74 billion in 2024, it grew to USD 4.49 billion in 2025 and is forecasted to reach USD 23.52 billion by 2034, with a robust CAGR of 20.1%.</p>
1622. <p><strong>Acne Medicine Market Key Players </strong></p>
1623. <p align="center"><img decoding="async" data-mce-src="/api/ImageRender/DownloadFile?resourceId=55144df7-cc2f-4dc1-8d70-430c1a670189&amp;size=3" height="356.27px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/55144df7-cc2f-4dc1-8d70-430c1a670189/image2.png" width="601.74px" /></p>
1624. <ul type="disc">
1625. <li style="margin-bottom:8pt;">GlaxoSmithKline</li>
1626. <li style="margin-bottom:8pt;">Bausch Health Companies Inc.</li>
1627. <li style="margin-bottom:8pt;">Teva Pharmaceuticals</li>
1628. <li style="margin-bottom:8pt;">Bayer AG</li>
1629. <li style="margin-bottom:8pt;">Sun Pharmaceuticals</li>
1630. <li style="margin-bottom:8pt;">Botanix Pharmaceuticals</li>
1631. <li style="margin-bottom:8pt;">Allergan</li>
1632. <li style="margin-bottom:8pt;">Zydus LifeSciences Limited</li>
1633. <li style="margin-bottom:8pt;">Johnson and Johnson</li>
1634. <li style="margin-bottom:8pt;">Pfizer Inc.</li>
1635. <li style="margin-bottom:8pt;">Cosmo Pharmaceuticals</li>
1636. </ul>
1637. <p><strong>Segments Covered in The Report</strong></p>
1638. <p><strong>By Therapeutic Class</strong></p>
1639. <ul type="disc">
1640. <li style="margin-bottom:8pt;">Retinoid</li>
1641. <li style="margin-bottom:8pt;">Topical and Combination Retinoid</li>
1642. <li style="margin-bottom:8pt;">Oral Retinoid</li>
1643. </ul>
1644. <p><strong>By Formulation</strong></p>
1645. <ul type="disc">
1646. <li style="margin-bottom:8pt;">Topical Medication</li>
1647. <li style="margin-bottom:8pt;">Oral Medication</li>
1648. <li style="margin-bottom:8pt;">Antibiotics</li>
1649. </ul>
1650. <p><strong>By Type</strong></p>
1651. <ul type="disc">
1652. <li style="margin-bottom:8pt;">Prescription Medicines</li>
1653. <li style="margin-bottom:8pt;">Oral Antibiotics</li>
1654. <li style="margin-bottom:8pt;">Hormonal Treatments</li>
1655. <li style="margin-bottom:8pt;">Oral Contraceptive Tablets</li>
1656. </ul>
1657. <p><strong>By Acne Type</strong></p>
1658. <ul type="disc">
1659. <li style="margin-bottom:8pt;">Non-inflammatory Acne</li>
1660. <li style="margin-bottom:8pt;">Inflammatory Acne</li>
1661. </ul>
1662. <p><strong>By Distribution Channel</strong></p>
1663. <ul type="disc">
1664. <li style="margin-bottom:8pt;">Retail Store</li>
1665. <li style="margin-bottom:8pt;">Pharmacy and Drug Store</li>
1666. </ul>
1667. <p><strong>By Region</strong></p>
1668. <ul type="disc">
1669. <li style="margin-bottom:8pt;">North America
1670. <ul type="circle">
1671. <li style="margin-bottom:8pt;">U.S.</li>
1672. <li style="margin-bottom:8pt;">Canada</li>
1673. </ul>
1674. </li>
1675. <li style="margin-bottom:8pt;">Asia Pacific
1676. <ul type="circle">
1677. <li style="margin-bottom:8pt;">China</li>
1678. <li style="margin-bottom:8pt;">Japan</li>
1679. <li style="margin-bottom:8pt;">India</li>
1680. <li style="margin-bottom:8pt;">South Korea</li>
1681. <li style="margin-bottom:8pt;">Thailand</li>
1682. </ul>
1683. </li>
1684. <li style="margin-bottom:8pt;">Europe
1685. <ul type="circle">
1686. <li style="margin-bottom:8pt;">Germany</li>
1687. <li style="margin-bottom:8pt;">UK</li>
1688. <li style="margin-bottom:8pt;">France</li>
1689. <li style="margin-bottom:8pt;">Italy</li>
1690. <li style="margin-bottom:8pt;">Spain</li>
1691. <li style="margin-bottom:8pt;">Sweden</li>
1692. <li style="margin-bottom:8pt;">Denmark</li>
1693. <li style="margin-bottom:8pt;">Norway</li>
1694. </ul>
1695. </li>
1696. <li style="margin-bottom:8pt;">Latin America
1697. <ul type="circle">
1698. <li style="margin-bottom:8pt;">Brazil</li>
1699. <li style="margin-bottom:8pt;">Mexico</li>
1700. <li style="margin-bottom:8pt;">Argentina</li>
1701. </ul>
1702. </li>
1703. <li style="margin-bottom:8pt;">Middle East and Africa (MEA)
1704. <ul type="circle">
1705. <li style="margin-bottom:8pt;">South Africa</li>
1706. <li style="margin-bottom:8pt;">UAE</li>
1707. <li style="margin-bottom:8pt;">Saudi Arabia</li>
1708. <li style="margin-bottom:8pt;">Kuwait</li>
1709. </ul>
1710. </li>
1711. </ul>
1712. <p><strong>Immediate Delivery Available | Buy This Premium Research @ </strong><strong>https://www.towardshealthcare.com/price/5309</strong></p>
1713. <p>Access our exclusive, data-rich dashboard dedicated to the healthcare market &#8211; built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.</p>
1714. <p><strong>Access the Dashboard: </strong><strong>https://www.towardshealthcare.com/access-dashboard</strong></p>
1715. <p><strong>Become a valued research partner with us &#8211; </strong><strong>https://www.towardshealthcare.com/schedule-meeting</strong></p>
1716. <p><strong>About Us</strong></p>
1717. <p><strong>Towards Healthcare</strong> is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a <strong>strong emphasis on life science research</strong>. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.</p>
1718. <p><strong>You can place an order or ask any questions, please feel free to contact us at </strong><strong>sales@towardshealthcare.com</strong></p>
1719. <p><strong>Europe Region: </strong>+44 778 256 0738</p>
1720. <p><strong>North America Region: </strong>+1 8044 4193 44</p>
1721. <p><strong>APAC Region</strong>: +91 9356 9282 04</p>
1722. <p><strong>Web: </strong><strong>https://www.towardshealthcare.com</strong></p>
1723. <p><strong>Our Trusted Data Partners</strong></p>
1724. <p><strong>Precedence Research</strong><strong> | </strong><strong>Statifacts</strong><strong> | </strong><strong>Towards Packaging</strong><strong> | </strong><strong>Towards Automotive</strong><strong> |</strong> <strong>Towards Food and Beverages</strong><strong> | </strong><strong>Towards Chemical and Materials</strong><strong> | </strong><strong>Towards Consumer Goods</strong><strong> |</strong> <strong>Towards Dental</strong><strong> | </strong><strong>Towards EV Solutions</strong><strong> | </strong><strong>Nova One Advisor</strong><strong> | </strong><strong>Healthcare Webwire</strong><strong> | </strong><strong>Packaging Webwire</strong><strong> | </strong><strong>Automotive Webwire</strong></p>
1725. <p><strong>Find us on social platforms: </strong><strong>LinkedIn</strong><strong> | </strong><strong>Twitter</strong><strong> | </strong><strong>Instagram</strong><strong> | </strong><strong>Medium</strong><strong> | </strong><strong>Pinterest</strong></p>
1726. <p><img alt="" src='https://ml.globenewswire.com/media/MWE5MGY0YWUtZGZmOS00ZDZmLWI0ZDItNWQwYTBkMGIwOWEzLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1727. ]]></content:encoded>
1731. </item>
1732. <item>
1733. <title>PFAS-Free Food Packaging Market Drives USD 84.96 Bn by 2034 &#124; Towards Packaging</title>
1734. <link>https://indiachron.com/pfas-free-food-packaging-market-drives-usd-84-96-bn-by-2034-towards-packaging/424953/</link>
1736. <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
1737. <pubDate>Mon, 01 Sep 2025 14:00:00 +0000</pubDate>
1738. <category><![CDATA[Brand Post]]></category>
1739. <guid isPermaLink="false">http://indiachron.com/pfas-free-food-packaging-market-drives-usd-84-96-bn-by-2034-towards-packaging</guid>
1740.  
1741. <description><![CDATA[According to Towards Packaging, the global PFAS-free food packaging market will grow from USD 48 billion in 2025 to USD 84.96 billion by 2034, with an expected CAGR of 6.55%. Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The PFAS-free food packaging market size surpassed USD 45.05 billion in 2024 and is estimated to hit around USD [&#8230;]]]></description>
1742. <content:encoded><![CDATA[<p><em>According to Towards Packaging, the global PFAS-free food packaging market will grow from USD 48 billion in 2025 to USD 84.96 billion by 2034, with an expected CAGR of 6.55%.</em></p>
1743. <p>Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) &#8212; The <strong>PFAS-free food packaging market size</strong> surpassed USD 45.05 billion in 2024 and is estimated to hit around USD 84.96 billion by 2034, growing at a CAGR of 6.55% from 2025 to 2034. A study published by Towards Packaging a sister firm of Precedence Research.</p>
1744. <p align="center"><img decoding="async" bis_size="{&quot;x&quot;:349,&quot;y&quot;:160,&quot;w&quot;:604,&quot;h&quot;:339,&quot;abs_x&quot;:391,&quot;abs_y&quot;:878}" data-mce-src="/api/ImageRender/DownloadFile?resourceId=d26d14c0-1db7-4992-8001-d810bfa5f594&amp;size=3" height="339.85px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/d26d14c0-1db7-4992-8001-d810bfa5f594/image1.png" width="604.18px" /></p>
1745. <p><strong>Get All the Details in Our Solutions – Access Report Sample: </strong><strong>https://www.towardspackaging.com/download-sample/5666</strong></p>
1746. <p>The market is expanding rapidly due to increasing consumer awareness and regulatory pressure to eliminate harmful per- and polyfluoroalkyl substances (PFAS) from food contact materials. Rising health and environmental concerns associated with PFAS exposure are driving manufacturers to adopt safer alternatives, such as biodegradable coatings and natural barrier materials.</p>
1747. <p>The growth of food delivery and e-commerce has further accelerated demand for PFAS-free packaging that ensures food safety and sustainability. Innovations in compostable and recyclable materials, coupled with stringent government regulations across North America and Europe, are positioning PFAS-free packaging as a key solution in modern, eco-conscious food packaging strategies.</p>
1748. <p><strong>What is Meant by PFAS-Free Food Packaging?</strong></p>
1749. <p>PFAS-free food packaging refers to <strong>food packaging materials</strong> that are manufactured without per- and polyfluoroalkyl substances (PFAS), a group of synthetic chemicals used for their water-, grease-, and stain-resistant properties. PFAS are persistent in the environment and have been linked to health concerns such as hormonal disruption, liver damage, and certain cancers.</p>
1750. <p>PFAS-free packaging uses alternative materials or coatings that provide similar grease- and moisture-resistant functionality without the harmful chemicals. These alternatives can include biodegradable coatings, plant-based waxes, and other eco-friendly barriers, making the packaging safer for both consumers and the environment while meeting food safety and sustainability requirements.</p>
1751. <p><strong>If there is anything you&#8217;d like to ask, feel free to get in touch with us @ </strong><strong>sales@towardspackaging.com</strong></p>
1752. <p><strong>What are the Latest Trends in the PFAS-Free Food Packaging Market?</strong></p>
1753. <p><strong>Shift to Sustainable Materials</strong></p>
1754. <p>Manufacturers are adopting biodegradable and compostable materials, such as plant-based coatings and seaweed-derived films, to replace traditional PFAS-laden packaging.  For instance, companies like Notpla are developing <strong>seaweed-based packaging solutions</strong><strong>v</strong> that are both biodegradable and free from harmful chemicals.</p>
1755. <p><strong>Advancements in Barrier Coatings</strong></p>
1756. <p>Innovations in water-based and graphene oxide coatings are providing effective alternatives to PFAS, offering similar protective qualities without the associated health risks.  Graphene oxide coatings, for example, have been developed as non-toxic, compostable substitutes for PFAS in food packaging.</p>
1757. <p><strong>Regulatory Pressures</strong></p>
1758. <p>Governments worldwide are implementing stricter regulations to limit PFAS usage in food packaging.  In the United States, several states have enacted laws restricting PFAS in food containers, prompting manufacturers to seek safer alternatives.</p>
1759. <p><strong>Consumer Awareness</strong></p>
1760. <p>There is a growing consumer preference for products with transparent and eco-friendly packaging.  Brands are responding by adopting PFAS-free packaging solutions to meet consumer expectations and enhance brand loyalty.</p>
1761. <p><strong>What Potentiates the Growth of the PFAS-Free Food Packaging Market?</strong></p>
1762. <p><strong>Health and Safety Concerns &amp; Consumer Preference for Sustainable Packaging</strong></p>
1763. <p>Rising awareness of the harmful effects of PFAS, which are linked to cancer, hormonal disruption, and other health issues, is pushing both consumers and manufacturers toward safer alternatives. Eco-conscious consumers increasingly demand packaging that is safe, biodegradable, and environmentally friendly, boosting PFAS-free solutions. The expansion of consumer preference for <strong>sustainable packaging is a major growth driver</strong> for the PFAS-free food packaging market.</p>
1764. <p>Modern consumers are increasingly eco-conscious and health-aware, seeking products packaged in materials that are safe, biodegradable, and environmentally friendly. This shift in behaviour encourages food and beverage companies to adopt PFAS-free alternatives, which avoid harmful chemicals while offering compostable or recyclable options. Brands that provide sustainable packaging can enhance their reputation, gain consumer trust, and differentiate themselves in competitive markets.</p>
1765. <p><strong>More Insights of Towards Packaging: </strong></p>
1766. <ul type="disc">
1767. <li style="margin-bottom:8pt;"><strong>Chemical Repackaging Market Insights 2025: JPFL Launches India’s First BOPA Nylon Films, Boosting Aroma Barrier Packaging</strong> &#8211; The chemical repackaging market is booming, poised for a revenue surge into the hundreds of millions from 2025 to 2034.</li>
1768. <li style="margin-bottom:8pt;"><strong>Agriculture Chemical Packaging Market: Driving Sustainability with Smart, Secure Solutions</strong> &#8211; The agriculture chemical packaging market is expected to increase from USD 4.91 billion in 2025 to USD 7.39 billion by 2034.</li>
1769. <li style="margin-bottom:8pt;"><strong>Chemical Packaging Material Market Insights, Forecast and Competitive Strategies</strong> &#8211; The chemical packaging material market is on a strong growth trajectory, with revenue expected to surge into the hundreds of millions from 2025 to 2034.</li>
1770. <li style="margin-bottom:8pt;"><strong>Chemicals Packaging Coding Equipment Market Strategic Insights for 2034</strong> &#8211; The chemicals packaging coding equipment market is forecast to grow from USD 1.22 billion in 2025 to USD 1.53 billion by 2034.</li>
1771. <li style="margin-bottom:8pt;"><strong>Daily Chemical Product Stand Up Pouches Market Strategic Growth, Innovation &amp; Investment Trends</strong> &#8211; The daily chemical product stand up pouches market size reached US$ 241.16 million in 2024 and is projected to hit around US$ 387.24 million by 2034.</li>
1772. <li style="margin-bottom:8pt;"><strong>Pharmaceutical and Chemical Aluminum Bottles and Cans Market Strategic Insights for 2034</strong> &#8211; The pharmaceutical and chemical aluminum bottles and cans market is anticipated to grow from USD 2368.51 million in 2025 to USD 2477.25 million by 2034.</li>
1773. <li style="margin-bottom:8pt;"><strong>Chemicals Packaging Market Key Business Drivers &amp; Industry Forecast</strong> &#8211; The chemicals packaging market is expected to increase from USD 16.56 billion in 2025 to USD 22.79 billion by 2034.</li>
1774. <li style="margin-bottom:8pt;"><strong>Cling Films Market Size Driven by 12.5% CAGR (2025-2034)</strong> &#8211; The global cling films market is forecast to grow from USD 13.06 billion in 2025 to USD 19.41 billion by 2034.</li>
1775. <li style="margin-bottom:8pt;"><strong>Industrial Bulk Packaging Market Size Driven by 3.25% (2025-34)</strong> &#8211; The global industrial bulk packaging market is projected to reach USD 37.86 billion by 2034, expanding from USD 28.39 billion in 2025.</li>
1776. <li style="margin-bottom:8pt;"><strong>North America Packaging Market Size Drives at 4.33% CAGR</strong> &#8211; The North America packaging market is forecasted to expand from USD 333.86 billion in 2025 to USD 488.92 billion by 2034.</li>
1777. </ul>
1778. <p><strong>Limitations &amp; Challenges in the PFAS-Free Food Packaging Market</strong></p>
1779. <p><strong>Limited Material Performance &amp; Supply Chain Constraints</strong></p>
1780. <p>The key players operating in the market are facing issues due to supply chain constraints and limited material performance. Some PFAS-free materials may not yet match the water-, grease-, and oil-resistant properties of PFAS-based packaging, which can limit their adoption, especially for high-demand food products. The availability of sustainable and PFAS-free raw materials can be limited, leading to production bottlenecks and slower market penetration.</p>
1781. <p><strong>Regional Analysis:</strong></p>
1782. <p><strong>Who is the leader in the PFAS-Free Food Packaging Market?</strong></p>
1783. <p>North America dominates the PFAS-free food packaging market due to a combination of stringent regulations, high consumer awareness, and strong industry adoption. Regulatory frameworks in the U.S. and Canada, such as state-level PFAS bans in food contact materials, have compelled manufacturers to shift toward safer alternatives.</p>
1784. <p>Additionally, consumers in North America are increasingly demanding environmentally friendly and chemical-free packaging, motivating brands to adopt PFAS-free solutions. Technological advancements and investments in sustainable materials, along with the presence of major food and beverage companies prioritizing health and safety, further strengthen the region’s leadership in the market.</p>
1785. <p><strong>U.S. Market Trends</strong></p>
1786. <p>The U.S. leads the market due to strict state-level regulations, such as California’s Safer Consumer Products program and New York’s bans on PFAS in paper-based food packaging, which compel manufacturers to adopt safer alternatives. Rising consumer awareness of the health risks associated with PFAS has further accelerated demand for chemical-free packaging solutions. Food and beverage companies are increasingly prioritizing PFAS-free materials to comply with regulations, maintain brand reputation, and meet consumer expectations, positioning the U.S. as a dominant player in this market.</p>
1787. <p><strong>Canada Market Trends</strong></p>
1788. <p>In Canada, regulators have recognized the risks of PFAS in food packaging and are exploring risk management and potential regulatory measures. Although comprehensive bans are not yet in place, growing consumer demand for sustainable and chemical-free packaging is encouraging manufacturers to adopt PFAS-free alternatives. Canadian companies are proactively shifting toward safer packaging to align with environmental concerns and anticipate future regulations, which is steadily driving market growth and positioning Canada as a significant adopter in the PFAS-free food packaging segment.</p>
1789. <p><strong>How is the Opportunistic Rise of the Asia Pacific in the PFAS-Free Food Packaging Market?</strong></p>
1790. <p>Asia-Pacific is witnessing the fastest growth in the PFAS-free food packaging market due to increasing consumer awareness about health and environmental impacts, rapid urbanization, and the rising demand for sustainable and safe packaging in the food and beverage sector.</p>
1791. <p>Governments in countries such as China, Japan, and South Korea are implementing stricter regulations and guidelines to reduce harmful chemicals in packaging, prompting manufacturers to shift toward PFAS-free alternatives. Additionally, the expansion of e-commerce and food delivery services in the region is <strong>driving demand for eco-friendly packaging solutions</strong>, further accelerating market growth and adoption of PFAS-free materials.</p>
1792. <p><strong>China Market Trends</strong></p>
1793. <p>China’s market is growing rapidly due to increasing consumer demand for safer and sustainable <strong>packaging solutions</strong>, along with stricter environmental regulations. Manufacturers are adopting PFAS-free materials to comply with domestic and international standards. The government’s focus on environmental sustainability further drives the shift toward safer packaging alternatives, encouraging innovation and adoption of chemical-free materials across the food and beverage sector.</p>
1794. <p><strong>Japan Market Trends</strong></p>
1795. <p>Japan leads in PFAS-free food packaging adoption, driven by stringent regulations and strong consumer preference for environmentally friendly products. Policies aimed at reducing harmful chemicals in packaging are motivating manufacturers to explore safer alternatives. Increasing public awareness of health and environmental concerns is accelerating the transition to PFAS-free solutions across the food industry.</p>
1796. <p><strong>India Market Trends</strong></p>
1797. <p>In India, the PFAS-free food packaging market is gradually expanding as consumers become more aware of health and environmental issues. Although regulations are still developing, manufacturers are exploring PFAS-free alternatives to meet global sustainability trends and growing demand in organized retail and foodservice sectors.</p>
1798. <p><strong>South Korea Market Trends</strong></p>
1799. <p>South Korea is witnessing significant growth due to strict environmental regulations and a strong focus on sustainability. Government policies reducing hazardous substances in packaging, coupled with rising consumer demand for eco-friendly products, are driving manufacturers to adopt PFAS-free packaging solutions and innovate in this segment.</p>
1800. <p><strong>Join now to access the latest packaging in industry segmentation insights with our Annual Membership: </strong><strong>https://www.towardspackaging.com/get-an-annual-membership</strong></p>
1801. <p><strong>How Big is the Success of the North America PFAS-Free Food Packaging Market?</strong></p>
1802. <p>Europe is growing at a notable rate in the market due to stringent environmental regulations, increasing consumer awareness of health and sustainability, and the strong push toward eco-friendly packaging solutions. Governments and regulatory bodies across countries such as Germany, France, and the UK have implemented policies to restrict harmful chemicals in food packaging, compelling manufacturers to adopt safer alternatives.</p>
1803. <p>Additionally, the growing preference for organic and clean-label products is driving demand for PFAS-free packaging. The presence of innovative packaging companies and rising investments in sustainable packaging technologies further support market expansion across Europe.</p>
1804. <p><strong>How Crucial is the Role of Latin America in the PFAS-Free Food Packaging Market?</strong></p>
1805. <p>Latin America is experiencing considerable growth in the PFAS-free food packaging market due to increasing consumer awareness of health and environmental issues, coupled with growing demand for safe and sustainable packaging solutions in the food and beverage sector. Governments in countries like Brazil, Mexico, and Argentina are beginning to implement regulations and guidelines that encourage the reduction of harmful chemicals in food contact materials.</p>
1806. <p>Additionally, the expansion of modern retail, e-commerce, and food delivery services is driving the adoption of PFAS-free packaging. Rising investments in sustainable materials and innovative packaging technologies further support market growth in the region.</p>
1807. <p><strong>How does the Middle East and Africa lead the PFAS-Free Food Packaging Market?</strong></p>
1808. <p>The Middle East and Africa (MEA) offers significant growth potential for the market due to a combination of regulatory initiatives, rising consumer awareness, and sustainability trends. Countries such as the UAE and Saudi Arabia are implementing stricter food safety and packaging regulations, encouraging manufacturers to adopt safer, PFAS-free alternatives.</p>
1809. <p>Increasing public awareness about the health risks associated with PFAS compounds is further driving demand for chemical-free packaging. Additionally, the growing emphasis on eco-friendly solutions and the expansion of modern retail and foodservice sectors are promoting the adoption of innovative and compliant PFAS-free packaging solutions across the region.</p>
1810. <p><strong>Elevate your packaging strategy with Towards Packaging. Enhance efficiency and achieve superior results &#8211; schedule a call today: </strong><strong>https://www.towardspackaging.com/schedule-meeting</strong></p>
1811. <p><strong>Segment Outlook</strong></p>
1812. <p><strong>Packaging Type Insights</strong></p>
1813. <p>The <strong>wraps and liners</strong> segment dominates the PFAS-free food packaging market due to its widespread use in quick-service restaurants, bakeries, and food delivery services, where grease and moisture resistance are critical. With growing concerns over the harmful effects of PFAS chemicals, foodservice providers are increasingly shifting toward PFAS-free wraps and liners that ensure safety while maintaining functionality.</p>
1814. <p>Consumer demand for healthier, non-toxic packaging solutions has further boosted adoption. Additionally, the rising popularity of takeaway and ready-to-eat meals has significantly increased the use of sustainable wraps and liners, making this segment the most widely adopted in PFAS-free food packaging.</p>
1815. <p>The <strong>clamshells and hinged container</strong> segment is the fastest-growing in the market due to the rapid rise of takeaway, delivery, and on-the-go food consumption. These containers are widely used for hot, greasy, or moist foods, which previously relied on PFAS-coated packaging for durability and resistance. With growing bans and restrictions on PFAS, foodservice providers are increasingly adopting safer alternatives that offer similar performance without harmful chemicals. The push for eco-friendly, compostable, and recyclable options also supports this growth, as consumers and businesses prefer sustainable packaging solutions that align with health and environmental priorities.</p>
1816. <p><strong>Material Type Insights</strong></p>
1817. <p>The <strong>paper and paperboard</strong> segment dominates the PFAS-free food packaging market because of its versatility, cost-effectiveness, and eco-friendly nature. With increasing bans on PFAS chemicals in food packaging, paper-based alternatives have emerged as the preferred choice for manufacturers and foodservice providers. They are widely used for wraps, cartons, trays, and liners due to their biodegradability and recyclability, aligning with global sustainability goals.</p>
1818. <p>Advances in barrier coatings and water-based technologies have improved the grease and moisture resistance of paper packaging, making it a strong replacement for PFAS-treated materials. Rising consumer demand for safe, non-toxic, and sustainable packaging further reinforces the dominance of this segment.</p>
1819. <p>The <strong>bioplastic</strong> segment is the fastest-growing in the market due to its strong alignment with sustainability trends and rising demand for eco-friendly alternatives. Unlike traditional plastics, bioplastics are derived from renewable sources such as corn starch, sugarcane, and cellulose, making them attractive to both consumers and regulators seeking to reduce environmental impact. They offer durability, flexibility, and improved barrier properties without relying on harmful PFAS chemicals.</p>
1820. <p>Growing investments in biopolymer innovation, along with increasing adoption by foodservice chains and packaging manufacturers, further accelerate growth. Additionally, consumer preference for <strong>compostable and biodegradable packaging fuels</strong> the rapid expansion of this segment.</p>
1821. <p><strong>End-Use Sector Insights</strong></p>
1822. <p>The <strong>quick-service restaurants</strong> segment dominates the PFAS-free food packaging market due to its high consumption of disposable packaging and strong pressure to adopt sustainable alternatives. With increasing regulations banning PFAS in food contact materials, QSRs are rapidly shifting to safer, eco-friendly options to maintain compliance and protect brand reputation.</p>
1823. <p>Major chains are adopting PFAS-free wraps, liners, clamshells, and cups to meet consumer expectations for health and environmental safety. The segment’s dominance is further reinforced by the large volume of daily transactions, where sustainable packaging directly impacts waste reduction. Growing customer preference for greener dining solutions strengthens QSRs’ leadership in this market.</p>
1824. <p>The <strong>retail and supermarkets</strong> segment is the fastest-growing in the market, as these outlets play a central role in directly influencing consumer choices. With rising consumer awareness about the health risks of PFAS and increasing demand for safer, eco-friendly packaging, supermarkets are under pressure to offer sustainable alternatives across fresh produce, bakery, frozen, and ready-to-eat categories.</p>
1825. <p>Many leading retailers are introducing PFAS-free packaging lines to align with corporate sustainability goals and comply with tightening regulations. The segment’s rapid growth is also supported by the high turnover of packaged goods and private-label brands, where eco-friendly packaging becomes a key differentiator to attract environmentally conscious shoppers.</p>
1826. <p><strong>Access our exclusive, data-rich dashboard dedicated to the PFAS-Free Food Packaging Market built specifically for decision-makers, strategists, and industry leaders. This interactive platform provides comprehensive statistical insights, segment-wise market breakdowns, regional performance analysis, detailed company profiles, annual updates, and much more. From market sizing and growth projections to competitive intelligence and regulatory trends, our dashboard serves as a one-stop solution to empower smarter decisions in the fast-evolving sustainable packaging industry.</strong></p>
1827. <p><strong>Access Now: </strong><strong>https://www.towardspackaging.com/contact-us</strong></p>
1828. <p><strong>Recent Breakthroughs in the Global Market</strong></p>
1829. <ul type="disc">
1830. <li style="margin-bottom:8pt;"><strong>In June 2025</strong>, Lecta Self-Adhesives announced the launch of &#8220;Adestor Gloss GP PFAS-free,&#8221; a new label solution designed specifically for the food packaging sector, which will broaden its portfolio of self-adhesive materials. Without the use of perfluoroalkyl substances (PFAS), this product offers a grease-resistant label while adhering to strict environmental and health regulations. Adestor Gloss GP PFAS-free is made from paper that has been certified by the Forest Stewardship Council (FSC) C011032, guaranteeing excellent performance and grease and oil resistance.</li>
1831. <li style="margin-bottom:8pt;"><strong>In April 2024,</strong> Kao Corporation wants to realize resource circularity in society by achieving net-zero waste in <strong>plastic packaging</strong> by 2040 and negative waste by 2050 for plastic containers used and discharged in its business operations. The company plans to achieve this by first using as little plastic packaging as possible in its operations and then recycling plastic waste produced by society to produce goods and services that are beneficial. Kao launched the Kirei Lifestyle Plan, its ESG strategy, in April 2019. This strategy supports the zero-waste leadership action, one of the 19 leadership actions outlined in this plan.</li>
1832. </ul>
1833. <p><strong>Global PFAS-Free Food Packaging Market Players</strong></p>
1834. <p align="center"><img decoding="async" bis_size="{&quot;x&quot;:345,&quot;y&quot;:5081,&quot;w&quot;:612,&quot;h&quot;:362,&quot;abs_x&quot;:387,&quot;abs_y&quot;:5799}" data-mce-src="/api/ImageRender/DownloadFile?resourceId=b31e35c7-1bec-4483-9aae-cef3b140c4b1&amp;size=3" height="362.4px" name="GNW_RichHtml_IMG" src="https://ml.globenewswire.com/Resource/Download/b31e35c7-1bec-4483-9aae-cef3b140c4b1/image2.png" width="612.06px" /></p>
1835. <ul type="disc">
1836. <li style="margin-bottom:8pt;">Huhtamaki</li>
1837. <li style="margin-bottom:8pt;">Footprint</li>
1838. <li style="margin-bottom:8pt;">Georgia-Pacific</li>
1839. <li style="margin-bottom:8pt;">Stora Enso</li>
1840. <li style="margin-bottom:8pt;">Vegware</li>
1841. <li style="margin-bottom:8pt;">Sabert Corporation</li>
1842. <li style="margin-bottom:8pt;">Novolex (Eco-Products)</li>
1843. <li style="margin-bottom:8pt;">Biopak</li>
1844. <li style="margin-bottom:8pt;">Genpak</li>
1845. <li style="margin-bottom:8pt;">Duni Group</li>
1846. </ul>
1847. <p><strong>Global PFAS-Free Food Packaging Market Segments</strong></p>
1848. <p><strong>By Packaging Type</strong></p>
1849. <ul type="disc">
1850. <li style="margin-bottom:8pt;">Plates, Bowls, and Trays</li>
1851. <li style="margin-bottom:8pt;">Molded fiber trays</li>
1852. <li style="margin-bottom:8pt;">Sugarcane bagasse plates</li>
1853. <li style="margin-bottom:8pt;">Cups and Lids</li>
1854. <li style="margin-bottom:8pt;">Paper cups with PLA/aqueous lining</li>
1855. <li style="margin-bottom:8pt;">Compostable biopolymer lids</li>
1856. <li style="margin-bottom:8pt;">Clamshells and Hinged Containers</li>
1857. <li style="margin-bottom:8pt;">Kraft paper-based</li>
1858. <li style="margin-bottom:8pt;">Plant-based plastics (e.g., PLA, PHA)</li>
1859. <li style="margin-bottom:8pt;">Wraps and Liners</li>
1860. <li style="margin-bottom:8pt;">Grease-resistant paper (non-fluorinated coatings)</li>
1861. <li style="margin-bottom:8pt;">Wax-based or clay-coated paper</li>
1862. <li style="margin-bottom:8pt;">Bags and Pouches</li>
1863. <li style="margin-bottom:8pt;">Bakery bags</li>
1864. <li style="margin-bottom:8pt;">Sandwich wraps Shape, Picture</li>
1865. </ul>
1866. <p><strong>By Material Type</strong></p>
1867. <ul type="disc">
1868. <li style="margin-bottom:8pt;">Molded Fiber and Pulp</li>
1869. <li style="margin-bottom:8pt;">Bagasse (sugarcane fiber)</li>
1870. <li style="margin-bottom:8pt;">Wheat straw</li>
1871. <li style="margin-bottom:8pt;">Bamboo</li>
1872. <li style="margin-bottom:8pt;">Paper and Paperboard (PFAS-free coated)</li>
1873. <li style="margin-bottom:8pt;">Aqueous-coated</li>
1874. <li style="margin-bottom:8pt;">Biopolymer-coated (e.g., PLA, CMC)</li>
1875. <li style="margin-bottom:8pt;">Bioplastics</li>
1876. <li style="margin-bottom:8pt;">Polylactic Acid (PLA)</li>
1877. <li style="margin-bottom:8pt;">Polyhydroxyalkanoates (PHA)</li>
1878. <li style="margin-bottom:8pt;">PBAT blends</li>
1879. <li style="margin-bottom:8pt;">Cellulose-based Films</li>
1880. <li style="margin-bottom:8pt;">Regenerated cellulose</li>
1881. <li style="margin-bottom:8pt;">Coated kraft films</li>
1882. <li style="margin-bottom:8pt;">Others</li>
1883. <li style="margin-bottom:8pt;">Clay-coated substrates</li>
1884. <li style="margin-bottom:8pt;">Bio-waxes Shape, Picture</li>
1885. </ul>
1886. <p><strong>By End-Use Sector</strong></p>
1887. <ul type="disc">
1888. <li style="margin-bottom:8pt;">Quick-Service Restaurants (QSR)</li>
1889. <li style="margin-bottom:8pt;">Burger wrappers, fry sleeves, clamshells</li>
1890. <li style="margin-bottom:8pt;">Retail and Supermarkets</li>
1891. <li style="margin-bottom:8pt;">Bakery trays, meat pads, frozen food wraps</li>
1892. <li style="margin-bottom:8pt;">Cafés and Beverage Chains</li>
1893. <li style="margin-bottom:8pt;">Cups, cup sleeves, lids</li>
1894. <li style="margin-bottom:8pt;">Institutional Catering</li>
1895. <li style="margin-bottom:8pt;">Trays, wraps</li>
1896. <li style="margin-bottom:8pt;">Others</li>
1897. <li style="margin-bottom:8pt;">Airlines, events, schools</li>
1898. </ul>
1899. <p><strong>By Region</strong></p>
1900. <ul type="disc">
1901. <li style="margin-bottom:8pt;">North America
1902. <ul type="circle">
1903. <li style="margin-bottom:8pt;">U.S.</li>
1904. <li style="margin-bottom:8pt;">Canada</li>
1905. </ul>
1906. </li>
1907. <li style="margin-bottom:8pt;">Europe
1908. <ul type="circle">
1909. <li style="margin-bottom:8pt;">Germany</li>
1910. <li style="margin-bottom:8pt;">UK</li>
1911. <li style="margin-bottom:8pt;">France</li>
1912. <li style="margin-bottom:8pt;">Italy</li>
1913. <li style="margin-bottom:8pt;">Spain</li>
1914. <li style="margin-bottom:8pt;">Sweden</li>
1915. <li style="margin-bottom:8pt;">Denmark</li>
1916. <li style="margin-bottom:8pt;">Norway</li>
1917. </ul>
1918. </li>
1919. <li style="margin-bottom:8pt;">Asia Pacific
1920. <ul type="circle">
1921. <li style="margin-bottom:8pt;">China</li>
1922. <li style="margin-bottom:8pt;">Japan</li>
1923. <li style="margin-bottom:8pt;">India</li>
1924. <li style="margin-bottom:8pt;">South Korea</li>
1925. <li style="margin-bottom:8pt;">Thailand</li>
1926. </ul>
1927. </li>
1928. <li style="margin-bottom:8pt;">Latin America
1929. <ul type="circle">
1930. <li style="margin-bottom:8pt;">Brazil</li>
1931. <li style="margin-bottom:8pt;">Mexico</li>
1932. <li style="margin-bottom:8pt;">Argentina</li>
1933. </ul>
1934. </li>
1935. <li style="margin-bottom:8pt;">Middle East and Africa (MEA)
1936. <ul type="circle">
1937. <li style="margin-bottom:8pt;">South Africa</li>
1938. <li style="margin-bottom:8pt;">UAE</li>
1939. <li style="margin-bottom:8pt;">Saudi Arabia</li>
1940. <li style="margin-bottom:8pt;">Kuwait</li>
1941. </ul>
1942. </li>
1943. </ul>
1944. <p><strong>Invest in Our Premium Strategic Solution: </strong><strong>https://www.towardspackaging.com/price/5666</strong></p>
1945. <p><strong>Become a Valued Research Partner with Us &#8211; Schedule a meeting: </strong><strong>https://www.towardspackaging.com/schedule-meeting</strong></p>
1946. <p><strong>Request a Custom Case Study Built Around Your Goals: </strong><strong>sales@towardspackaging.com</strong></p>
1947. <p><strong>About Us</strong></p>
1948. <p>Towards Packaging is a global consulting and market intelligence firm specializing in strategic research across key packaging segments including sustainable, flexible, smart, biodegradable, and recycled packaging. We empower businesses with actionable insights, trend analysis, and data-driven strategies. Our experienced consultants use advanced research methodologies to help companies of all sizes navigate market shifts, identify growth opportunities, and stay competitive in the global packaging industry.</p>
1949. <p><strong>Stay Connected with Towards Packaging:</strong></p>
1950. <ul type="disc">
1951. <li style="margin-bottom:8pt;"><strong>Find us on Social Platforms: </strong><strong>LinkedIn</strong><strong> | </strong><strong>Twitter</strong><strong> | </strong><strong>Instagram</strong></li>
1952. <li style="margin-bottom:8pt;"><strong>Subscribe to Our Newsletter: </strong><strong>Towards Sustainable Packaging</strong></li>
1953. <li style="margin-bottom:8pt;"><strong>Visit Towards Packaging for In-depth Market Insights: </strong><strong>Towards Packaging</strong></li>
1954. <li style="margin-bottom:8pt;"><strong>Read Our Printed Chronicle: </strong><strong>Packaging Web Wire</strong></li>
1955. <li style="margin-bottom:8pt;"><strong>Get ahead of the trends – follow us for exclusive insights and industry updates: </strong><br /><strong>Pinterest</strong><strong> | </strong><strong>Medium</strong><strong> | </strong><strong>Tumblr</strong><strong> | </strong><strong>Hashnode</strong><strong> | </strong><strong>Bloglovin</strong> <strong>| </strong><strong>LinkedIn – Packaging Web Wire</strong></li>
1956. <li style="margin-bottom:8pt;"><strong>Contact: APAC: +91 9356 9282 04 | Europe: +44 778 256 0738 | North America: +1 8044 4193 44</strong></li>
1957. </ul>
1958. <p><img alt="" src='https://ml.globenewswire.com/media/ODJmYzZkOTgtYTJlYS00NDQxLWJhNTgtYTdiZjUxYWI1NjIwLTEyMTM4NDktMjAyNS0wOS0wMS1lbg==/tiny/Precedence-Research.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.</p>
1959. ]]></content:encoded>
1963. </item>
1964. </channel>
1965. </rss>
1966.  

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

1. Download the "valid RSS" banner.

2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

3. Add this HTML to your page (change the image src attribute if necessary):

   <a href="http://www.feedvalidator.org/check.cgi?url=https%3A//indiachron.com/feed/"><img src="valid-rss-rogers.png" alt="[Valid RSS]" title="Validate my RSS feed" /></a>

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=https%3A//indiachron.com/feed/

Home · About · News · Docs · Terms